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Abstract 
Chemical glycopeptide synthesis requires access to gram quantities of glyco-amino 
acid building blocks. An efficient and fast synthetic route has been developed for 
such building blocks (111, 116, 118, 120, 122, 124, and 126) with high yields using 
microwave-assisted Kochetkov amination as a key reaction. The resulting glyco-
amino acid building blocks (116 and 118) were successfully incorporated into target 
glycopeptides (127 and 128) by Fmoc-solid phase peptide synthesis (SPPS) and were 
characterized by LC-MS and FIRMS (FAB). 
The glycopeptides were used to investigate the effect of glycosylation on enzymatic 
cleavage of peptide bonds. At first, enzyme-cleavable linkers for solid-phase peptide 
and glycopeptide synthesis were developed. The hydroxymethylphenoxy linker 
(Wang Linker) commonly used in solid phase synthesis was surprisingly susceptible 
to efficient cleavage by the serine protease chymotrypsin. In order to investigate this 
observation further a broad range of amino acid residues were coupled to PEGA 1900 
resin using the Wang linker (153-161) and subsequent treatment with chymotrypsin 
gave cleavage of the amino acids (162-170) from the resin in quantitative yields. A 
similar strategy was also applied to a glyco-tripeptide (178) and again chymotrypsin 
hydrolysis gave glycopeptide (179) in quantitative yield. It was also established that 
not only the acid-labile linker (HMPA) but also base labile (HMBA) and unreactive 
ester (HOA) linkers could be cleaved using chymotrypsin. 
The solid supported peptide (200) and glycopeptides (201-206) were then used to 
study the effect of glycosylation on proteolytic hydrolysis of peptides with two 
different proteases such as chymotrypsin and thermolysin. Our hydrolysis results in 
Abstract 
combination with those of others show that protection from hydrolysis is highly 
dependent on the individual protease and on the position of the glycosylation site in 
respect to the scissile bond. 
The second part of the project was concerned with the total chemical synthesis of 
homogeneous and structurally defined proteins and glycoproteins. Synthesis of 
membrane co-factor protein module 1 (233) was achieved using Fmoc-SPPS and 
native chemical ligation strategies. The final product was characterized by LC-MS 
and gel electrophoresis. 
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Chapter i 	 Introduction 
1. Background and Introduction 
1.1 Introduction to Glycoproteins 
Glycoproteins are an important class of biomacromolecules that are biosynthesized 
through post-translational modification of proteins.' Oligosacchardes covalently 
linked to proteins can intensely affect protein folding, stability, immunogenicity, and 
biological activity. 1,1,4,1,6  In addition, glycoproteins have important clinical roles in 
the contexts of vaccines, 7 diagnostics, 8 and therapeutics. 9 
Glycoproteins isolated from natural sources exist as a heterogeneous mixture of 
glycoforms,' °  protein molecules which differ in the structures of the bound 
oligosaccharides. Such glycoform mixtures are not suitable for structural and 
functional analysis. The isolation of homogeneous glycoproteins from natural 
sources in significant quantity is extremely difficult. 1 ' To understand the relationship 
between oligosacchande structure and glycoprotein function, homogeneous 
glycoproteins containing well-defined oligosaccharide structures must be obtained. 
Homogeneous and structurally well defined glycoproteins can be obtained from total 
chemical synthesis.' 2 
15 
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1.2 Structure of Glycoprotein 
AGtu. •Fi,cce • Mm,oe • al.min 
Figure 1: Structure of Glycoprotem (For example, Erythropoietin contains an 0-linkage at Ser' 26 and 
N-linkages at Asn24, Asn38, Asn83, reproduced from Warren, J. D et al. J. Am. Chem. Soc. 2004, 126, 
6576-6578). 
Structurally, a glycoprotein (figure 1) consists of a polypeptide covalently linked to 
an oligosaccharide moiety. The oligosaccharide can make up anywhere from less 
than 1 % to more than 80 % of the total protein mass. The saccharide chains 
referred to as a glycans can be linked to the polypeptide in two major ways. The 
predominant carbohydrate attachment in glycoproteins of mammalian cells has 
shown to be via N-glycosidic linkage, with glycans linked to proteins via a glycosyl 
amidic linkage to asp aragine residues.' 3 
The site of N-glycosylation in N-linked glycoproteins is characterized by a tripeptide 
codon Asn-X-Ser/Thr (where X could be any amino acid except proline). 
Structurally, the N-glycan (1) contains a common core pentasaccharide at the 





Substructures of N-glycans are classified according to further branching; for 
example, hybrid type, high mannose type, and complex type. 
H 
Figure 2: Structure of Glycan of N-Linked Glycoproteins. 
Next to the N-glycans, the second large groups are the O-glycans, which are linked to 
protein hydroxyl groups of serine or threonine residues. 
14 O-Glycans are generally 
shorter oligomers than N-glycans and are classified by a number of conserved cores, 
for example, the O-glycan core 2 contains a typical core II trisaccharide with N-
acetylgalactosamine at the reducing end 
15  (figure 3). 
Figure 3: Structure of Glycan of 0-Linked Glycoproteins. 
17 
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1.3 Synthetic Strategies for Glycopeptides and Glycoproteins 
The methodology for the chemical synthesis of peptides and small proteins of 
defined amino acid sequence has been the subject of investigation for more than five 
decades. In contrast, the chemical synthesis of glycopeptides is less developed. 
However, significant advances in glycopeptide assembly have been achieved in the 
complex area of glyco-conjugates. 
Naturally, the construction of the peptide moiety of a glycopeptide depends upon the 
established chemistry of pure peptide synthesis. However, the chemical sensitivities 
of the carbohydrate must also be taken into account. The sugar may be present during 
the synthesis as only a minimum monosaccharide, such as in simple glyco-amino 
acid building block, or the carbohydrate moiety may be added to the peptide at a later 
stage of the synthesis. 
A glycopeptide can theoretically be constructed in at least five different strategies' 
6,17 
(figure 4). 
Strategy 1: Strategy 1 is also known as the building block approach. In this 
approach, a suitably protected derivative of the appropriate amino acid is first linked 
to a mono- or disaccharide derivative. The resulting glyco-amino acid building block 
is then usually incorporated into the N-terminus of a growing peptide chain. 
Alternatively, the building block may undergo peptide chain extension in solution at 
Chapter 1 	 Introduction 
its N- or C-terminus. This strategy has been the one most reported in the literature for 
the synthesis of N-linked glycopeptides in solution 
18  or by solid phase 
synthesis"' 9,20,21  and for the synthesis of 0-linked glycopeptides by solution 
22,23 or 
solid phase synthesis. 24,25 
Strategy 2: An alternative strategy is extension of the carbohydrate portion of a 
glyco-amino acid building block, followed by peptide extension. 
26,27 
Strategy 3: A further approach is to first construct the oligosaccharide and then 
couple to a suitably protected derivative of an amino acid or a short peptide (di- or 
tn-), followed by peptide extension of this intermediate glycopeptide. 28 '29 
Strategy 4: in this approach, a suitably protected derivative of the appropriate 
amino acid is first linked to a mono- or disaccharide derivative. The resulting glyco-
amino acid building block is then usually incorporated into the N-terminus of a 
growing peptide chain. Subsequently, the carbohydrate portion of the glycopeptide 
undergoes extension, mostly by enzymatic method 
.30,31 
Strategy 5: Strategy 5 is also known as the convergent approach. Here, the desired 
carbohydrate and peptide chain are constructed independently, and the glycopeptide 





These five strategies have shown schematically in figure 4 and specific examples are 
given in the following paragraph. 
	
I_Amino acid I 	 Glyco-Amino Acid' 	 I Mono / Disaccharide I 
Building Bloc 
Strategy 1 Extend Peptide 
Minimum Carbohydrate-Peptide 	 Oligosaccharide 








Extend Peptide 	 Convergent 





Mono I Disaccharide 	 OIigosaccharide 	I 
Figure 4: Possible Synthetic Strategies for Glycopeptide Synthesis. 
The effort in the development of synthetic methods for model glycopeptides has been 
directed towards the synthesis of those having a relatively small carbohydrate 
component using the building block approach. However, in recent years, the need has 
arisen for glycopeptides containing more complex oligosaccharide moieties. 
20 
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1.3.1 Chemical Synthesis of Glycopeptides and Glycoproteins 
Synthesis of homogeneous glycopeptides could greatly enhance insight into 
glycobiology.6  The prospect of total chemical synthesis of homogeneous 
glycoproteins provides the best option for gaining access to such structures. Several 
methods have been reported for glycopeptide synthesis. Glycans have been 
introduced into peptides by means of amino acid 'cassettes' with protected 
saccharides, 35  through enzymatic manipulations of glycopeptides, 36 '37 or by 
conjugation of fully elaborated, complex saccharides to short synthetic peptides. 
38 
Bertozzi and co-workers have extended the 'cassette' approach by applying native 
chemical ligation to the synthesis of a biologically active glycoprotein with two 
single-residue 0-linked glycans. 12 Hojo et al. have reported the synthesis of a 
glycopeptide domain of Emmprin, which contains as N-linked chitobiose unit, by 
fragment condensation method .39 
1.3.2 Chemical Synthesis of N-Linked Glycopeptides 
Several groups have been working on the chemical synthesis of simple to complex 
N-linked type glycopeptides. Recently, Imperiali and co-workers 2 ' have reported an 
improved synthesis of a chitobiose-asparagine building block by modifying the 
Kochetkov amination conditions and this was subsequently incorporated into a 39 
residue peptide by Fmoc-SPPS. Chitobiose was obtained from chitin by enzymatic 
digestion with chitinase at pH 6.2 and subsequent crystallization of the acetyl- 
21 
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protected carbohydrate followed by Zemplen hydrolysis to afford 3. In the next step 
the substrate, 3 was treated with ammonium carbamate in methanol and then freeze 
dried to afford fl-chitobioseamine 4 in 76 % yield. Subsequently, the intermediate 4 
was treated with Fmoc-Asp-OA11 under HBTU/HOBt in DIv[F activation conditions. 
In the next step all hydroxyl groups were capped with TBDMS followed by removal 
of the allyl group by Pd (0) to afford glyco-amino acid building block 5 in 56 % 
overall yield (scheme 1). 




2. Chitinase, pH 6.2, 	
AcHN phosphate buffer cHN OH 
AcO, NaOAc 	 3 
NaOMe, MeOH 
4. Ammonium carbamate, 
MeOH, then high vacuum 
OH 	 OH OH 	 6. Fmoc-Asp-OAII, OH 
HBTU, HOBt, DMF 
0 	 NH 	7. TBDMS-OTt, AcHN 
AcHN 	 DMAP, pyridine 	 AcHN 
5 	 8. Pd(PPh3)4 , PhSiH3, DCM 	 4 
/ 
FmocHN CO OH 
Scheme 1: Synthesis of Chitobiose-Asparagine Building Block 5 (Reproduced from Imperiali, B etal. 
J. Org. Chem. 2005, 70, 3574-3578). 
The resulting building block 5 was incorporated into a C-peptide analogue, which 
plays an important role in unglycosylation form, on inhibition of HIV membrane 
fusion process by binding to the viral envelope glycoprotein gp 41.40 The C-peptide 
consists of 39 amino acid residue and includes a natural glycosylation sequon from 
positions 14-16.' The peptide Y15-G39 was synthesized on a TentaGel resin by 





synthesizer and the glyco-amino acid building block was incorporated under 
PyAOP/collidine activation by manual coupling conditions. The glycopeptide 6 was 
cleaved from the resin using cocktail K, subsequently purified by preparative HPLC 
and analysed by MALDI (scheme 2). 
Ac-GHTTWMEWDR El N NYTS L  HSLI E ESQNQQ EKN EQ E LLG 
Glycosylation site 
H2N — Q 
5, PyAOP, collidine, DCM 






AcHN 	 NH 
AcHN 0 
AcHN—[ 	]NXCONH CONH2 
H 
6 
Scheme 2: Fmoc-SPPS of Glycosylated C-Peptide Analogue of Gl-G 39. 
Complex N-linked glycopeptides are commonly synthesized by a cassette method, 
where a glyco-amino acid is incorporated into a growing peptide using Fmoc based 
SPPS. The glyco-amino acid building block 8 is generally prepared by coupling of a 
reactive glycosylamine 7 with an activated ester of aspartic acid. The glycosylamines 






OP 	 OP 	 OP 




AcHN OH 	 AcHN 	 PHN COOP 	 AcHN 	
0 
7 	 8 
P = protecting group 	 PHN COOP 
R = H, oligosaccharide 
R1 = activated ester 
Scheme 3: General Synthetic Strategy for Glycosylated-Asparagine Building Blocks. 
Ogawa and co-workers have successfully applied this methodology to produce a 
synthetic CD52 glycopeptide with a core pentasaccharide of N-glycan. 42 
Monosaccharide building blocks were assembled to afford the fully protected azido-
pentasaccharide 9, which was then converted to the corresponding glycosylamine by 
using Lindlar's catalyst in the presence of hydrogen gas. Subsequently, the 
glycosylamine was coupled to an activated aspartic acid under DCC/HOBt activation 
conditions followed by tert-butyl ester hydrolysis using TFAIDCM to afford a fully 
protected glyco-amino acid building block 10. The resulting building block 10 was 
incorporated into CD52 peptide by standard Fmoc-based SPPS by activation with 
DCC/HOBt on a Wang resin using automated peptide synthesis. The cleavage of 
glycopeptide from the resin was performed with a mixture of TFAIEDT to afford 





OBn 	 Bn 
HO F 
NPhth 	 NPhth 







Fmoc-Asp-OtBu, HBTIJ. HOBt, 
DIPEA, DMF 
TFNDCM 
I Fmoc-SPPS on Wang resin 
Scheme 4: Synthesis of CD52 Glycopeptide by Fmoc-SPPS. 
Another strategy for the synthesis of glycosylamine is the condensation of a free 
reducing sugar with ammonium bicarbonate, commonly known as Kochetkov 
amination44 (scheme 5). Detailed discussion of Kochetkov amination will follow in 
chapter 2 of this thesis. 
OH 	 OH 
NH4HCO3 (sat) 




R = H, oligosacchande 




Several groups have used the resulting glycosylamines in the synthesis of glyco-
amino acid cassettes. 45 ' 46  The convergent coupling of glycosylamines to aspartyl side 
chains of a protected peptide has also been achieved. Danishefsky and co-workers 
have applied this convergent approach to short peptides containing large N-linked 
glycans. Pentasaccharide 13 was achieved by glycal assembly method 
46  and 
subsequently, converted to glycosylamine 14 by Kochetkov amination conditions. 
The resulting glycosylamine 14 was coupled to a pentapeptide 15 in a convergent 
fashion, using HATU/HOBt activation conditions to afford glycopeptide 16 (scheme 
6). These synthetic achievements have facilitated landmark studies of the 





HO 	several steps 
HO 







AcHN 	 AcHN 
14 	
= deprotected tetrasaccharide 
13 
COOK 	OH 
HATU, HOBt, DMF 
AcHN 
o H 0 H o 
15 
Scheme 6: Convergent Synthesis of N-Linked Glycopeptide 16. 
In a different approach, Danishefsky and co-workers have reported a convergent 
synthesis of an N-linked glycopeptide, which was extended to a glycoprotein by 
native chemical ligation. 20 The synthesis of trisaccharide 17 of the N-glycan was 
achieved by glycal assembly from number of steps. 
1,46  Subsequently, the reducing 
sugar 17 was treated with ammonium bicarbonate to afford 18. The resulting 
glycosylamine 18 was treated with a pre-activated pentapeptide 19 with 
HATU/DIPEA in DMSO to afford glycopeptide 20 as a fl-linked isomer, and this 




overall 70 % yield. In addition to the desired product, the side product aspartimide 
formation was also observed in this case. 
OH 	OH 	 OHHO 
HO-0 Glycal assembly 
























21 	 I 	Excess SHCH2CH2SO2Na, 









Scheme 7: Synthesis of N-Linked Glycopeptide 22 by Native Chemical Ligation. 
The peptide thioester 21 was obtained by employing Fmoc-SPPS on a PEG-type 
Wang resin method reported by Hilvert et al.47 The cleavage of the peptide was 
achieved with trimethylaluminium and EDT in DCM to afford thioester 21. Ligation 
M. 
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of 20 and 21 was performed in aqueous PBS, 0.2 M in both saline and phosphate, pH 
7.4, in the presence of excess sulfanylethane-2-sulfonate to afford glycopeptide 22 
(scheme 7). Similar synthetic strategy was also applied to a pentasaccharide 
containing pentadodecyl glycopeptide. 
1.3.3 Chemo-enzymatic Synthesis of N-Linked Glycopeptides 
Chemical synthesis performed with additional enzymatic extension is now widely 
used approach for the synthesis of N-linked type glycopeptides. To understand the 
effect of an N-linked glycan on local peptide conformation, the Imperiali and 
Yamamoto groups have undertaken the synthesis of glycosylated fragments of the 
extracellular domain of nicotinic acetylcholine receptor (nAChR). 48 Haneda and co-
workers have applied an enzyme in their synthesis of glycosylated versions of 
calcitonin, a 32 amino acid residue hormone, which regulates calcium levels. 
49  In 
order to investigate the effect of glycosylation at a potential N-linked site, a 
glycopeptide containing a single G1cNAc residue on the Asn of the triplet sequence 
was synthesized. Transglycosylation by Endo-M using a di-sialo transferring glyco-
amino acid (STF-GP) as the glycosyl donor gave the desired glycosylated calcitonin 
















Scheme 8: Chemo-Enzymatic Synthesis of Calcitonin Derivative 23 as Complex N-Linked 
Glycopeptide. 
1.3.4 Synthesis of Glycopeptide Mimetics by Chemoselective 
Ligation Reaction 
Chemoselective ligation reactions are an attractive way of assembling glycopeptide 
mimetics by convergent coupling of unprotected oligosaccharides with cognate 
functionalized peptides. Several groups have reported the unique reactivity of 
cysteine residues to chemoselectively ligate a-haloacetmido by Flitsch et a150 or 




non-native sugar-peptide linkages (figure A & B of 5). In a different approach 
Boons52 and Davis et al.  53  have utilized the sulfhydryl group on the side chain of 
cysteine residues to form a disulfide bond to the carbohydrate fragment (figure C of 
5). These strategies allow the site-specific attachment of glycans, if no other thiols or 
disulfide bonds are present on the protein. 
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Figure 5: Chemoselective Modification of Cysteine Side Chains in Assembly of Glycopeptide 
Mimetics. 
1.3.5 Chemical Synthesis of 0-Linked Glycopeptides 
Synthesis of mucin-type glycopeptide is usually achieved by incorporation of a 
suitably protected O-glyco-amino acid into a peptide by SPPS. Of the two standard 
methods reported in the literature, Fmoc-strategy is more often used than Boc- 
31 
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strategy for the SPPS of glycopeptides. The sequential removal of base-labile Fmoc 
protecting group for peptide extension is compatible with the presence of acid labile 
glycosidic bonds, avoids repeated exposure to TFA and final protection with HF, 
common to Boc-based methods. 
The a-O-GalNAc-Ser/Thr building blocks required for SPPS of mucin-type 
glycopeptides are usually synthesized by glycosylation on the appropriate serine or 
threonine alcohol acceptor. The use of a 2-azido halo- or thioglycoside donor ensures 
high a-selectivity in the glycosylation reaction. 
54 Conversion of azido group to N-
acetamido group provides the Fmoc-Ga1NAc-Ser/Thr building blocks 24 and 25, 
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Figure 6: Synthesis of a-0-Ga1NAc-Ser 24 and Thr 25 Building Blocks. 
The major problem in the synthesis of complex 0-linked glyco-amino acids is 
obtaining high a-selectivity in the formation of the O-Ser/Thr mucin type linkage. 
This selectivity problem for complex structures is avoided by formation of the 
desired a-0-Ser/Thr linkage prior to addition of branching residues onto the core 




27. Rather than uniform protection with benzoyl or acetyl esters, having orthogonally 
removable protecting groups on the C-3, C-4 and C-6 hydroxyl groups of a-0- 
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Figure 7: Synthesis of Complex 0-Linked Glyco-Amino Acids for SPPS of Serine and Threonine 
Cassettes 26 and 27. 
Danishefsky and co-workers have used the cassette based approach for generating a 
variety of different complex 0-linked glyco-amino acids bearing tumour related 












were prepared from appropriate threonine and serine cassettes for the synthesis of 0-
linked glycopeptides (figure 8). Variants of the glycopeptide 28 bearing Tn, TF, and 
2,6-STF antigens were designed for generating anti-tumour vaccines 
56  and were also 
used for NMR structure determination of the CD43 mucin domain. 
57 The clustered 
TnITF glycoforms of 28 and other glyco-conjugates have been evaluated as vaccines 
for prostate cancer and 29 has advanced into ovarian cancer trials. 
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Figure 8: Glycopeptides Prepared by Cassette Synthesis Bearing Tumour-Associated Antigens Tn, 
TF, and 2,6-Sialyl TF (STF) on 28 and a Mucin Domain of CD43, and Lewis y Antigen on 29. 
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The cassette-based approach to glycopeptides has proven to be an effective way of 
generating the mucin-type glycopeptides. Recent developments in oligosaccharide 
synthesis, such as automated solid-phase synthesis 58 and programmable one-pot 
synthesis methods '59  should accelerate the production of glyco-amino acids for the 
synthesis of complex 0-linked glycopeptides. 
1.3.6 Synthesis of 0-Linked Glycoproteins by Native Chemical 
Ligation 
The methods described above for the synthesis of 0-linked glycopeptides are for 
relatively short glycopeptides (nearly 20 amino acid residue). Natural mucin-type 
oligosaccharides that are present on proteins exceed this size limit. To achieve these 
longer peptides and proteins, the coupling of peptide segments by native chemical 
ligation (NCL) strategy has been widely used. Details of the native chemical ligation 
will follow in chapter 5 of this thesis. NCL is efficient, highly selective, and the 
reaction conditions are compatible with carbohydrates and native proteins. Bertozzi 
et al. 60  have reported the total chemical synthesis of 0-linked glycoproteins such as 
Lymphotactin by NCL. 
Lymphotactin (Lptn) is a 93-amino acid residue chemokine that serves as a potent 
chemo-attractant for both T cells and natural killer cells, with a small mucin-like 
domain located at its C-terminus. The structure organisation of Lptn is divided by the 




30 and a 46-residue glycopeptide 31 with an eight a-Ga1NAc residue contained 
cysteine fragment. The thioester 30 was synthesized using Boc-SPPS, and Fmoc-
based synthesis with a-0-Ga1NAc-Ser/Thr afforded the mucin domain 31 of 
lymphotactin. Ligation of the two fragments 30 and 31 gave the glycosylated 
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Figure 9: Synthesis of Glycosylated Lymphotactin 32 using Native Chemical Ligation (Reproduced 
from Marcaurelle etal. Chem. Eur. J. 2001, 7, 1129-1132). 
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1.4 Solid Phase Peptide Synthesis 
1.4.1 General Introduction 
The classical solution phase synthesis of peptides yielded great success in the 
preparation of several biologically active peptides. 61 However, these procedures are 
not ideal for the synthesis of longer peptides because of the difficulties with 
solubility and purification. To overcome this limitation Bruce Merrifield introduced a 
solid phase peptide synthesis strategy, which was initially applied for the synthesis of 
a tetrapeptide. 62 
The concept of the SPPS is illustrated by figure 10, where the first protected amino 
acid was attached to an insoluble polystyrene solid support via an acid labile linker. 
The amino acids were protected by a temporary acid labile protecting group (Boc) on 
the a-amino acid position and by an acid stable benzyl type protecting group on the 
functionality of the side chain. The Boc group was removed by treatment with TFA 
followed by in situ neutralisation. In the next step the protected amino acid was 
coupled to an amino peptide resin in the presence of an activator. The deprotection 
and coupling steps were repeated until the desired peptide sequence was assembled. 





Attach to linker 	H 	
0 
CU e -1ppOrt 	 x N 
HjX , . OH 	 V 
Remove X and couple 
'I' 	 next protected amino acid 
Z  
Repeat the deprotection 	 R2




0 	R2 	0 	 Cleavage of peptide 	0 	R2 	0 
X(N%N 1f 	o_(kcr—[iw0rt 
from linker 	(H2NkN )NAOH 
Rn 
H o 1 	 H o li 
V 
Figure 10: Representation of Solid Phase Peptide Synthesis (SPPS). 
1.4.2 Fmoc-SPPS Strategy 
The SPPS strategy with a temporary base-labile a-amino acid protecting group, 9-
fluorenylmethoxycarbonyl (Fmoc) was introduced by Carpino et al.63 The Fmoc 
strategy is based on an orthogonal protecting group strategy, using the Fmoc group 
for the protection of the a-amino group and acid-labile, side-chain protecting group 
and resin linkage. Fmoc-based SPPS provides an alternative to the Boc-SPPS 
strategy and offered the advantage of a mild acid cleavage process. The Fmoc group 
is stable towards acidic reagents, however it can be cleaved under certain basic 
conditions. Piperidine is the routinely used reagent for the deprotection of Fmoc 
group at room temperature via an Elcb elimination mechanism (figure 11). 




33 0 	34 
Figure 11: Mechanism for Fmoc-Deprotection. 
The 	dibenzocyclopentadienide 	33 	produced 	from 	the 	stabilized 
dibenzocyclopentdienide anion form the adduct 34 on reaction with excess 
piperidine. The fulvene piperidine adduct 34 has a strong UV absorbance at 301 nm 
and this property has been used in developing a system for monitoring the efficiency 
of each coupling step in Fmoc-SPPS. 
Generally, in Fmoc-SPPS, the first amino acid is coupled to the linker via an ester 
linkage to the hydroxyl function of the linker. Subsequently, the Fmoc group of the 
amino acid is cleaved under 20 % piperidine in DMF. After appropriate washings, 
the second Fmoc-amino acid is coupled either by symmetrical anhydride formation, 
or by the use of several different activators. These sequences of events are repeated 
until the target sequence is obtained. The completed peptide is then cleaved from the 
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Scheme 9: Representation of Fmoc-SPPS for a Dipeptide. 
1.4.3 First Amino Acid Residue Attachment 
The first step in SPPS is the attachment or loading of a C-terminal amino acid onto 
resin. The esterification of the first amino acid to the hydroxyl group on the resin is 
one of the key steps to produce a high quality peptide. Incomplete loading and 
enantiomerisation lead to truncated and epimerised peptides, respectively. The 
Rol 
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commonly used loading methods are the HOBt active esters and symmetrical 
anhydrides. The enantiomerisation problem is most serious with cysteine and 
histidine, and for these residues the use of trityl-based resins is recommended as 
these are loaded under conditions which do not cause enantiomerisation. 
Peptides containing proline or N-alkylated amino acids in the C-terminal dipeptide 
sequence present problems because these dipeptides cyclize to give the 
corresponding diketopiperazine 64  (figure 12). This may lead to the generation of 
truncated sequences through the acylation of the generated starting resin. The 
formation of this side reaction is most problematic but can be avoided using a 
hindered trityl resin. 
0 (Th 	 o __ 
0 	____ 
N H '—N N-R2 + HO—O 
0 	R12 	 R1 
Figure 12: Representation of Diketopiperazme Formation. 
1.4.4 Activation and Coupling 
The formation of an amide bond involves the activation of the carboxyl group of an 
amino acid. In order to convert the carboxyl acid into acylating agents their hydroxyl 
groups must be replaced with an electron withdrawing group, X, in order to increase 
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Figure 13: Acylation of an Amino Acid: Coupling. 
The activation of an amino acid carboxyl function with an electron withdrawing 
group, X (35), can lead to the racemisation of the peptide. The mechanism of 
racemisation of a peptide involves the formation of oxazolone 36, and 38, on 
treatment with a base. The oxazolones are themselves activated carboxylic acid 
derivatives and reaction with an amine can lead to the formation of the peptide. 
Racemisation via the stabilised anion of 37 occurs more rapidly than aminolysis and 
both possible epimers 39 and 40 are formed (figure 14). 
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1.4.5 Symmetrical Anhydrides 
Symmetrical anhydrides are usually prepared from the two equivalents of amino acid 
derivative reaction with one equivalent of carbodiimide. Carbodiimides are among 
some of the most popular activating reagents for the peptide synthesis. N,N'-
Dicyclohexylcarbodiimide (DCC) 65  and NM-diisopropylcarbodiimide (DIC) 66 are 
extensively used in SPPS. The major drawback with the DCC activation is the 
formation of an insoluble dicycohexyl urea as by-product. In order to avoid this by-
product formation the DIC is often used in SPPS. 
The peptide coupling can be achieved by activation of carboxyl function of the a-
amino acid with the carbodiimide to form an O-acylurea 41. The intermediate 41 
reacts with different functionalities such as amines, alcohols, and acids to form 
amides 42, active ester 43, and symmetrical anhydrides 44, respectively (figure 15). 
The amide 42 can also be achieved by reaction of amine with an active ester 43 and 
symmetrical anhydride 44. 
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Although the activation via carbodiimide results an acylating agent 41 with greater 
reactivity than 43 and 44, this method of activation can lead to side reactions such as 
racemisation, carboxamide dehydration of asparagine and glutamine and also to the 
formation of N-acyl urea (figure 16). 
A = Carboxamide Dehydration of Asparagine 
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Figure 16: By-product Formation via DIC Activation Method. 
1.4.6 Active Esters 
The coupling rates of activated esters are usually slower than those of the 
















symmetrical anhydrides, such as, no amino acid waste and minimal side reactions. A 












Figure 17: Commonly Employed Coupling Reagents in Fmoc-SPPS. 
1.4.6.1 HOW Active Esters 
Hydroxybenzotriazole (HOBt) was first introduced into the peptide synthesis as an 
additive to the carbodiimide method to prevent racemisation, and forms an active 
ester in Fmoc-SPPS. HOBt esters of protected amino acids are easily formed for 
example DICIHOBt. HOBt esters can also be formed from phosphonium or uronium 
derivatives, for example BOP, 67 PyBOP, 68 TBTU,69 and HBTU (figure 17). The 
phosphonium reagent BOP is an excellent peptide coupling reagent. However, the 
formation of the carcinogenic hexamethyiphosphorictriamide (HMPA) by-product 




reagents, such as phosphonium salt HBTU and uronium salt TBTU and amongst 
others were introduced. The general mechanism of TBTU activation of an amino 
acid is highlighted in figure 18. 
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Figure 18: Mechanism of Peptide Bond Formation by TBTU Activation. 
1.4.7 Cleavage and Removal of Side Chain Protecting Groups 
Fmoc-SPPS is designed for simultaneous cleavage of the anchoring linkage and 
global deprotection of side chain protecting groups with TFA. The most commonly 
used cleavage cocktail is reagent K (TFAlthioanisole/water/phenoIJEDT) 
(82.5:5:5:5:2.5). The general cleavage choice of cocktail for the Fmoc-SPPS is 
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Figure 19: Flow-Chart for Selection of Cleavage Cocktail for Fmoc-SPPS (Reproduced from 
Novabiochem catalogue 3.16). 
1.5 Project Objectives 
Consequently, the main aim of our project was to develop an efficient method that 
would give us access to gram scale synthesis of glycosylated-asparagine building 
blocks for the synthesis of natural N-linked type glycopeptides and a number of their 
analogues by using Fmoc-SPPS. 
In addition to the Fmoc-SPPS of peptides and glycpeptides, we were also interested 
in investigating the proteolytic hydrolysis of such peptide and glycopeptide 




The development of enzyme cleavable linkers for peptide and glycopeptide synthesis 
was a further aim of the project. 
In addition to the above aims, we also wished to investigate the chemical synthesis of 
proteins and glycoproteins using Fmoc-SPPS and native chemical ligation. In 
particular, the total chemical synthesis of membrane co-factor protein modules. 
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2. Synthesis of Glyco-Amino Acids and Glycopeptides 
2.1 Introduction 
The importance of carbohydrates in biological recognition has been evaluated 
extensively in the last three decades. 
56,70,71,72 It is estimated that more than half of all 
proteins carry carbohydrate side chains, with the majority being N-glycans linked to 
asparagine residues that are part of the Asn-X-Ser/Thr tripeptide codon for N-
glycosylation. 73  The influence of carbohydrate chain on the stability and activity of 
glycoproteins is not much understood because of the heterogeneity of glycoprotein 
samples obtained from biological systems. 
N-Glycan can influence glycoprotein structure and activity in many ways. An 
interesting question is the role of highly conserved pentasaccharide core of N-glycans 
(figure 2). Recent NIMR and crystallographic results revealed that the core 
pentasaccharide of N-glycans especially the first two N-acetylglucosamine residues, 
can have important interactions with polypeptide backbone and be responsible for 
stabilization of the active protein structure. 74 '75 
To address questions of the structure activity relationship of N-glycans, we were 
seeking to develop synthetic methods that would give us good access to 
glycopeptides carrying natural N-glycans structures and a number of specific 
analogues. Previously, two different approaches have been employed for the 
49 
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synthesis of glycopeptides. One strategy introduces the carbohydrate as part of a 
glyco-amino acid building block during solid phase synthesis of the peptide chain 
reported by Melda1 38 and Kunz et al.76 
Meldal and co-workers 38 have reported the synthesis of glycosylated-asparagine 
building blocks 73-79. The syntheses of /3-glycosyl amines 52-58 were achieved by 
treating reducing sugars 45-51 with NaHCO3 using Kochetkov amination conditions. 
The resulting glycosyl amines 52-58 were reacted with pre-activated aspartic acid 
derivative of Fmoc-Asp(ODhbt)-O tBu (2 eq) and DIPEA (1.2 eq) in DMSO, 
followed by preparative HPLC purification affording precursors of glycosylated-
asparagines 59-65. In the next step free hydroxyl groups of 59-65 were capped as 
acetates, using Ac 20 and pyridine conditions gave fully protected glyco-amino acid 
building blocks 66-72. Finally, the tert-butyl ester of 66-72 was hydrolyzed with 
TFA treatment followed by preparative HPLC to afford glycosylated-asparagine 
building blocks 73-79 (scheme 10). The building blocks 73-79 were incorporated 
into the target peptide VITAFNEGLK [mouse haemoglobin-derived decapeptide Hb 
(67-76)] by Fmoc-SPPS on a PEGA linked to acid-labile HMPA linker and pre-
activated Fmoc-amino acid in DMF. The major draw back of this methodology is 
preparative HPLC purification of glycosylated-asparagines, which might not suitable 
for gram scale synthesis of building blocks. Incorporation of fully acetylated glyco-
amino acid building blocks 73-79 into peptide by Fmoc-SPPS, and subsequent 
removal of acetyl groups requires basic conditions, which might lead to the 
enantiomerisation of the glycopeptides. 
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Scheme 10: Synthesis of Glycosylated-Asparagine Building Blocks 73-79. 
Kunz et a!76  have reported the synthesis of chitobiose-asparagine building block 85 
using multiple protecting group strategy. The synthesis began by treating 
chitobioseoctaacetate 80 with saturated hydrogen chloride in acetyl chloride to afford 
81. Subsequently, 81 was treated with sodium azide under phase transfer conditions 
afforded chitobiosyl azide 82, followed by reduction with Raney nickel to give 
chitobiosyl amine 83. In the next step chitobiosyl amine 83 was coupled to Fmoc-
Asp (OH)-OA1I using TBTU, HOBt and DIPEA to give fully protected chitobiose-
asparagine 84. The allyl ester of 84 was hydrolyzed using palladium (0) catalyzed 
allyl transfer to sodium p-toluenesulfonate to afford the Fmoc-N-asparagine building 
block 85. The building block 85 was incorporated into glycododecapeptide [L V Q V 




Results and Discussion 
activation conditions (scheme 11). This synthetic strategy requires multiple 
protection and deprotection steps, which takes longer period of time. 
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Scheme 11: Synthesis of Chitobiose-Asparagine Building Block 85. 
Alternatively, Lansbury et al. 33 have reported a convergent glycopeptide synthesis, in 
which the carbohydrate was attached to a selectively deprotected aspartic acid 
residue once the polypeptide has been achieved (scheme 12). In fact, this is a 
landmark development in the convergent synthesis of glycopeptides, however 
suffering from a drawback such as an aspartimide formation as a by-product. The 
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Scheme 12: By-product Aspartimide Formation. 
To overcome this aspartimide by-product formation, recently Danishefsky and co-
workers 20  have reported an improved convergent synthesis of glyco-pentapeptide by 
treating the chitobiosyl amine 86 with two fold excess of pentapeptide (87 and 88) 
employing HATU (5 eq) and DIPEA (3-4 eq) in DMSO activation conditions 
(scheme 13). The overall yields of the glycopeptides 89 and 90 were increased to 58-
70 %, which represents a significant improvement over the best yields previously 
reported. Though this by-product formation is competitive with glycopeptide 
formation in terms of rate, their products are exclusively peptide derived. Thus an 
excess of peptide starting material avoids the aspartimide formation even with an Ala 
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Scheme 13: Synthesis of Glycopeptides 89 and 90 by Avoiding Aspartimide Formation. 
In a different strategy, Flitsch et a178 have reported a similar convergent synthesis for 
un-natural type of glycopeptide 93, in which a glycosyl iodoacetamide 92 was treated 
with cysteine thiol of the peptide 91 under pyridinelDMF (1:1) conditions (scheme 
14). The synthesis of peptide 91 was achieved by standard Fmoc-SPPS. The glycosyl 
iodoacetamide 92 was obtained starting from commercially available reducing sugar 
from number of steps. 78 
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Scheme 14: Synthesis of Un-natural Type Glycopeptide 93. 
All of the above reported synthetic routes to peptides bearing N-glycans generally 
use ,Li-glycosyl amines as key intermediates, with subsequent acylation by a suitably 
protected amino acid or a polypeptide side chain depending on the strategy chosen. 
Such glycosyl amines are accessible by two different synthetic routes; first one is 
from suitably protected glycosyl azides required multiple protection and deprotection 
steps32 '79 ' 8° (scheme 15). 
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Cl-I3COCI 	Ac \ 	 DCM/H20 
R OH Rci 	 R 
R= OH, NHAc 	 I 
Reduction conditions 
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Remove AcO 	Fmoc-Asp(OH)-OPAcO 
NBTU0rTBTU, 	 R 
HOBt, DIPEA 
FmocHNCOOH 	 FmocHN 1COOP 
P = protecting group 
Scheme 15: General Synthetic Route for Glyco-Amino Acids by Multiple Protecting Group Strategy. 
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Second approach is the direct amination from reducing sugars using the Kochetkov 
amination reaction in a single step, in which the reducing sugar was treated with 
saturated aqueous ammonium bicarbonate solution (40-50 fold excess) at 30 °C for 6 
days to afford exclusively fl-isomer of the corresponding amine 44 ' 81 '82 (scheme 5). 
This approach is an excellent route for generating glycosyl amines in a single step. 
However, it suffers from the major drawbacks such as longer reaction times, 
difficulties in removing excess ammonium bicarbonate effectively by repeated 
lyophilization and electrodialysis method. 
11,14, 
Consequently, the aim of our project was to develop a methodology that would 
overcome practical the drawbacks of this key reaction for glyco-amino acid building 
blocks and glycopeptide synthesis. In particular, shorten reaction time, difficulties in 
purification of glycosyl amines by Amberlist 15 H resin, laborious work-up 
procedure for evaporation of excess bicarbonate and reduce the amount of the 
bicarbonate needed. 
At the same time Loupy and Verma et al. 
85,86  have shown that the reaction of 
primary and secondary amines reacts with aldehydes and ketones are substantially 
accelerated by microwave-irradiation to afford high yields of imine 94 and enamine 
95, respectively (figure 20). 
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Figure 20: Formation of Imine 94 and Enamine 95 under Microwave Irradiation. 
Inspired by this report on microwave accelerated imine formation and decided to 
apply microwave-irradiation conditions for the synthesis of glycosyl amines by 
modifying the conventional Kochetkov amination conditions. 
2.1.1 Optimisation of Kochetkov Amination under Microwave 
Irradiation 
The microwave-irradiation conditions were initially optimized for N-acetyl-D-
glucosamine 96, which is conserved as the reducing monosaccharide unit of the core 
pentasaccharide of the N-glycan. The reducing sugar 96 (0.25 g) was treated with 
ammonium carbonate (1.25 g, 5 fold excess) in different solvents (anhydrous MeOH, 
CH3 CN, DMF and DMSO) under microwave-irradiation (10 watts) as microwave 
power, 400 60 °C at 250 psi for 45-90 mm. Out of the various solvents tried, only 
DMSO resulted in good yield of 103 (entry 1-4, table 1). Gratifyingly, the reaction 
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was found to be more efficient with only 5 fold excess (w/w) of ammonium 
carbonate over reducing sugar compared to the 40-50 fold excess required for 
conventional reaction conditions. 44  The reaction appeared to be complete after 90 
min of microwave irradiation (10 watts), while maintaining the reaction temperature 
at 40 °C, at maximum pressure of 250 psi whilst cooling the vessel. 
OH 	 OH 
(NH4 )2CO3 (5 fold excess) 	
NH2 Solvent (Anh), MW (10 watts), 
ACHN OH 400.60 0C, 45-90 mm, 250 psi 	 AcHN 
96 	 103 
Entry Solvent T (°C) Time (mm) Product 
(%)a 
Dimer (%) 
MeOH 40 90 no product not determined 
2 CH3CN 40 90 no product not determined 
3 DMF 40 90 trace not determined 
4 DMSO 40 90 80-90 5 
5 DMSO 50 90 60-70 15 
6 DMSO 60 90 50-60 20 
7 DMSO 40 45 60-70 5 
U  Yields were estimated based on the ratio of an anomeric proton peak of the reducing sugar and 
glycosylamme. 
Table 1: Optimisation of Kochetkov Amination under Microwave Irradiation. 
In addition to the product 103, a small amount of side product, diglycosylamine was 
also observed by mass spectrometry and such dimer was formed by further 
condensation of 103 to starting reducing sugar 96. The formation of this dimmer was 
significantly increased at higher temperatures such as 50 0  and 60 °C (entries 5-7, 
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table 1), and reaction temperatures were therefore kept at 40 °C. The formation of 
this dimer in up to 10 % yield was also observed in thermal conditions 44 '81 '82 '87 and 
has been shown not to interfere with subsequent acylation reactions. 
2.1.2 Synthesis of fl-Glycosyl Amines 103 -109 
The optimised microwave-assisted Kochetkov amination conditions were 
successfully applied to a variety of reducing sugars (96-102) such as mono (G1cNAc, 
glucose), di (cellobiose, lactose, maltose and chitobiose) and tri saccharides 
(maltotriose) to afford glycosyl amines 103-109 (table 2 & figure 21) in excellent 
yields (3 5-95 %). In all cases, the small excess of ammonium carbonate and DMSO 
OH 	 OH 
R1O\ \, 	
(NH4)2CO3 (5 fold excess)
NH R1O DMSO (Anh), MW (10 watts), 	H 
R OH 40 0C, 90 mm, 250 psi 	 R 
96.102 	 103-109 
Entry R1 R Glycosyl amine 
1 H NHAc 103 
2 H OH 104 
3 G1c(1— OH 105 
4 Gal (I31— OH 106 
5 Glc(ctl— OH 107 
6 G1cNAc (I31— NHAc 108 
7 Glc(a1-4)G1c(a1— OH 109 
Table 2: Synthesis of Ji-Glycosyl Amines via Microwave-Assisted Kochetkov Amination. 
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was successfully removed by freeze drying the reaction mixture overnight to afford 
hygroscopic solids 103-109. Selective formation of the ,I3-glycosyl amines was 
demonstrated by 'H NMR (J,,2 = 8.0-9.0 Hz). The yields of the crude glycosyl 
amines were calculated from 1 H NMR spectra in D 20 and are based on the 
integration of the anomeric proton peak (H: 4.0-5.0 ppm) of the crude glycosyl 
amine (103-1 09) and substrate (96-1 02) anomeric proton peak (s,-,: 4.5-4.9 ppm). The 
'H NMIR and mass spectral data of crude glycosyl amines were compared and were 
similar to the previous reports. 8 ' The crude glycosylamines were used for further 
acylation studies without any purification. 
	
OH 	 OH 	 OH 	 OH 
Ho--N 	0 NH2 HO— 2 	O H NH NH 2 
AcHN 	 HO 	 HO 	 HO 
103, 90% 	 104, 80% 	 105, 95% 
HOOH 	 OH 	
OH
HO
HO 	 OHO 	 NH 2 	
OH HO 
HOl L_o HO 	 HO q NH2 
106, 75% 	 HO 
107, 70% 
OH 
OH 	 OH 	 HO' 	
OH HO 
HO 
AcHN 	 AcHN OH ~H\O L_o. 
108, 35% 	 109,70% 	
OS%...'\NH2 
HO 
Figure 21: Glycosyl Amines 103-109/Library. 
The formation of the glycosyl amine was also attempted starting from peracetylated 
chitiobiose and lactose to determine whether deacetylation and amination could be 
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the 1-0-deacetylated glycoside together with trace amounts of glycosyl amines was 
observed (scheme 16). 
OAc 	 OAc 	 (NH4 )2CO3 (5 fold excess) 
AcO' - 
DMSO (Anh), MW (10 watts), 
R2 	 R1 OAc 40°C 90 min, 250 psi 
R1, R2 = OH, NHAc 	 Expected 
I (NH)2CO3 (5 fold excess) 
Observed I DMSO (Anh), MW (10 watts), 
400C, 90 mm, 250 psi 
OAc 	 OAc 
AcO - 	 + 
R2 	 R1 OH 
major 
OH 	 OH 
Ho ~ NH 
R2 	 R1 
R 1 , R2 = OH, NHAc 
OAc 	 OAc 
ACOL°S 	
NH2 AcO---.-' 
R2 	 R1 
minor 
R1, R2= OH, NHAc 
	 R1, R2 = OH, NHAc 
Scheme 16: Microwave-Assisted Kochetkov Amination with Peracetylated Sugars. 
2.2 Synthesis of Glycosylated-Asparagine Building Blocks 
2.2.1 Chemo-enzymatic Synthesis of 111 via Acid Fluoride Method 
Tokuda et a184 have reported a chemo-enzymatic synthesis of Cbz-protected glyco-
amino acid 111 via acylation of 103 with 114 to afford 110, followed by isobutyl 
ester hydrolysis of 110 using papain to afford 111. This synthetic route was further 
investigated, starting with 103, which has prepared from microwave-assisted 
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Scheme 17: Synthesis of Glyco-Amino Acid 111. 
The acid fluoride 114 was prepared from commercially available Cbz-Asp-OH in 
three steps. The synthesis began with treatment of Cbz-Asp-OH with para-
formaldehyde in benzene under reflux conditions to afford 112. Subsequently, 112 
was treated with sodium in isobutanol at 65 °C to open up the oxazolidinone ring to 
afford 113. In the next step, intermediate 113 was treated with cyanuric fluoride in 









HOOCç'O Na, isobutano 
CbzN—' 65 °









pyridine, CH2Cl2I N )II  N 
RT,2hrs 	I ) 
F N F 
75%  
114 
Scheme 18: Synthesis of Acid Fluoride 114. 
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Subsequently, the glycosylamine 103 (synthesized by microwave-assisted Kochetkov 
amination) was treated with 114 in the presence of NaHCO3 in DMF at room 
temperature for 2.5 hrs to afford compound 110 in good yield. The isobutyl ester 
hydrolysis of 110 was achieved by treating with papain in the presence of catalytic 
L-cysteine and maintaining the pH 7.0 (by adding dii. NaOH solution) at room 
temperature for 7 hrs to afford compound 111 in good yield (scheme 17). 
22.2 Synthesis of Glyco-Amino Acid 116 by Acid Fluoride Method 
Having successfully demonstrated the preparation of Cbz-protected glyco-amino acid 
111 by a chemo-enzymatic method, access to an Fmoc protected glyco-amino acid 
for Fmoc-based SPPS and Fmoc-SPGPS was investigated. In order to prepare the 
compound 115, the glycosyl amine 103 was treated with N-a-Fmoc-Asp(F)-O tBu in 
the presence of NaHCO3 and DMF for 3 hrs. The N-a-Fmoc-Asp(F)-O tBu was 
prepared using a reported procedure by Carpino et al.88 In a typical experiment the 
commercially available N-ct-Fmoc-Asp(OH)-O tBu was treated with cyanuric fluoride 
in DCM at room temperature. The resulting tert-butyl ester 115 was hydrolyzed 
using TFA/DCM/anisole at room temperature for 4 hrs to afford 116 (scheme 19). 
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Scheme 19: Synthesis of 116 by Acid Fluoride Method. 
After low yielding attempts on the synthesis of 116 by the acid fluoride route, the 
synthetic strategy was changed by coupling of the amines 103-109 (1 eq) with a pre-
activated solution of N-a-Fmoc-L-aspartic acid-a-tert-butyl ester (1.2 eq), HBTU (3 
eq) and HOBt (1.2 eq) in DMF. Subsequent acidolysis of tert-butyl ester was 
performed with TFAJDCM/anisole for 4 hrs at room temperature, resulting in 
production of the corresponding Fmoc-protected glyco-amino acids 116, 118, 120, 
122, 124, and 126 in overall good yields. Optimised yields were obtained with only 
1.2 fold excess of amino acid over crude amine, which indicates that most of the 
ammonium carbonate had been successfully removed during workup from the 
previous reaction mixture. The fl-linkage between sugar and amino acid was 
confirmed by 'H NIMR (J1,2 = 8.0-12.0 Hz). The glyco-amino acids 116, 118, 120, 
122, 124, 126 and their precursors 115, 117, 119, 121, 123, 125 were characterised 
by 'H, 13C NMR, COSY, HSQC, MS (ESI) and HRMS (FAB). 
ME 
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2.2.3 Synthesis of Glyco-Amino Acid 116 
The glycosyl amine 103 was treated with a pre-activated solution of N-a-Fmoc-Asp-
(OH)-O'Bu (1.2 eq), HBTU (3 eq) and HOBt (1.2 eq) in dry DMF for 24 hrs to 
afford 115 in 88 % yield. The acidolysis of tert-butyl ester 115 was performed using 
TFAIDCMlanisole at room temperature for 4 hrs to afford 116 in 86 % yield (scheme 
20) 
OH 





FmocHN) OBu  
0 
OH 
HBTU, HOBt 	HO ° NH 
>=O 
DMF, RT, 24 hrs 	 AcHN 	










86 % TFA/DCM/anisole 
RT, 4 hrs 
Scheme 20: Synthesis of Glyco-Amino Acid 116. 
2.2.4 Synthesis of Glyco-Amino Acid 118 
The glycosyl amine 105 was treated with pre-activated solution of N-a-Fmoc-Asp 
(OH)-O'Bu (1.2 eq), HBTU (3 eq) and HOBt (1.2 eq) in dry DMF for 24 hrs to 
afford 117 in 92 % yield. The resulting intermediate 117 was subjected to acidolysis 
using TFAJDCM/anisole for 4 hrs to afford 118 in 80 % yield (scheme 21). 
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FmocHN 	 OMF, RT, 24 his 
0 	 92% 
HO 	 OH 	
HO 	 OH 
TFNDCM/anisole 
HO 	 L-0 RT. his 
_____________ 	
NH 
HO 	 HO 	
HO— 	\\ 
1 0 118 	FmocHN 	
17 	FmocHN 
	
80% 	 HO 	 HO 	
0 
0 	 0 
Scheme 21: Synthesis of Glyco-Amino Acid 118. 
2.2.5 Synthesis of Glyco-Amino Acid 120 
The glycosyl amine 106 was treated with a pre-activated solution of N-a-Fmoc-Asp 
(OH)-O'Bu (1.2 eq), HBTU (3 eq) and HOBt (1.2 eq) in dry DMF for 24 hrs to 
afford 119 in 70 % yield. The intermediate 119 was treated with a mixture of 
TFAIDCMIanisoIe for 4 hrs to afford 120 in 87 % yield (scheme 22). 
HOOH 	 OH 
NH 2 + 
HO 	 HO 
106 
0 
HO 	 HBTU, HOBt 
OBu ______________ 
FmocHN( 	DMF, RT, 24 hrs I 
0 I 70% 
V 
HOOH 	 OH 	 HOOH 	 OH 





HO\ / 	 '
HO HO 	 HO
H 	
87% 	 HO
120 FmocHN 	 119 FmocHN 
0 0 
Scheme 22: Synthesis of Glyco-Amino Acid 120. 
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2.2.6 Synthesis of Glyco-Amino Acid 122 
The synthesis of 122 was achieved by treating the glycosyl amine 108 with a pre-
activated solution of N-a-Fmoc-Asp(OH)-O'Bu (1.2 eci), HBTU (3 eq), HOBt (1.2 
eq) and DIPEA (1.2 eq) in dry DMF for 24 hrs to afford 121 in 70 % yield. In this 
particular case the reaction was sluggish without a base, after addition of DIPEA (1.2 
eq) the reaction proceeds well. In the next step the intermediate 121 was treated with 
a mixture of TFAIDCM/anisole for 4 hrs to afford 122 in 89 % yield (scheme 23). 
OH 	 OH 
	
HO O 	
NH2 + HO\---   
AcHN 	 AcHN 
108  
HO 	 HBTU, HOBt, DIPEA 
FmocHNflOtBu DMF, RT, 24 his 
0 	 70% 
HO OH 	
HO 	 OH 
HO--° 	 TFNDCM/Anisole HO HO 	\\ NH HO. ,,O 
RT, 4 h AcHN 	AcHN 	o 	







Scheme 23: Synthesis of Glyco-Amino Acid 122. 
2.2.7 Synthesis of Glyco-Amino Acid Building Block 124 
The synthesis of 124 was achieved by treating 109 with a pre-activated solution of N-
ct-Fmoc-Asp(OH)-O tBu (1.2 eq), HBTU (3 eq) and HOBt (1.2 eq) in dry DMF for 24 
hrs to afford 123 in 71 % yield. In the next step the intermediate 123 was treated with 
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OH 
HO
O OH 	 0 
HO I 




109 	 HO 
HBTU, HOBt, 
DMF, RT, 24 hrs 
71 % 
Scheme 24: Synthesis of Glyco-Amino Acid 124. 
2.2.8 Synthesis of Glyco-Amino Acid Building Block 126 
The synthesis of 126 was achieved by treating the glycosyl amine 104 with a pre-
activated solution of N-a-Fmoc-Asp(OH)-O tBu (1.2 eq), HBTU (3 eq) and HOBt 
(1.2 eq) in dry DMF for 24 hrs to afford 125 in 86 % yield. Subsequently, the 
resulting intermediate 125 was treated with a mixture of TFA!DCM/anisole for 4 hrs 
to afford 126 in 89 % yield (scheme 25). 
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HBTU, HOBt 	HO NH 
HO . 	— 















89 % TFA/DCM/anisole 
RT, 4 his 
Scheme 25: Synthesis of Glyco-Amino Acid 126. 
2.3 Fmoc-SPPS of Glycopeptides 127 and 128 
One of the aims of our project was the chemical synthesis of the measles binding 
domains of the CD46 complement cofactor in humans. 
89  Structural studies have 
shown that the core saccharides, in particular, the first two G1cNAc residues of the 
core pentasaccharide strongly interact with the polypeptide backbone and functional 
studies have shown that glycosylation is essential for measles virus recognition. 
Our target was the total chemical synthesis of such receptor modules bearing defined 
natural and unnatural carbohydrate chains using native chemical ligation. Such 
synthesis requires access to glycosylated peptides such as 127 and 128. Total 
chemical synthesis of such module (MCP 1 module) will follow in chapter 5 of this 
thesis. 
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Thus, the glycosylated-asparagine building blocks 116 and 118 were incorporated 
into target glycopeptides 127 and 128 using Fmoc-SPPS on a commercially available 
Wang resin (100-200 mesh) (figure 22). 
OH 	 OH 	 OH 
HO \) 
ACHN T OH 	 OH 7= 
H2N-Cys-Asp-k9-HNCO-His-Thr-COOH 	 H2N-Cys-Asp-Arg-HNCO-His-Thr-COOH 
127 	 128 
Figure 22: Target Glycopeptides 127 and 128. 
The first amino acid Fmoc-Thr(O tBu)-OH (6 eq) was coupled to Wang resin by 
using the symmetrical anhydride method with DIC (3 eq), DMAP (0.1 eq) in DCM at 
0 °C for 30 mm. The loading of Fmoc-Thr(OtBu)-OH was calculated by a standard 
Fmoc cleavage test and was found to be 0.38 mmolg'. The same coupling process 
was repeated to get better loading and this time the loading was increased to 0.58 
mmolg 1 . The Fmoc group was removed with 20 % piperidine in DMF for 1 hr. The 
remaining glycopeptide was assembled by activation of Fmoc-amino acid (4 
eq)/glyco-amino acid (2 eq) with TBTU (4 eq), HOBt (4 eq) and DIPEA (8 e in 
DMF for 4 hrs. All coupling steps were single couplings except for coupling of the 
glyco-amino acids 116 and 118, which were incorporated into the peptide using 




Results and Discussion 
The crude glycopeptides were cleaved from the resin using a mixture of TFAIEDT/ 
H20/TIS (94:2.5:2.5:1) for 4 hrs, in good overall yields (67 % for 127 and 54 % for 
128 based on a loading of 0.56 mmolg of resin) (scheme 26). 
Fmoc-Thr(OtBu)-OH 
HO— DIC, DMAP, 0CM 
Wang resin 0 °C, 30 mm 
Fmoc-Thr—O_20% Piperd'ne in DMF - H2N
-Thr___O 
I Fmoc-SPPS 
TBTU, HOBt, DIPEA, 
Fmoc-AA-OH or 	hrs 
Glyco-amino add' DMF, RT, 4 I followed by Fmoc 
deprotection 
TFAIEDT/H20/TIS 
H2N-Cys-Asp-Arg-An-His-Thr-COOH (94:2.5:2.5:1), RT, 4 hrs 
OH 
== Glycopeptide 127 
AcHN 
OH 	 OH 
= 	 = Glycopeptide 128 
HO 
OH 	 OH 
Scheme 26: Fmoc-SPPS of Glycopeptides 127 and 128. 
The glycopeptides were analysed by LC-MS using reverse phase conditions. The 
LC-MS results revealed that the glycopeptides 127 and 128 displayed a retention 
time of 18.3 min and 19.1 min respectively. Glycopeptides 127 and 128 were also 
analysed by HRMS (FAB), calculated mass for 127, C35H57N 1 3016S, 948.3845 
[M+H] and was found at 948.3849 [M+H]. Calculated mass for 128, 
C39H64N12021S, 1069.4108 [M+H] and was found at 1069.4105 [M+H]. 
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2.4 Conclusions 
In conclusion, we have developed a fast and efficient synthetic route from 
unprotected sugars to glycosylated-asparagine building blocks for glycopeptide 
synthesis by using microwave-assisted Kochetkov amination as a key reaction. This 
approach can be applied to mono- and oligosaccharides and yields glycosylated 
asparagine building blocks in a short period of time with minimal workup. The 
overall yields of the microwave-assisted aminations appear similar to that reported 
for the thermal conversion and suggest that this methodology will be very useful for 
other applications such as the preparation of glyco-conjugates for subsequent 
immobilization. 79  The application of the glyco-amino acid building blocks in 
glycopeptide synthesis of 127 and 128, which are key intermediates for the synthesis 
of glycoproteins by native chemical ligation, was successfully demonstrated. 
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3. Enzyme Cleavable Linkers for Peptide and 
Glycopeptide Synthesis 
3.1 Introduction 
Enzymatic methods may open up advantageous alternatives to chemical methods 
since enzyme-catalyzed transformations often proceed under mild conditions (pH 
5.0-8.0, 25°-40 °C) and with high chemo-, regio-, and stereo selectivity. 90,91 Several 
groups have reported different enzyme cleavable linkers, which allow the release of a 
variety of compounds from solid supports through enzyme mediated 
hydrolysis. 91'92'93'94'95'3 1,96 
Waldman et al. 91  have reported a new enzyme-labile safety catch linker strategy for 
combinatorial synthesis on a soluble polymeric support POE 6000. The target 
molecule was cleaved by a key enzymatic transformation using penicillin G acylase. 
The new linker system was designed such that a biocatalyzed transformation is 
combined with a subsequent intramolecular cyclisation reaction, according to the 
principle of 'assisted removal' of the desired target molecule. 97 '98 Here, the linker 
contains a functional group, which is recognized by a biocatalyst. The enzyme 
liberates an intermediate which cyclizes, with release of the target molecule (scheme 
27). The linker was attached to an amino- functionalized carrier as a carbamate 129, 
which allowed the attachment of alkyl halides, alcohols, amines as carboxylic acid 
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Scheme 27: Principle for Development of an Enzyme-Labile Safety Catch Linker (Reproduced from 
Waldmann, H etal. Angew. Chem. mt. Ed. 2000, 39, 1629-1632). 
The target molecule releases according to the safety catch principle in two steps. In 
the first step, the penicillin G acylase hydrolyzes the phenylacetamide under mild 
conditions (pH 7.0, room temperature). Subsequently, the benzyl amine 130 was 
generated as an activated intermediate, which cyclizes to form the polymer-bound 
lactam 131 and releases the corresponding target molecule 132. 
The linker 134 was synthesized from commercially available homovanilinic acid 
methyl ester 133 from number of steps (scheme 28). The polymeric carrier chosen 
for attachment to the linker was a soluble polyethylene glycol functionalized at both 
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Scheme 28: Synthesis of the Linker 134 and Coupling to Polymer (POE 6000). 
The suitability of the polymer-linker conjugate 135 for combinatorial synthesis and 
the possibility of its applicability were studied for a variety of different 
transformations such as Heck, 101 Suzuki, 
02  Sonogashira,' °3 Mitsunobu and Diels-
Alder reactions. 
In a different strategy Waldman et al. 93 have reported another linker system, which 
contain an acyl group, for example, acetate that can be cleaved by lipases or 
esterases. A phenolate 136 is generated, which fragments to afford quinone methide 
137 and then releases the desired compound, for example, combinatorial library 
synthesis 138 (scheme 29). The quinone methide 137 remains linked to the solid 
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(bound as carbamates), alcohols (bound as carbonates), and carboxylic acids (bound 
as esters) can be cleaved from the solid support. 
enzyme-labile 
bond 





X= NH, O.CR2 	
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X = NH:amines (-0O2) 
X = OH: alcohols (-0O2) 
X = CR2: carboxylic acids 
Scheme 29: Principle of an Enzyme Labile 4-acyloxy-benzyloxy Linker Group (Reproduced from 
Waldmann, H etal. Angew. Chem. mt. Ed. 1998, 37, 1143-1146). 
The polymer support selected for the subsequent transformation on the solid support 
was TentaGelS-NH2, a polystyrene resin onto which terminally N11 2-ftinctionalized 
oligoethylene glycol units had been grafted. 104  Its polar surface and the good 
solvation in aqueous systems are advantageous properties that facilitate the 
enzymatic cleavage of the linker. 
The linker 140 was obtained from commercially available 5-methyl salicylic acid 
139 in three steps and subsequently coupled to a TentagelS-NIH2 to form an amide 
bond. In the next step substrate, 141 was subjected to enzymatic hydrolysis by lipase 
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under mild conditions. The amino acid ester 142 was isolated in 73 % yield (scheme 
30). The similar strategy was applied to tetrahydro-J3-carbolines by Pictet-Spengler 









'TrI68 	 0 	NHLeuOtBu 
141 
TentaGel 
7. lipase RB 001-05, 












j5. C002, toluene 
0 OAc 
6. Leu OtBu, DCMO
NH 










Scheme 30: Synthesis of Substrate 141 on a TentaGel Resin and Cleavage by Lipase. 
Flitsch et al. 94  have reported a novel linker system for the attachment of alcohols to a 
polymer support and subsequent release from the solid support by penicillin G 
amidase. Penicillin G amidase is known to catalyze the hydrolysis of a wide range of 
amines protected as the corresponding phenylacetyl derivatives. In order to 
incorporate the enzyme recognition site, the linker 143 was designed as shown in 
scheme 31, in which —OR represents the alcohol group. 
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Ph 	 PerticillinG 
NH 	
amid ase H,N~ ROH 
r H20 
143 	 144 
Scheme 31: Design of an Enzyme-Cleavable Linker (Reproduced from Flitsch etal. Tetrahedron 
Lett. 1998, 39, 3819-3822). 
It was predicted that cleavage would be initiated by hydrolysis of the phenyl 
acetamide group, generating the hemiaminal 144, which should easily hydrolyze in 
aqueous system, releasing the alcohol. 
The linker 145 was obtained by a synthetic route developed by Katritzky et al. 105 
Amine linker 145 was coupled to a solid support (PEGA or Tentagel) to afford 146. 
A number of TentaGel and PEGA resins were studied because of their compatibility 
with aqueous reaction conditions and also had been reported to be suitable for 
enzyme catalyzed transformations. The thioethyl group of 146 was activated by 
treating with NIS followed by displacement with alcohol to afford substrate 147. In 
the next step 147 was subjected to penicillin G amidase to afford alcohol 148 in good 
yield (scheme 32). This strategy was applied to a range of alcohol functionalities, 
such as sugars and amino alcohols, etc. 
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Scheme 32: Synthesis of Substrate 147 on Solid Support and Hydrolysis by Penicillin G Amidase. 
In a different approach Wong et al. 31  have reported a new linker strategy, which 
facilitates the formation of peptide bonds chemically and glycosidic bonds 
enzymatically using glycosyl transferases on a silica-based solid support. The key 
element in this strategy is to attach a proper acceptor-spacer group with a selectively 
cleavable bond to the solid support so that enzymatic coupling can be effectively 
achieved and the glycopeptide can be released. The synthesis of glycopeptide 149 
was achieved by a chemo-enzymatic synthesis on aminopropyl silica as a solid 
support because it is compatible with aqueous and organic solvents, and has got a 
large surface area accessible for enzymes. A selective cleavage site was implemented 
for the release of intermediates and final products by addition of a-chymotrypsin 
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Scheme 33: Synthesis of Glycopeptide Substrate 149 by Chemo-enzymatic Method (Reproduced 
from Wang, C. H etal. J. Am. Chem. Soc. 1994, 116, 1135-1136). 
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All of the above described linker strategies have been specially designed and were 
synthesized by a number of steps to incorporate enzyme recognition motifs, some of 
which remain as tags in the final compound library. The need for such motifs has 
limited the application of enzyme-cleavable linkers. 
During our enzymatic studies on PEGA 1 900 solid support using chymotrypsin and 
thermolysin for the peptide hydrolysis/synthesis,' °7 the unexpected cleavage of an 
ester linker that would be commonly employed in solid phase peptide synthesis, such 
as the Wang linker (hydroxymethylphenoxyacetic acid, HMPA) was observed 
(figure 23). These initial observations were discovered by Dr Beatrice A Maitman 
from the School of Chemistry, University of Edinburgh. 
ci -Chymotrypsin 
I 	__,,ft/-o 
% 	o\ OH HMPA 	PEGA 
cL-Chymotrypsin 0 	150 
1:2 
Figure 23: Representation of Unexpected Cleavage of an Ester Bond by a-Chymotrypsin. 
3.2 Initial Serendipitous Observations 
In the first instance, the chymotrypsin-catalyzed cleavage of peptide such as 150, 
which was linked through a Wang linker to PEGA 1 900 (a copolymer of polyethylene 
glycol and polyacryl amide), was investigated. PEGA 1 900 was chosen as the solid 
EXI 
Chapter 3 	 Results and Discussion 
support because it has been shown to provide fully accessible functional sites for 
enzyme catalysis.' 07,108,109,110,1 The synthesis of 150 was achieved by treating the 
PEGA 1900 with an activated solution of I{MPA (3 eq), HOBt (6 eci) and DIC (6 eq) in 
DMF. Subsequently, HMPA-PEGA resin was allowed to swell in DMF and DMAP 
(0.1 eq). The resin was then filtered and replaced with a pre-reacted solution of 
Fmoc-Asp(O-2-Ph'Pr)-OH (10 eq) and DIC (5 eq) in DMF. The Fmoc group was 
removed with 20 % piperidine in DMF for 1 hr. The remaining peptide synthesis was 
carried out by standard Fmoc-SPPS using TBTU (4 eq), HOBt (4 eq) and DIPEA (8 
eq) in DMF for 4 hrs. The side chain protecting group of Asp was removed by 
treating the resin with a solution of TFAITIS/DCM (2:8:90) to afford substrate 150 
(scheme 34). 
H2N 	 1. HMPA, DIC, HOBt 	
HOj1H 
PEGA 1900 	DMF, RT, overnight 
HMPA - PEGA 
4. Fmoc-Phe-OH, 
TBTU HOBt. DIPEA. .  
2. Fmoc-Asp(O-2-PhiPr)-OH, 
DIC, DMAP, DMF, 
RT, overnight 
3. 20 % piperidine 
in DMF, RT, 1 hr 
DMF,RT,4hr 	 0 
{o 	piperidine in 	PPh-20 
DMF, RT, 1 hr H2N1(0Q 




Scheme 34: Synthesis of Dipeptide Substrate 150 on PEGA 1900 . 
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The resin bound substrate 150 (75 mg, corresponding to 7.5 mg dry weight, 0.001 
mmol) was treated with chymotrypsin (2 mg/ml of 0.1 M KPi buffer pH 8.0) for 16 
hrs. The hydrolysis reaction mixture was analysed by LC-MS using reverse phase 
conditions. The LC-MS results revealed, rather unexpectedly, that the predominant 
hydrolysis product of 150 was the dipeptide FmocPheAsp 152 as opposed to the 
expected FmocPhe 151, with 151 and 152 in a ratio of 1:2, respectively (scheme 35). 
Subsequently, in a control experiment the substrate 150 (75 mg, corresponding to 7.5 
mg dry weight, 0.001 mmol) was subjected to KPi buffer without chymotrypsin for 
16 hrs. However, the hydrolysis of the Wang linker was not observed. 








0.1 M KPi buffer (pH 8.0), 
RT,  
0 	
, 	 0 	 0 
OH 
HN-OH + %
O'K  HN HN 
0 	
0 	OH 
151 	 152 	
0 
Scheme 35: Hydrolysis of Solid-Supported FmocPheAsp 150 by Chymotrypsin. 
Chymotrypsin is well known to be specific for phenylalanine and tyrosine residues in 
the P, site' 12  and thus the PheAsp bond should present an excellent substrate site for 
this protease. The ester bond of the Wang linker on the other hand, was flanked by a 
RK 
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negatively charged amino acid (Asp) in the pseudo P 1 position (i.e. the position that 
would be occupied by the P 1  residue in the corresponding amide) and such substrate 
would not be expected to be cleaved by chymotrypsin. Also surprising was the 
stability of dipeptide 152 as the major product in the reaction mixture, even if 152 
was initially formed by ester hydrolysis, one would expect it to be hydrolysed rapidly 
in solution by chymotrypsin. This was further studied by incubation of a pure sample 
of 152 with chymotrypsin in solution, however, no hydrolysis product 151 was 
observed, possible explanation might be due to the insolubility of 152 in aqueous 
buffer. 
The interesting lability of the commonly used Wang linker to chymotrypsin-
catalyzed hydrolysis had not been observed before and was further in  First 
of all, the C-terminal amino acid residue attached to the Wang linker was replaced by 
amino acids with diverse functionalities to investigate the tolerance of chymotrypsin 
at the 'pseudo P 1 ' site of the ester. 
3.3 Synthesis of Substrates 153-161 and Cleavage by Chymotrypsin 
A series of resin bound Fmoc-L-amino acids incorporating the acid labile Wang 
linker were synthesized by reacting HMPA-PEGA with pre-activated solution of 
Fmoc-amino acid (10 eq) and DIC (5 eq) in DMF. Subsequently, side chain 
protecting groups were removed with appropriate conditions to afford substrates 153- 
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161. The resin bound substrates 153-161 were subjected to chymotrypsin (2 mg/ml 
of 0.1 M KPi buffer pH 8.0) for 16 hrs (scheme 36). 
H2N— 	
1. HMPA, DIC, HOBt 
PEGA1900 	
DMF, RT, overnight 
HOQ H 
HMPA - PEGA 
Fmoc-amino acid, 
DIC, DMAP, DMF, 
RT, overnight 
Removal of side chain 
protecting group 
V 
Chymotrypsin (2 mg/ ml 	 0 
R 	




FmocHN-IY 	 or 	 FmocHN1(0O 	
NH- 
0 	95 % TFA, RT, 3 hrs 	 o 153-161 
162-170 
Scheme 36: Synthesis of Substrates 153-161 and Hydrolysis by Chymotrypsin. 
The cleavage reaction mixture was analyzed by LC-MS using reverse phase 
conditions. The LC-MS results are reported in table 3. 
Entry Substrate R Product Yield % Retention time 
in mm 
1 153 CH2Ph 162 100 22.14 
2 154 CH3 163 100 20.27 
3 155 CH2CH(CH3) 2 164 100 22.85 
4 156 CH20H 165 60 18.93 
5 157 CH2COOH 166 100 18.93 
6 158 (CH2)4NH2 167 100 16.74 
7 159 H 168 24 19.95 
8 160 D-CH21?h 169 0 
9 161 CH2CO2(2-'PrPh) 170 25 21.48 
Table 3: Chymotrypsin Hydrolysis of Substrates 153-161. 
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The LC-MS results show that complete hydrolysis was achieved for Fmoc-L-amino 
acids containing hydrophobic (entries 1, 2 and 3, table 3), polar (entry 4, table 3) and 
charged (entries 5 and 6, table 3) side chains. Fmoc-Gly 159 appeared to be the only 
substrate obtained in poor conversion (entry 7, table 3). The hydrolysis was possible, 
but sluggish, with substrates containing larger hydrophobic protecting groups (entry 
9, table 3). 
A great advantage of biocatalysis over chemical synthesis is that reactions can often be 
highly stereoselective. Thus, chymotrypsin is known to be highly specific for L-amino 
acids. Such stereospecificity was also observed for the present linker cleavage: 
whereas the L-amino acid in 153 was efficiently cleaved from the resin, its D-
enantiomer 160 did not yield any 169 under the same conditions (entry 8, table 3). This 
result confirms that the observed cleavage of the linker is indeed catalyzed by the 
enzyme. Given that the C-terminal amino acid is often prone to racemization during 
peptide synthesis or cleavage, chymotrypsin catalyzed cleavage is an attractive option 
for the simultaneous cleavage and kinetic resolution of C-terminal epimers. 
3.4 Synthesis of Substrates 171-173 and Cleavage by Chymotrypsin 
The Wang linker is well known in Fmoc peptide synthesis because of its acid lability. 
However, acid lability did not seem to be important for chymotrypsin hydrolysis, 
since the base labile HMBA (hydroxymethylbenzoic acid) linker was also readily 
cleaved by the enzyme (table 4). The substrates 171-173 were synthesised by 
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coupling of Fmoc-amino acid onto HIMBA-PEGA, followed by side chain protecting 
group was removed by TFAITIS/DCM (2:8:90) to afford substrates 171-173. The 
substrates 171-173 (75 mg, 0.001 mmol) were subjected to chymotrypsin (2 mg/ml 
of 0.1 M KPi buffer pH 8.0) for 16 hrs (scheme 37). 
1-12N—. 	
1. HMBA, DIC, HOBt 
PEGA1900 	
DMF, RT, overnight 
4. Chymotrypsin (2 mg/ ml 
R 	
0.1 M KPi buffer, pH 8.0), 
RT,l6hrs 
FmocH N fl OH 
162, 163,166 
0 
HO '~'e H 
HMBA- PEGA 
2. Fmoc-amino acid, 
DIC, DMAP, DMF, 
RT, overnight 







Scheme 37: Synthesis of Substrates 171-173 and Hydrolysis by Chymotrypsin. 
The cleavage of Fmoc-amino acid was monitored by LC-MS using reverse phase 
conditions. The LC-MS results revealed that the cleavage of Fmoc-amino acids was 
successful and the hydrolysis yield was found to be 100 % (table 4). 
Entry 	Substrate R Product Yield % Retention time 
in mm 
171 CH21?h 162 100 22.14 
2 	172 CH3 163 100 20.08 
3 	173 CH2COOH 166 100 18.88 
Table 4: Chymotrypsin Mediated Hydrolysis of Substrates 171-173. 
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Thus, chymotrypsin can be employed to cleave both acid and base-labile ester linkers 
and might be useful for orthogonal linker strategies. Bordusa et al." 3 have shown that 
chymotrypsin can accept activated esters of aromatic alcohols, in which the leaving 
group binds to the aromatic pocket i site). To investigate if the present linker 
presents such a substrate mimetic, the non-aromatic hydroxyoctanoic acid (HOA) was 
investigated as another ester linker system. 
3.5 Synthesis of Substrates 174-176 and Cleavage by Chymotrypsin 
The substrates 174-176 were again synthesised on HOA-PEGA. The resin bound 
substrates 174-176 (75 mg, 0.001 mmol) were incubated with chymotrypsin (2 mg/ml 
of 0.1 M of KPi buffer pH 8.0) for 16 hrs (scheme 38). 
H2N—C 	 H0J N; 
PEGA1900 	 HOA - PEGA 	
H 
Fmoc-amino acid, 
IJIC, DMAP, DMF, 
RT, overnight 
Removal of side chain 
protecting group 
R 
FmocHN ) ]- 
OH 
0 
162, 166, 168 
0 
4. Chymotpsin (2 mg/ ml) 
FmocHN 
0.1 M KPi buffer, pH 8.0, 	 o 
RT. 16 hrs 	
174-176 
Scheme 38: Chymotrypsin Hydrolysis of Substrates 174-176. 
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The cleavage of Fmoc-amino acid was analysed by LC-MS using reverse phase 
conditions. The LC-MS results revealed that the enzymatic hydrolysis of amino acid 
was again in 100 % yield. The hydrolysis results appeared to be unaffected by the 
change in linker structure (table 5). 
Entry Substrate R Product Yield % Retention time 
in mm 
1 174 CH21?h 162 100 22.24 
2 175 H 168 35 19.74 
3 176 CH2COOH 166 100 18.99 
Table 5: Chymotrypsin Mediated Hydrolysis of Substrates 174-176. 
The results obtained using this linker system show that cleavage is still possible and 
hence, the selective ester cleavage by chymotrypsin in 150 might be a result of the 
much more labile ester bond rather than due to any additional recognition of the 
aromatic group of the HMPA or HMBA linker. 
106 
An interesting application for enzyme-cleavable linkers is in glycopeptide synthesis 
because of the additional complexity that the carbohydrate side chains bring to solid 
phase peptide synthesis, such as problems of acid lability. Here, a protocol using 
enzymes as highly selective and orthogonal catalysts under physiological conditions 
is very attractive. To investigate the applicability of the enzyme-labile linker, we 
chose as a target the highly conserved N-glycan motif (Asn-X-Ser/Thr tripeptide 
codon where X= any amino acid except Pro) 73 in particular, the tripeptide Asn-Gly-
Ser, in which the Asn side chain was N-glycosylated. 
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3.6 Synthesis of Glycopeptide Substrate 178 and Cleavage by 
Chymotrypsin 
The synthesis of glycopeptide 178 began from attachment of HMPA linker to 
PEGA,90o (0.15 mmollg (dry), 10 % wt in MeOH) by activating with DIC, HOBt in 
DMF to yield HMPA-PEGA. Subsequently, the first amino acid, Fmoc-Ser(Trt)-OH 
was coupled to HMPA-PEGA via the symmetrical anhydride approach to afford 177. 
The trityl side chain protecting group was selected in order to enable its deprotection 
in the presence of the TFA labile HMPA linker. The remaining glycopeptide 178 
was then assembled by standard Fmoc solid-phase glycopeptide synthesis, using the 
glycoamino acid, Fmoc-Asn(G1cNAc)-OH (116), which is prepared by a newly 
improved method in our laboratory. 114  The side chain protecting group was removed 
with TFAITIS/DCM (1:5:94) to afford resin bound glycopeptide substrate 178. 
Subsequently, the substrate 178 was subjected to the enzymatic cleavage using 
chymotrypsin (2 mg/mi of 0.1 M of KPi buffer pH 8.0) for 16 hrs (scheme 39). In 
order to compare the hydrolysis yield, the glycopeptide substrate 178 was subjected 
to 95 % TFA cleavage conditions and subsequently, analysed by LC-MS using 
reverse phase conditions (figure 24). Both, chymotrypsin mediated and chemical 
hydrolysis reactions gave quantitative yield of the glycopeptide 179. 
HE 
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H2N -cE 
PEGA 1 900 
1. HMPA, DIC, HOBt 
DMF, RT, overnight 
0 
HO ) 	 H 
HMPA - PEGA 
Fmoc-Ser(OTrt)-OH, 
DIC, DMAP, DMF, 
RI, overnight 
20 % piperidine 
Fmoc-amino acid or 	 I 	'' 
Fmoc-Asn(GIcNAc)-OH (116), 	 o 
IBTU, HOBt, DIPEA, 	O(Trt) 
DMF, RT, 4 hr 
H 2N I 	. 20 % piperidine 177 
Fmoc-SPPS 	in DMF, RT,1 hr 
6. TFA/TIS/DCM (1:5:94) 
OH 
H Q NH  
AcH 	 OH 	
°—NH—(c 
N  uT 
HN HN 
0 178 	 m Chyotrypsin (2 mg/ ml) 
FmocHN 	
0.1 M KP1 buffer, pH 8.0) 








95 % TEA, RI, 3 hrs 
Scheme 39: Fmoc-SPPS of Glycopeptide Substrate 178 and Cleavage by Chymotrypsin or TFA. 
The LC-MS results show that the hydrolysis of the desired glycopeptide 179 was 
achieved in quantitative yield and at 16.88 min of retention time (figure 25). Thus 
enzyme cleavage is an efficient as TFA cleavage and compatible with glycopeptide 
functionalities. Calculated mass for 179, 701.19 [M] and was found 702.2 [M+H] 
from mass data of LC-MS. 
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Figure 24: UV Trace of LC-MS for Cleavage of Glycopeptide 179 using 95 % TFA [Luna Sp. C18 
column (250 x  2 mm) and 0-85 % MeCN (0.1 % TFA)/ H 20 (0.1 % TFA) as a gradient with flow rate 
of 0.2 ml mm'] 
Figure 25: UV Trace of LC-MS for Chymotrypsin Mediated Cleavage of Glycopeptide 179 [Luna 5 t 
C18 column (250 x 2 mm) and 0-85 % MeCN (0.1 % TFA)/ H 20 (0.1 % TFA) as a gradient with flow 
rate of 0.2 ml min'] 
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3.7 Conclusions 
In conclusion, we have shown that the commonly used HIvIIPA and HMBA ester 
linkers in SPPS, as well as alkyl ester linkers can be cleaved quantitatively in 
PEGA 1 900 by chymotrypsin catalyzed hydrolysis under very mild conditions. Enzyme 
catalysis is therefore a useful complementary method to the cleavage of such esters 
under acidic or basic conditions. The linkers are commercially available and can be 
incorporated using well established SPPS methodologies. Furthermore, in combination 
with PEGA 1 900 they do not require any additional spacers to ensure sufficient 
accessibility of enzyme. 
Despite its known preference for aromatic/hydrophobic residues at the P 1 site of 
amides, chymotrypsin appears to cleave esters of a range of hydrophilic and charged 
amino acids efficiently in high yields. Thus, the present enzyme-labile ester linkers can 
be used for the synthesis of a much broader range of peptide sequences than previously 
suggested ,3 ' and is not restricted to those with C-terminal aromatic amino acids. 
The only limitation of this methodology is that it may not be suitable for the hydrolysis 
of peptides containing aromatic amino acids anywhere in the sequence other than the 
ester terminus, due to the competing hydrolysis at the specified amide bond. 
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4. Synthesis of N-Linked Glycopeptides as Potential 
Substrates for Proteases 
4.1 Introduction 
Oligosaccharides covalently linked to proteins can intensely affect many functions of 
the protein. One of the effects of protein glycosylation has shown to be protection of 
the polypeptide from proteolysis by proteases. 2 '3 '4 '74" 5 Proteases have found 
applications as biocatalysts in organic chemistry as a result of their ability to 
selectively synthesize or hydrolyze peptide bonds under mild conditions. 
113 Proteases 
are important class of enzymes in biological systems, which are often specific for 
certain polypeptide sequences, characterized as P,, P 2 , P 3 .. ..and P t ', P2 ', P3 '. . ..etc' 16 
depending on their position to the scissile bond as shown in figure 26. 
	
I2 	P 1 	
P 1 . P2 . ........ 
0 R2 a R1 	o 
H 0 = 1 H o R2 
Protease 
0 R2 H 	0 	 R 1 H 
+ H 2N(NYNH 
H 6 R
i o R2 
Figure 26: Proteolytic Hydrolysis of Peptides and Proteins by Proteases. The Amino Acids Flanking 
the Hydrolysis Site are Commonly Labelled as P 1 , P2 .. .and P 1 ', P2 '.. .etc (Bejugam, M etal. 
Tetrahedron: Asymmetry. 2005, 16, 21-24). 
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Proteases are classified according to their catalytic mechanism. Four mechanistic 
classes have been recognized such as serine proteases, cysteine proteases, aspartic 
proteases, and metallo proteases. 
4.2 Serine Proteases 
Serine proteases consist of two different families. The first one is chymotrypsin 
family, which includes the mammalian enzymes, such as chymotrypsin and trypsin. 
Second class of family is subtilisin family, which includes bacterial enzyme such as 
subtilisin. The general 3D structure is different in the two families but they have the 
same active site geometry and then catalysis proceeds via the same mechanism. 
4.3 Chymotrypsin 
Chymotrypsin is a digestive enzyme found in the small intestine, which belongs to 
the serine protease family. Chymotrypsin primarily catalyzes the peptide bonds of 
proteins adjacent to the carboxyl group of the aromatic amino acids such as Trp, Tyr, 
and Phe. 117  Proteolysis can also occur adjacent to other large hydrophobic amino acid 
residues, for example Leu and Met. 118  The enzyme also catalyzes hydrolysis of 
amides and esters of aromatic amino acids and a large number of other hydrophobic 
compounds.' 9  Chymotrypsin has a molecular weight of approximately 25 kDa and 
contains 241 amino acid residues. The molecule has three peptide chains: an A chain 
of 13 residue, a B chain of 131 residue, and a C chain of 97 residue (figure 27). 
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Figure 27: Crystal and Molecular Structure of the Bovine a-Chymotrypsin-Eglm C Complex at 2.0 A 
Resolution (Reproduced from Protein Data Bank). 
The main driving force for the catalysis of chymotrypsin is due to combination of 
three amino acids known as a catalytic triad i.e His 57, Asp 102, and Ser 195 (figure 
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Figure 28: Catalytic Triad of a-Chymotrypsm (Reproduced from The Enzymes; Boyer, P. D., Ed.; 
Academic press: New York, 1971, 3, 609-647). 
The first step in the catalysis is the formation of the acyl enzyme intermediate 
between the substrate and the essential Ser. The formation of this covalent 
intermediate proceeds through a negatively charged tetrahedral transition state 
intermediate and then the peptide bond is cleaved. During the second step of 
deacylation, the acyl-enzyme intermediate is hydrolyzed by a water molecule to 
release the peptide and restore the Ser-hydroxyl of the enzyme. The deacylation also 
involves the formation of a tetrahedral transition state intermediate through the 
reverse reaction pathway of acylation. A water molecule is the attacking nucleophile 
instead of the Ser residue. The His residue provides a general base and accepts the 
OH group of the reactive Ser (figure 29). 
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Figure 29: Catalysis of Peptide Bond Hydrolysis with a -Chymotrypsin (Reproduced from The 
Enzymes; Boyer, P. D., Ed.; Academic press: New York, 1971, 3, 609-647). 
4.4 Glycosylation effect Studies on Proteolytic Hydrolysis of Peptides 
/ 
Very few studies have been reported to investigate the susceptibility of glycopeptides 
to hydrolysis by proteases. As far as we know there is only one report published by 
Bock et al.  120  on the effect of glycosylation on enzymatic hydrolysis of peptides, 
however few studies have reported the glycosylation effect of protein structure and 
conformation. ' 2 ' Bock and co-workers have shown that unnatural glycosylation of an 
aspartic acid residue by lactose and lactitol in the recognition site of the protease 
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savinase can protect soluble glycopeptides from proteolytic cleavage with the effect 
most pronounced in the P i position. 
The enzyme savinase was studied in a model reaction on the hydrolysis of 
glycosylated compared with un-glycosylated peptides. Savinase is a subtilisin-type 
enzyme, which contains an extended binding cleft with up to eight binding subsites 
(denoted S5 to S3). 122  The peptide ABzPheGInPro-Leu-Asp-Glu-TYr(NO2)A5P 
OH, has shown to be a ideal substrate for this enzyme (table 6). An aromatic residue 
was desirable at P 4  position. A proline residue was accommodated preferentially at 
P2 position relative to the other sites and this directed the site of bond cleavage to the 
bond between the P 1 and the P 1 ' residues of the substrates (table 6). 
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Scissile bond 	 KcatIKm 
P5 	P4 	P3 	P2 	P i 	Pi' 	P2 ' 	P3 ' 	 P4 ' 	 (moY'itM') 
182 1125 
183 ABzAsnGlnProLeu-Asp-G1u-Ty1(NO2)-ASP-0H 1.76 
184 0.39 
185 ABzPheAsnProLeu-Asp-G1U-TYr(NO2)ASP-OH 296 
186 204 
187 ABz-Phe-Gln-Pro -Asn-Asp-Glu-Tyr(NO 2)-ASP-OH 11 
188 ABz-Phe-GIn-Pro 0.30 
189 ABz-Phe-Gln-Pro -Leu-Asn-Glu-Tyr(NO 2)-Asp-OH 4749 
190 ABz-Phe-Gln-Pro 1407 
191 ABz-Phe-Gln-Pro -Asn-Asp-Glu-Tyr(NO 2)-ASP-OH 2260 
192 ABz-Phe-Gln-Pro 852 
Asn* Indicates the Glycosylated-Asparagine 
Table 6: Kinetic Data of Hydrolysis of Substrates 182-192 with Savinase (Reproduced from Bock, K 
et al. J. Chem. Soc., Perkin Trans. 1999, 1, 1445-1452). 
4.5 Fmoc-SPPS of Glycopeptides 184-192 and Peptides 182-191 
The synthesis of glyco-amino acid 181 was achieved by using multiple protecting 
group strategy in four steps from commercially available lactose in a 31 % overall 
yield (scheme 40). Subsequently, the resulting building block 181 was incorporated 
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Scheme 40: Synthesis of Glyco-Amino Acid Building Block 181. 
4.6 Enzymatic Studies on Peptides 182-191 and Glycopeptides 184-
192 
The peptides 182-191 and glycopeptides 184-192 were generated as internally 
quenched fluorogenic compounds. The fluorogenic ABz group and the quenching 
Tyr(NO2) residue were placed at opposite sides of the site of the bond cleavage. 
Determination of the enzyme activity was performed on a luminescence 
spectrometer. The ABz group was excited at 320 nm and its emission monitored at 
420 mm In the absence of the enzyme the fluorescence was quenched 
intramolecularly by Tyr(NO 2). Upon addition of the savinase an increase in the 
fluorescence was observed, which stabilized after some time. The activity and kinetic 
constants (Kcat l KM)  obtained for each substrate are presented in table 6.120 
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The effect of the disaccharide was dependant on its position along the peptide chain. 
Although the P 4 position is important for enzyme-substrate binding, only 4 fold loss 
in activity was observed upon glycosylation at this position as compared with Asn. 
The maximum effect of the sugar residue was observed, when the site of 
glycosylation was in P 1 adjacent to the site of the bond cleavage.' 23 Thus, the 
glycosylation at P, position results in 40 fold loss in enzyme activity. These results 
suggest that the glycosylation of the peptide does not effect the peptide 
conformation. However, the differences in the rate of the enzymatic hydrolysis were 
possibly due to a steric effect of the carbohydrate moiety. 
In order to investigate the glycosylation effect on proteolysis of peptide, we have 
used the naturally occurring glycosylation motifs, in particular N-glycan motifs (Asn-
X-Ser/Thr), in which the Asn residue is glycosylated by the highly conserved core 
saccharides (G1cNAc in 193 and chitobiose in 194) and analogues (Gte in 195 and 
cellobiose 196) (figure 30). The synthesized peptide 197 and glycopeptides 198-203 
were tested against the commonly used proteases such as chymotrypsin from bovine 










195 R 	0  
196 R = 3(1-GIc 
Figure 30: Natural N-Glycans (193 and 194) and Analogous (195 and 196). 
102 
Chapter 4 	 Results and Discussion 
The core structure of N-glycosylation is highly conserved in the majority of higher 
organisms, both in the peptide and carbohydrate components. Many of these 
structures consist of tripeptide codon Asn-X-Ser/Thr, where X can be any amino acid 
except proline. Furthermore, the N-glycan linkage between sugar and polypeptide 
(figure 30), and the first five carbohydrate building blocks ('core pentasaccharide' 
Man al-3(Man al-6) Man /31-4 G1cNAc /31-4 GlcNAc) are found throughout nature. 
The present study has therefore focused on these highly conserved core structures, 
incorporating at the same time potential proteolysis sites. 
In a previous report, 107  we have shown that in PEGA 1900 both chymotrypsin and 
thermolysin have access to all reactive sites and can cleave susceptible peptide bonds 
on the resin quantitatively. Given that peptides and glycopeptides are often not 
soluble in aqueous buffers, it was decided to evaluate the substrates on solid phase. 
Thus, a control peptide 200 and glycopeptides 201-206 were generated on a 
PEGA 1900 , linked to the resin via the Wang linker (HMPA, 
hydroxymethylphenoxyacetic acid) (scheme 41). The un-glycosylated peptide 200 
containing a tert-butyl ester of aspartic acid was selected as the control peptide 
sequence because of the problems with dehydration were observed when trying to 
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4.7 Fmoc-SPPS of Peptide 200 and Glycopeptides 201-206, 
Subsequent Hydrolysis with Chymotrypsin. 
The solid supported protease substrates were synthesized by standard Fmoc-SPPS 
method. In the first step HMPA (3 eq) was coupled to amino functionalized 
PEGA 1900 (0.15 mmolg 1 d, 10 % wt in MeOH) resin 197 in the presence of HOBt (6 
eq) and DIC (6 eq) in DMF to afford 198. Subsequently, Fmoc-Ser(Trt)-OH (10 eq) 
was coupled to 198 via the symmetrical anhydride method to afford 199. The 
remaining synthesis of peptide 200 and glycopeptides 201-206 were achieved with 
Fmoc-L-amino acidlglyco-amino acid (4 eq), TBTU (4 eq), HOBt (4 eq) and DIPEA 
(8 eq) in DMF. The deprotection of trityl group of Ser was achieved using 
TFAITIS/DCM (1:5:94) to generate substrates 200-206 (scheme 41). 
1. HMPA, HOBt, DIC, 	 O)l N_ 







Fmoc-SPPS DIC, DMAP, DMF 
RI, overnight 
V 	 3. 20 % pipendine in 
I DMF, RT, 1 hr 
Fmoc -Asn-Phe - X-Ser(Trt)-HMPA —(Z Fmoc-Ser(Trt)-HMPA —E2 
4. Fmoc-Amino Acid/ 
Glyco-Amino Acid, 199 
TBTU, HOBt, DMF, 
RT. 4 hrs 
5. TFIS/DCM (1:5:95) 
Fmoc -Asn-Phe- X -Ser-HMPA— . 
5 min x 4 
200-206 
= ter-Butyl. X = Gly, Table 7, entry 1 	= Carbohydrate, X = Gly, Table 7, entries 2.3 
= Carbohydrate, X = none, Table 7, entries 4,5,6,7 
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The chemical synthesis could be conveniently monitored by hydrolysis of the Wang 
linker using TFA/H 20 (95:5) and subsequent analysis by LC-MS. The chemical 
cleavage allowed us to determine the loading of the resin and hence efficiency of 
subsequent enzymatic hydrolysis. The solid supported substrates 200-206 (0.075 g, 
0.001 mmol) were washed thoroughly with buffer prior to enzymatic cleavage and 
then subjected to enzymatic hydrolysis by incubating with protease chymotrypsin (2 
mg/mi of 0.1 M KPi buffer pH 8.0) for 16 hrs (table 7). 
0 
Fmoc -APhe-XHNL0 j 
OH HMPA 	PEGA 
200-206 
= Sugar, tert-Butyl, X=Gly, none 
chymotrypsin (2 mg/ ml of 0.1 M 
KPi buffer, pH 8.0), RT, 16 hrs 
7 
Fmoc -Asn-Phe-COOH + Fmoc -Asn-Phe-X-Ser-COOH 
207-213 	 214-220 
Entry Peptide /Glycopeptides Product (ratio) 
1 Fmoc-Asp(OtBu)-Phe-Gly-Ser-HMPA-PEGA 200 207: 214 (6: 1) 
2 Fmoc-Asn(G1cNAc)-Phe-Gly-Ser-HMPA-PEGA 201 208: 215(1: 1.6) 
3 Fmoc-Asn(Chitobiose)-Phe-Gly-Ser-HMPA-PEGA 202 209: 216 (1:1.8) 
4 Fmoc-Asn(G1cNAc)-Phe-Ser-HMPA-PEGA 203 210: 217 (1: 2) 
5 Fmoc-Asn(Glc)-Phe-Ser-HMPA-PEGA 204 211: 218 (1: 2.2) 
6 	Fmoc-Asn(Chitobiose)-Phe-Ser-HMPA-PEGA 205 	212: 219 (1: 2.5) 
7 	Fmoc-Asn(Cellobiose)-Phe-Ser-HMPA-PEGA 206 	213: 220 (1: 2.5) 
Table 7: Chymotrypsin Mediated Hydrolysis of Substrates 200-206. 
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The hydrolysis mixtures were analysed by LC-MS using the reverse phase 
conditions. The chymotrypsin mediated and TFA hydrolysis yields were calculated 
from LC-MS data. 
We have already shown in chapter 3 of this thesis that the protease chymotrypsin 
catalyzes the hydrolysis of the ester bond of the Wang linker in peptides such as 200-
206 in competition with any peptide bond containing Phe or Tyr in the P 1 position. 
124 
Thus two possible products 207-213 and 214-220 can be obtained by hydrolysis of 
200-206 with chymotrypsin. Analysis of the substrates 200-206 incubation with 
chymotrypsin is shown in table 7. When the glycosylated peptide 203 was incubated 
with chymotrypsin, hydrolysis of the Wang linker was preferred to hydrolysis of the 
Phe-Ser bond leading to a mixture of 210 and 217 in a ratio of 1:2, respectively 
(entry 4, table 7). It was interesting to note that the product 217 could be isolated; 
given that in itself it should be a substrate for the chymotrypsin. However, we had 
previously observed that soluble FmocPheAsp and FmocPheGly did not undergo any 
hydrolysis when incubated with chymotrypsin. A possible explanation might be 
issues of solubility of the peptide, which could make it inaccessible to enzymatic 
hydrolysis. 
The sugar and the sugar-peptide linkage in 203 present the natural highly conserved 
core structure. When the next saccharide was added to form a chitobiosyl peptide 
205 (entry 6, table 7), selectivity for the Wang linker cleavage was not significantly 
enhanced. Equally, hydrolysis ratios were also the same for the unnatural 
glycopeptides 204 and 206 (entries 5 and 7, table 7), suggesting that the 2-N-acetyl 
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groups of G1cNAc and chitobiose are not involved in stabilization of the linkage 
towards hydrolysis by chymotrypsin. The ratios of hydrolysis products also remained 
similar when a Gly residue was introduced into the Phe-Ser sequence (entries 2 and 
3, table 7), suggesting that cleavage at the Wang linker was not much affected by 
distant glycosylation. However, when the N-glycan site on the peptide in the P 2 
position was replaced with the tert-butyl ester of aspartic acid 200 (entry 1, table 7), 
the selectivity was reversed and the Phe-Ser bond was preferentially cleaved to give 
207 and 214 in a ratio of 6:1. Thus it appears that even a monosaccharide in the P 2 
position can inhibit the proteolysis by chymotrypsin. 
4.8 Hydrolysis Studies of Substrates 200-202 with Thermolysin 
In a different experiment, the substrates 200-202 were incubated with another 
protease thermolysin (2 mg/ml of 0.1 M KPi buffer pH 8.0) for 16 hrs. The 
hydrolysis mixture was analysed by LC-MS using the reverse phase conditions. 
Analysis of the substrates 200-202 upon incubation with thennolysin are shown in 
table 8. 
Substrates 200-202 were also potential substrates for the protease thermolysin and 
were therefore further investigated. Based on our previous research, thermolysin 
would be expected to cleave the Asn-Phe bond but not the Wang linker. Analysis of 
the incubation products of 200-202 with thermolysin appeared to show that 
glycosylation at the P 1 position site did not affect the proteolysis giving products 










= Sugar, tert-Butyl 
200-202 
thermolysin (2 mg/ ml of 
0.1 M KPi buffer pH 8.0), 




Entry 	 Peptide /Glycopeptides 	 Product (yield %) 
I 	Fmoc-Asp(OtBu)-Phe-Gly-Ser-HMPA-PEGA 200 	221(100 %) 
2 	Fmoc-Asn(G1cNAc)-Phe-Gly-Ser-HMPA-PEGA 201 	222(100%) 
3 	Fmoc-Asn(Chitobiose)-Phe-Gly-Ser-HMPA-PEGA 202 	223(100 %) 
Table 8: Thermolysin Mediated Hydrolysis of Substrates 200-202. 
4.9 Conclusions 
In conclusion, we have shown that the natural N-glycan and their analogues of 
glycopeptides can protect peptides from proteolysis. However, our results in 
combination with those of others show that protection from proteolysis is highly 
dependant on the individual protease and also the position of the glycosylation site 
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5. Total Chemical Synthesis of Membrane Co-Factor 
Protein Module 1 (MCP 1) 
5.1 Introduction 
Chemical synthesis of proteins has great potential for the understanding of protein 
structure and function. During the period of 1990-2005, the applicability of chemical 
protein synthesis has greatly expanded by a significant increase in the size of 
accessible proteins. Introduction of the native chemical ligation strategy to join two 
peptide segments, such as N-terminal cysteine 224 and C-terminal thioester 225 in an 
aqueous system at pH 7.0 has facilitated the synthesis of proteins. 
125,126,127,128 Native 
chemical ligation involves the reaction of a peptide a-thioester 225 with cysteine 
peptide 224. A reversible thioester-thiol exchange with the N-terminal cysteine 
residue affords a thioester linked intermediate 226, which undergoes an 
intramolecular rearrangement to produce a full length peptide 227 with a native 
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H3N-PePide1J-R H25_ COO. 
225 	 224 
Transthioesterfication 
H3N-fptidei 	





H3N-eptide1 i5_ _ Coo. 
227 
Figure 31: Representation of Native Chemical Ligation to Afford Full Length Peptide 227. 
Different ligation chemistries have been developed 121,111,131,132  and have led to the 
practical chemical synthesis of a variety of different classes of proteins.' 27 Synthetic 
access to proteins has been used to reveal the protein folding, stability and 
function,' 33  to design and generate proteins of novel structure, 
134  and to determine 
the structure of proteins by NMR.' 35 Chemical protein synthesis has also been used 
to develop protein therapeutic agents with improved activities.' 11,13'  The target of the 
present project was the synthesis of glycoproteins, specifically human CD46. 
5.2 Structure and Functions of Human CD46 
The measles virus is a paramyxovirus, which is a major cause of morbidity and 
mortality all over the world. Human CD46 has been shown to be the receptor for at 
least two measles virus strains. 89 Human CD46 is also known as a membrane co- 
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factor protein (MCP), which is a widely expressed glycoprotein. SCR I and SCR 2 
are the two N-terminal modules of human CD46, which is the part of the 
complement co-factor system. Recent studies have shown that recombinant CD46 
inhibits complement activation, suggesting a potential role for the molecule as a 
therapeutic agent. 137  Two short peptides of CD46, such as SCR I and SCR 2 
probably interact with the measles virus. 138  X-ray crystallography studies have been 
used in order to understand the interaction between CD46 and the measles virus and 
to study the role of the short consensus repeats (SCR) as virus receptors. 
5.3 Structure Determination of Human CD46 
In order to obtain a homogeneous and high mannose glycoform of human CD46, a 
soluble fragment containing two N-terminal short consensus repeats was expressed in 
a lectin-resistant Chinese hamster ovary, Lec 3.2.8.1 cell line. The crystallized 
protein consists of 126 amino acid residue and two N-linked high-mannose sugars. 89 
The structure of the two N-terminal short consensus repeats (SCR) of CD46 is shown 
in figure 32. The structure reveals that the polypeptide chain folds into two 
concatenated fl-barrels, each of these barrel containing two disulfide bonds and an N-
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Figure 32: Structure of Two N-Terminal Short Consensus Repeats (SCR 1 and SCR 2) of CD46 
(Reproduced from Casasnovas, J. M etal. EMBOJ. 1999, 18, 2911-2922). 
The N-linked glycan attached to Asn 80 in SCR 2 has been shown to be essential for 
measles virus binding89 (figure 33). The glycan is located on the side opposite to the 
virus-binding surface and makes hydrophobic interactions with residues Tyr 87 and 
Ile 104 in all six crystallographic independent copies of the molecule. Therefore, one 
would not expect this carbohydrate to contact the virus. However, it has been 
suggested that glycosylation stabilizes the conformation of the virus-binding surface 
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Figure 33: Representation of Interaction between Tyr 87 and Methyl Group that Belongs to First 
GIcNAc of Core Pentasaccharide in SCR 2 (Reproduced from Casasnovas, J. M et al. EMBO J. 1999, 
18, 2911-2922). 
Previously, O'Leary 139  has attempted the chemical synthesis of membrane co-factor 
protein module 1 (MCP 1) using linear and stepwise synthesis, to investigate the 
comparative study with recombinantly expressed MCP 1. 
The synthesis of MCP 1 corresponding to native human MCP sequence (figure 38) 
was performed on 0.1 mmol scale of Wang resin, using stepwise Fmoc-SPPS. The 
amino acids were coupled using DIC/HOBt activation conditions except for His 78 
and His 85 and residues Asp 61 to Lys 66 were double coupled. 139  During the 
synthesis of MCP 1, —30 % of the resin was removed due to excess swelling. A 
number of coupling steps appeared to be in more than 100 % yield, which might be 
113 
Chapter 5 	 Results and Discussion 
due to excess swelling of the resin. Another limitation of the synthesis was that 
coupling efficiencies decreased in case of Asn 83 and Asp 61 to Lys 66, despite the 
double coupling cycles. These decreased coupling efficiencies indicate that the 
synthesis of MCP 1 did not proceed efficiently. 
In order to differentiate the target sequence from deletion and truncated sequences, 
an isotopically labeled Fmoc-Gly(' 4C-UL)-OH was introduced at the N-terminus of 
the resin bound protein. Subsequent analysis indicated that only 2 % of the 14C label 
was incorporated into the protein, despite 10-fold excess of Fmoc-Gly(' 4C-UL)-OH 
over the resin bound protein. This observation suggests that only 20 % of the resin 
bound peptides consist of a free terminal amino group, indicating that the synthesis 
of the full-length sequence did not progress satisfactorily and that the majority of the 
resin bound species were truncated and deleted peptides. 
The polypeptide was cleaved from the resin using a cleavage cocktail of 
TFAIEDT/TIS/phenol/thioanisole and at the same time side chain protecting groups 
were removed. Subsequently, the crude protein mixture was dissolved in 8 M urea, 
0.1 M TrisHCl, 0.2 M fl-mercaptoethanol then incubated at 37 °C to denature and 
reduce the proteins. 
Scintillation counting confirmed the incorporation of the 14C label. The yield of the 
14C labeled protein was calculated by specific activity of Fmoc-Gly( 14C-UL)-OH and 
was found to be 14 j.tmmol. The total yield (-. 52 tmmo1) of the crude peptide 
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The cleaved peptide mixture was analyzed by RP-HPLC and HPLC results of crude 
protein mixture revealed that the presence of a number of closely eluted protein 
species over the range 43-50 % acetonitrile (0.1 % TFA) (figure 34). The 14C label 







Figure 34: RP-HPLC of Crude Peptide Mixture (C4 reverse phase column with a gradient of 10-50 % 
of acetonitrile (0.1 % TFA) in water over 30 mm) (Reproduced from thesis of O'Leary. 1999). 
Subsequently, the purification of crude reaction mixture was subjected to size 
exclusion chromatography to remove small truncated and deletion peptides. The 
crude peptide mixture eluted from the column contained two broad peaks A and B, 
respectively (figure 35). The fractions collected for peak A had the expected elution 















Figure 35: Size Exclusion Chromatography of MCP 1 reaction mixture [Pharmacia G 30 HiLoad 
Superdex 16/60 column in 8 M urea, 0.1 M TrisHCl (pH 8.8) and 50 m mercaptoethanol at 0.5 
ml/min] (Reproduced from thesis of O'Leary. 1999). 
Subsequently, the fractions collected from SEC for peak A were concentrated and 
performed by the refolding experiment, using refolding buffer of 0.1 M TrisHCl (pH 
8.2), 3 mM reduced glutathione (GSH), 0.3mM oxidized glutathione (GSSH) and 1 
mM EDTA, in order to dilute the protein to - 100 p.gIml. It was anticipated that the 
presence of the glutathione redox pair would provide an appropriate oxidizing 
environment to the formation of disulphide bonds of MCP 1. 
Following, the refolded sample for fraction A was analysed by RP-HPLC and then 
ES-MS. The HPLC data shows an overlapping broad peak and mass spectral data 
revealed a range of molecular weights was observed along with some material of 
expected mass of synthetic MCP 1 (775513a). 
RP-HPLC and ES-MS analysis was performed with sample fraction B. The mass 
data of fraction B revealed that only peptide masses in the range of 3.5-4.8 kDa were 
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identified as deleted and truncated peptides. The major mass units were at 4421 Da 
and 4348 Da. 
In the next stage, the major MCP 1 containing fractions were subjected to anion 
exchange chromatography. The results of anion exchange chromatography shows 
that a good separation from a number of other protein containing fractions was 
achieved. 
Isolation of the protein contained within the major peak by RP-HPLC and 
subsequent ES-MS confirmed that the major protein identified had a mass of 7757.3 
Da, which was in agreement with calculated oxidized synthetic MCP 1 mass. Of the 
remaining contaminants, one was identified as oxidized methionine (7773.5 Da). 
Subsequently, the fractions contained MCP 1 collected from the ion exchange 
chromatography, was subjected to hydrophobic interaction chromatography (HIC). 
Application of the major protein fractions obtained from ion exchange 
chromatography to the hydrophobic matrix resulted again in a broad peak. Analysis 
of the major protein containing fractions such as A and B from hydrophobic 
interaction chromatography by ES-MS suggests that purification of MCP 1 to 
homogeneity was not achieved. 
After unsuccessful attempts on the linear synthesis of MCP1 by O'Leary,' 
39  it was 
decided to take up the chemical synthesis of MCP 1 module by means of Fmoc-SPPS 
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and native chemical ligation strategy developed by Kent et al. 
128  rather than using 
linear and stepwise approach. 
The linear and stepwise synthesis of peptides larger than 50 amino acid residue, is 
compromised by the accumulation of the resin bound by-products such as deleted 
and truncated peptides. 121,62  Most of the full length proteins of biologically interest 
exceed this length and therefore are not accessible by conventional methods. To 
overcome this limitation of peptide synthesis, selective ligation strategies have been 
developed for the assembly of proteins with native amide bonds from unprotected 
peptide segments. 128,140 
Recently Kent and co-workers ' 4 ' have reported the total chemical synthesis of 
crambin by employing the ligation of three segments with overall 46 % yield (figure 
36). Crambin is a small protein isolated from the seeds of the plant Crambe 
abyssinica. Crambin has been used as a model for the development of advanced 
crystallography, NIMR techniques and for computational folding studies. Initially the 
synthesis of crambin was achieved from two peptide ligation strategy. 14 ' The peptide 
fragments were synthesized by Boc-SPPS strategy and subsequent native chemical 
ligation gave synthetic crambin. The synthetic crambin was folded in good yield. 
However, there were a few problems associated with the synthesis, such as 
difficulties in purification of peptide segments and also the overall yield was poor. 
To overcome this problem, the synthesis of crambin was obtained by three segment 
ligation. The acetamidomethyl group (Acm) was used to protect the side chain thiol 
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the final ligation. The yield of the polypeptide was increased 10 fold with higher 
purity from three segment ligation. 
Boc-SPPS 
36% 













46% 1. Native chemical ligation 1 
2. Removal of Acm group 
SH 
HS  
16-31 I)c N7 r 32-46 1OH 
H2N 	 H 
70 % 13. Native chemical ligation 2 
H2N—1 	1-15 	 32-46  H 	 OH H 
80 % Refolding 
V 
Crambin 
Figure 36: Total Chemical Synthesis of Crambin by Three Segment Ligation (Reproduced from Kent, 
S. B. H etal. J. Am. Chem. Soc. 2004, 126, 1377-1383). 
Consequently, we have decided to apply a crambin synthetic strategy to membrane 
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5.4 Initial Synthetic Strategy for Membrane Co-Factor Protein 
Module 1 (233) 
The synthetic strategy for membrane co-factor protein module 1 (MCP 1, 233) is 
outlined in figure 37. The MCP 1 module contains 66 amino acid residue and was 
divided into three different segments. In our initial synthetic strategy the amino acid 
Ile (79 th  amino acid in the sequence) was replaced with Ala, as the bulky nature of lie 
is known to lead to extremely sluggish ligation reactions. 141 
Fmoc-SPPS 	 Fmoc-SPPS 	 Fmoc-SPPS 
110 110 110 
AcmS 	 11 	HS—\.._. )
80- 
232 	 H2N 	229 	 H2N 	 228 
1. Native chemical ligation 1 
AcmS 	
_64 - 	 80 - 97 V0H 
H2N 	 230 H 




H2N 	 231H 







Membrane Co-Factor Protein Module I 
Figure 37: Initial Synthetic Strategy for MCP 1 (233). 
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Retrosynthetic analysis of the MCP 1 module (233) provided three peptide segments 
228, 229 and 232. The C-terminal cysteine fragment 228 (80-97 residue), could be 
synthesized on a Wang resin employing Fmoc-SPPS followed by cleavage under 
acidic conditions with the appropriate scavengers. The second fragment 229 is a 
thioester (64-79 residue), which can be achieved by safety catch linker strategy 
developed by Ellman' 42 and Fmoc-SPPS followed by activation and cleavage of 
thioester. Subsequently, native chemical ligation between fragments 228 and 229 to 
afford Acm protected peptide 230. 
The middle thioester fragment 229 has both an N-terminal cysteine and a C-terminal 
thioester moiety, either a-amino or the side chain thiol of the cysteine must be 
protected until after the first ligation to avoid the undesired cyclization. 143 The 
acetamidomethyl group (Acm) was used to protect the side chain thiol of cysteine of 
the middle peptide segment, 126,144 which can be removed under silver or mercuric 
acetate 136  followed by quenching the reaction with ,8-mercaptoethanol or DTT to 
afford peptide 231. N-Terminal thioester fragment 232 (32-63 residues) again can be 
synthesized using safety catch linker strategy and Fmoc-SPPS followed by activation 
cleavage with appropriate scavengers. 
After removal of the Acm group of peptide 230 by Ag(OAc)2 or Hg(OAc) 2 , final 
ligation could be performed from cysteine fragment 231 and thioester fragment 232 
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32SDACEEPP 40TFEAMELIGK 50PKPYYEIGER 60VDYKCKKGYF 
70YIPPLATHTI 80CDRNHTWLPV 90SDDACYRE 
Figure 38: Target Sequence of Native MCP 1 (233). 
5.5 Fmoc-SPPS of C-Terminal Cysteine Fragment 228 
The cysteine fragment 228 was assembled on a pre-loaded Fmoc-Glu(O tBu)-Wang 
resin (0.08 g, 0.05 mmol, which is based on 0.62 mmolg 1 of loading). The resin was 
treated with 20 % piperidine in DMF followed by standard Fmoc-SPPS, using TBTU 
(4 eq), HOBt (4 eq) and DIPEA (8 eq) in DMF activation conditions for 4 hrs. The 
progress of the reaction was monitored by Kaiser test. The resin was washed with 
standard washing protocol followed by ether and dried, prior to final cleavage of the 
peptide from the resin. The vacuum dried resin was treated with a cleavage cocktail 
of TFAJEDTIH2O/TIS (94:2.5:2.5:1) for 4 hrs to afford peptide 228 in 32 % yield. 
The cleavage mixture contains EDT and TIS, which act as scavengers for tert-
butyl/trityl cations (scheme 42). 
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Scheme 42: Fmoc-SPPS C-Terminal Cysteine Peptide 228. 
The crude peptide was analyzed by LC-MS using reverse phase conditions. The LC-
MS results are shown in figure 39 & table 9: The LC-MS data shows that the 
presence of a desired peak at 15.73 mm (mass 2180.3) of retention time and a 
deletion peptide at 17.06 mm (mass 1119). 
Figure 39: UV Trace of LC-MS for Crude Cysteine Peptide 228 (Luna 5 t C18 column and 5-60% 
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Entry Retention time 
1 15.73 mm 
2 17.06 mm 
MS (ES!) 
2181.3 [M+H], 1091 [+2] 
1119, 948 
Table 9: Mass Data of LC-MS for Crude Peptide 228. 
The crude peptide 228 was purified by LC-MS(ZMD) using reverse phase conditions 
to afford 228 as a white fluffy solid. Subsequently, the purified peptide was analysed 
by LC-MS using reverse phase conditions (figure 40). Unfortunately, the recovery of 
the purified material on LC-MS(ZMD) was very poor (5-10 %). The desired peak 
was found at a retention time of 15.03 mm (mass 2180.3) and the mass spectrum 





Figure 40: UV Trace of LC-MS for Purified Cysteine Peptide 228 (Luna 5p. C18 column and 5-60% 
MeCN (0.1 % TFA)1H 20 (0.1 % TFA) as a gradient with flow rate of 0.2 ml min -' for 33 mm). 
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5.6 Synthesis of Middle Thioester Fragment 229 
Traditionally, thioester fragments have been synthesized by two different strategies. 
The first one is by Boc-strategy developed by Kent et a!, which requires strong HF 
treatment to cleave the peptide thioester from the solid support. The second approach 
uses Fmoc-strategy, which has been developed by Eliman, using an 
alkanesulfonamide safety catch linker 142  based on Keimer's original 
arenesulfonamide safety catch linker. 145  The Kenner's sulfonamide safety catch 
linker 234 was used to attach the carboxylic acids to the solid support and the linker 
was found to be stable under both acidic and basic conditions (scheme 43). 









_________ 	\\// Nucleophile 
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235 R 1 = CH3 
236 R 1 = CH 2CN 
Scheme 43: Representation of Kenner's (235) and Eliman's (236) Safety Catch Linkers. 
Kenner had originally employed an arenesulfonamide linker for SPPS, which was 
activated with diazomethane to afford NN-methylacylsulfonamide 235, can 
subsequently be cleaved under forcing conditions such as aminolysis, hydrazinolysis 
and saponification furnishing primary amides, hydrazones and carboxylic acids 
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respectively. However, Kenner's linker system suffered from few a limitations such 
as poor loading, enantiomerisation in the loading step and poor reactivity of the N,N-
methylacylsulfonamide that is obtained from diazomethane activation. 
In Ellmans strategy, the alkanesulfonamide safety catch linker was activated by N-
alkylation of N-acylsulfonamide by haloacetonitrile to afford a very reactive N,N-
cyanomethyl acylsulfonamide 236, for mild nucleophilic displacement. 
146 The alkane 
sulfonamide safety catch linker strategy was applied to the synthesis of a variety of 
peptides and they were activated and cleaved with very good yields and minimum 
enantiomerisation (scheme 43). Consequently, we have decided to apply Eliman 
safety catch linker strategy for the synthesis of thioester segments of MCP 1 (233). 
The synthesis of middle thioester segment 229 was performed on a pre-loaded Ala 
sulfamylbutyrylNovaSyn-TG resin (0.1 mmol, based on 0.23 mmolg' of loading). 
The extension of the peptide chain was achieved using Fmoc-SPPS by activation of 
the amino acid with TBTU (4 eq), HOBt (4 eq) and DIPEA (8 eq) in DMF followed 
by Fmoc deprotection with 20 % piperidine in DMF. After final amino acid coupling 
the resin was washed extensively with standard washing protocol followed by ether 
and then dried in 'a vacuum oven. The dried resin was activated with iodoacetonitrile 
(100 eq) and DIPEA (10 eq) in NMP and agitated at room temperature for 24 hrs. 
Subsequently, the resin was treated with benzyl mercaptan (50 eq) and 
sodiumthiophenoxide (0.5 eq) in THE ' 2 The resin was filtered and the filtrate was 
precipitated with cold ether followed by treatment with TFAIH 20/TIS (95:2.5:2.5) to 
remove the side chain protecting groups afford the peptide thioester 229 (scheme 44). 
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Scheme 44: Fmoc-SPPS of Middle Thioester Fragment 229. 
The crude peptide 229 was analysed by LC-MS using reverse phase conditions. The 
LC-MS results are shown in figure 41 & table 10. The LC-MS data shows that the 
presence of a desired mass at 17.64 mm (mass 1987.3) of retention time as well as 





Figure 41: UV Trace of LC-MS for Crude Peptide 229 (Luna 5j.t C18 column and 5-60% MeCN (0.1 
%TFA)/H20 (0.1 % TFA) as a gradient with flow rate of 0.2 ml min - ' for 33 mm). 
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Entry Retention time 	MS (ESI) 
1 	17.64 min 	1988.3 [M+H], 995.2 [+2] 
2 	17.84 min 	1916.8, 959.4 
3 	18.81 min 	1020.9, 927.6 
Table 10: Mass Data of LC-MS for Crude Peptide Thioester 229. 
The crude peptide thioester 229 was purified by LC-MS(ZMD) using reverse phase 
conditions. Subsequently, the purified peptide 229 was analysed by LC-MS using 
reverse phase conditions (figure 42). The recovery of the purified peptide thioester 
on LC-MS(ZMD) was again very poor (5-10 %). The desired product was observed 
at retention time of 17.5 mm (mass 1987.3) under 214 nm. 
ty:r1m0O'I0 rjIxv  LNI 
MI 
Time 
Figure 42: UV Trace of LC-MS for Purified Thioester Peptide 229 (Luna 5i C18 column and 5-60% 
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5.7 Synthesis of Peptide 230 by Native Chemical Ligation 
5.7.1 Ligation with Crude Peptide Segments 
Initially the ligation for peptide 230 was performed with crude substrates cysteine 
segment 228 and thioester segment 229, because of the inefficient purification of the 
peptides using LC-MS(ZMD) purification system. The synthesis of peptide 230 was 
performed using the crude peptide thioester 229 (0.9 jimol) and crude cysteine 
peptide 228 (0.9 p.mol) in a 0.1 M phosphate buffer pH 7.8 (650 p1) containing 
thiophenol (12 p.!) at room temperature for 24 hrs (scheme 45). 
AcmS 
H2NCO-KKGY FYIPPLATHTNI(SBn 
229 	 0 
HS.. 	 + 
H 2N'CO RNHTWLPVS D DACYRECOO 
228 
6 M Gn HCI, 0.1 M Phosphate buffer pH 7.5 
1 % v/v Thiophenol, RT, 24 hrs 
AcmS-1 
H2NCO4( KG Y F Y I P P L A T H T A C D RN HT W  P V S D D ACYRE-CO0 
230 
Scheme 45: Synthesis of Peptide 230 by Native Chemical Ligation. 
The reaction mixture was analysed by LC-MS using reverse phase conditions (figure 
43). The LC-MS data of crude ligation mixture revealed the presence of a desired 
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mm (mass 2180.9) and 229 at 18.53 mm (mass 1987.3) respectively (table 11). The 
purification attempts using C18 colunm and reverse phase conditions of the crude 
ligation product 230, by LC-MS(ZMD) was unsuccessful. 
Figure 43: TIC of LC-MS for Crude ligation Mixture of 230 (Luna 5j.t C18 column and 5-60% 
MeCN (0.1 % TFA)/H 20 (0.1 % TFA) as a gradient with flow rate of 0.2 ml min' for 33 mm). 
Entry Retention time 	 MS (ES!) 
15.93 min 	 1091.7, 727.9 
2 	17.03 min 	1349.1 [+3], 1012.1 [+4], 810 [+5] 
3 	17.82 min 	1792.5, 897.7, 598.3 
4 	18.53min 	 994.8, 663.7 
Table 11: Mass Data of LC-MS for Crude Ligated Peptide 230. 
5.7.2 Ligation of Purified Peptide Segments to Afford 230 
After unsuccessful attempts at the synthesis and purification of peptide 230 using 
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purified peptides. In a typical experiment the cysteine fragment 228 (0.22 .tmol) and 
peptide thioester 229 (0.22 j.xmol) were added to 0.1 M phosphate buffer pH 7.5 
contained 6 M On HC1 (152 p.1) and thiophenol (1.5 p.1, 1 % v/v). The overall 
reaction concentration was maintained at 1.5 mM. The reaction mixture was left on 
an agitator for 24 hrs (scheme 45). The aliquots were taken into 1 ml of 
CH3CN/H20/TFA (1:1:0.1) and the reaction mixture was analysed by LC-MS using 
reverse phase conditions. The LC-MS data revealed that the presence of a major 
desired mass peak at retention time of 20.12 mm (mass 4043.4) and also a starting 
material 228 at retention time of 21.26 mm (mass 2181.3) (figure 44 & table 12). 




Figure 44: UV Trace of LC-MS for Ligated Peptide 230 (Luna 5 it C18 column and 5-60 % MeCN 
(0.1 % TFA)1H 20 (0.1 % TFA) as a gradient with flow rate of 0.2 ml min ' for 33 mm). 
Entry Retention time 	 MS (ESI) 
1 
	
20.12min 	 2181.3, 727.9 
2 	21.26min 	2021.9 [+2], 1349.3 [+3], 1011.9 [+4] 
Table 12: Mass Data of LC-MS for Ligation Reaction Mixture of 230. 
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After 24 hrs, peptide 229 (0.2 mg) was added to the reaction mixture to complete the 
reaction and was left at room temperature for 24 hrs. The reaction was again 
monitored by LC-MS using the reverse phase conditions. The LC-MS data shows 
that both starting materials were consumed. However, there was no indication of 
desired product this time. We believe that the peptide may have decomposed due to 
the long reaction time (48 hrs). 
After unsuccessful attempts on native chemical ligation of peptide 230 and problems 
in the purification of the peptide fragments 228, 229 and 230 by LC-MS(ZMD) 
purification system, it was decided to change the synthetic strategy of MCP 1 (figure 
45). In this strategy a single ligation from two long peptide segments, such as 232 
and 237 was chosen instead of two ligations from three peptide segments (figure 37). 
Fmoc-SPPS 	 Fmoc-SPPS 
II 0 	 HS  
32 -63 I)SR 	




1. Native chemical ligation 
SH 




Membrane Co-Factor Protein Module I 
Figure 45: Second Synthetic Strategy for MCP 1 (233). 
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5.8 Fmoc-SPPS of C-Terminal Cysteine Fragment 237 
The synthesis of the 32mer cysteine fragment 237 was performed on a pre-loaded 
Fmoc-Glu(O tBu)-Wang resin (0.15 mmol, based on 0.62 mmolg' of loading). The 
Fmoc was removed with 20 % piperidine in DIv[F for 1 hr. The peptide was extended 
by Fmoc-SPPS by activation with TBTU (0.6 mmol), HOBt (0.6 mmol) and DIPEA 
(0.12 mmol) in DMF for 4 hrs. The resin was washed with standard washings 
followed by ether and then dried in a vacuum oven. The vacuum dried resin was 
treated with cleavage mixture of TFAIEDT/H 20/TIS (94:2.5:2.5:1) to remove the 
side chain protecting groups and at the same time to cleave the peptide from the resin 
to afford peptide 237 (scheme 46). 
Fmoc-Glu—Ø 
1. 20% piperidine in DMF, RT,1 hr 
Fmoc-SPPS 2. Fmoc-amino acid, TBTU, 
HOBt, DIPEA, DMF, RT, 4 hrs 
E-COOH  
3 TFA1TIS/H 20/EDT (94:1:2.5:2.5) 
RT, 5 hrs 
H2N-C K K G Y F Y I P P L A T H T I C D R N H T W L P V S D D A C Y R E-COOH 
237 




Results and Discussion 
The crude peptide 237 was analysed by LC-MS using reverse phase conditions. The 
LC-MS data shows that the presence of a desired peak at 16.83 mm (mass 4014.5) 




Figure 46: UV Trace of LC-MS for Crude Cysteine Peptide 237 (Luna 5i C18 column and 5-60 % 
MeCN (0.1 % TFA)/H 20 (0.1 % TFA) as a gradient with flow rate of 0.2 ml mm' for 33 mm). 
Entry Retention time 	 MS (ESI) 
1 	16.83 min 	2008.4 [+2], 1339.1 [+3], 1004.9 [+4], 804.5 [+5] 
2 	17.13 min 	 1361.7, 1022.1, 817.7, 681.8 
3 	17.72 min 	 1048.2, 838.7, 699.5 
4 	18.60 min 	 1427.7, 1071.5, 857.7 
5 	18.19 min 	 1388.7, 1064.9, 833.7, 710.5 
Table 13: Mass Data of LC-MS for Crude Cysteine Peptide 237. 
The crude peptide 237 was purified by LC-MS(ZMD) using reverse phase 
conditions. The purified peptide 237 was analysed by LC-MS using reverse phase 
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Figure 47: UV Trace of LC-MS for Purified Cysteine Peptide 237 (Luna 5p. C18 column and 5-60% 
MeCN (0.1 % TFA)/H20 (0.1 % TFA) as a gradient with flow rate of 0.2 ml min - 1 for 33 mm). 
5.9 Synthesis of N-Terminal Thioester Fragment 232 
It was decided to perform the synthesis of peptide thioester 232 using the safety 
catch linker strategy as previously discussed for the synthesis of thioester peptide 
229. The pre-loaded Fmoc-Lys-sulfamylbutyryl resin was not commercially 
available and it was necessary to load it onto the sulfamylbutyryl resin. Hence, 
Fmoc-Lys was coupled as the acid fluoride following the literature procedure. 
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5.9.1 Synthesis of Fmoc-Lys(Boc)-COF 238 
The synthesis of the acid fluoride 238 was performed using a method developed by 
Carpino et al. 88  The Fmoc-Lys(Boc)-OH (4.26 mmol) was treated with cyanuric 
fluoride (8.52 mmol) and pyridine (4.28 mmol) in DCM at room temperature to 
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NHBoc Cyanuric fluoride 	
NHBoc 
FmocHNflOH 	Pyridine, DCM, RT FmocHN 
3 hrs 
0 	 0 
238 
Scheme 47: Synthesis of Acid Fluoride 238. 
5.9.2 Loading of 238 onto Sulfamylbutyryl AM Resin 
147  to Afford 
239 
The sulfamylbutyryl AM resin (0.22 mmol based on 1.1 mmolg 1 ) was allowed to 
swell in CH202 containing DMAP (0.44 mmol) and DIPEA (0.66 mmol). The 
compound 238 (0.66 mmol) in CH202  was added to the resin. The resin was left on 
an agitator at room temperature for 2 hrs (scheme 48). This process was repeated 
once more to get better loading. The resin was washed with standard washing 




+ 	H 2N- ---- HN-L;J 
FmocHN 
0 	 DIPEA,DMAP, 
238 DCM, RT, 2 hrs 
V 




Scheme 48: Loading of Fmoc-Lys onto Sulfamylbutyryl AM Resin 239. 
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The loading of Lys was calculated by Fmoc test using the following equation derived 
from Beer-Lamberts equation and was found to be 0.58 mmolg 1 . 
A x v 
LUV 	= (CxlO3xWt) 
A= The UV absorbance (A) at Xmax= 301 nm; E = 7800 M 1 cm; resin weight (weight 
in mg, wt); 20 % piperidine in DMF (v in 10 ml); The absorbance was measured 
against a blank containing 20 % piperidine in DMF to give three concordant results. 
5.9.3 Fmoc-SPPS of Peptide Thioester 232 
The remaining synthesis of peptide thioester was performed on a pre-loaded Fmoc-
Lys(Boc)-Sulfamylbutyryl AM resin 239 (0.12 mmol). The Fmoc was removed with 
20 % piperidine in DMF 1 hr. The extension of the peptide was obtained by standard 
Fmoc-SPPS by activation of Fmoc-amino acid (4 eq) with TBTU (4 eq), HOBt (4 eq) 
and DIPEA (8 eq) in DMF activation conditions for 4 hrs. Subsequently, the resin 
was treated with iodoacetonitrile (100 eq), DIPEA (10 eq) in NMP for 24 hrs, with 
exclusion of light. The resin was washed thoroughly by standard washing protocol 
followed by ether and was dried in a vacuum oven. The activated resin was treated 
with benzyl mercaptan (50 eq) and sodiumthiophenoxide (0.5 eq) in THF at room 
temperature to afford peptide thioester 232. The fully protected peptide thioester was 
dissolved in 5 ml mixture of TFAIEDTIH 20/TIS (94:2.5:2.5:1) and the reaction 
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this peptide was very low, which might be due insufficient loading and also size of 
the fragment. 




1. 20 % piperidine in DMF, RT, 1 hr 
Fmoc-SPPS 2. Fmoc-amino acid, TBTU, HOBt, 
DIPEA, DMF, RT, 4 hrs 
o 
Boc S D A C E E P PT F E A M E L I G K P K P Y Y E I G E R V D Y K— HN—L,J 
3.ICH2CN, DIPEA, NMP, RT,24 hrs 
4.BnSH, NaSPh, THF, RT, 24 hrs 
5.TFA/H20fflS/EDT 
(94:2.5:1:2.5), RI, 4 hrs 
HAS DACEEPPTFEAM ELI GKPKPYYEIGERVDYK'SBn 
232 
Scheme 49: Fmoc-SPPS of N-Terminal Thioester Peptide 232. 
The crude peptide was analyzed by LC-MS using reverse phase conditions. The LC-
MS data shows the presence of a major desired product with retention time of 19.38 
mm (mass 3811.1), also a major by-product, which was oxidised methionine sulphur 
to form a sulfoxide with retention time of 18.67 mm (mass 3817.2), which is a 
common by-product formation observed in methionine containing peptides. The 
formation of this by-product can be avoided by performing the cleavage under 
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Figure 48: UV Trace of LC-MS for Crude Thioester Peptide 232 (Luna 5i1 C18 column and 5-60% 
MeCN (0.1 % TFA)1H 20 (0.1 % TFA) as a gradient with flow rate of 0.2 ml mm' for 33 mm). 
Entry 	Retention time 	 MS (ESI) 
1 	18.47 min 	 1915.7, 1277.7, 958.5 
2 	19.20 min 	1907.1 [+2], 1271.6 [+3], 954.7 [+4] 
Table 14: Mass Data of LC-MS for Crude Thioester Fragment 232. 
The crude peptide thioester 232 was purified by LC-MS(ZMD) purification system 
using reverse phase conditions and purified peptide was again analysed by LC-MS 
using reverse phase conditions (figure 49). 
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Figure 49: UV Trace of LC-MS for Purified Thioester Peptide 232 (Luna 5t C18 column and 5-60% 
MeCN (0.1 % TFA)1H 20 (0.1 % TFA) as a gradient with flow rate of 0.2 ml min d for 33 mm). 
5.10 Native Chemical Ligation to Afford MCP 1 Module 233 
The native chemical ligation of 233 was performed with purified material of thioester 
232 (0.16 l.Lmol) and cysteine fragment 237 (0.16 p.mol) in 0.1 M phosphate buffer 
pH 7.5 (0.157 p.!) containing 6 M Gn HC1 and thiophenol (1.5 p.!). The reaction 
mixture was left on an agitator and at room temperature for 27 hrs (scheme 50). The 
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H2NCOK K C V FY I P P LAT HTICD RN HT WLP VSD DAC YRE C0OH 
237 
6 M Gn HCI, 0.1 M phosphate buffer pH 7.5, 
1 % v/v thiophenol, RT, 27 hrs 
H2N-S D A C E E P P T F E A M ELIGKPKPVYE I G E R V D Y K 
C K K C Y F V I P P L AT H T I C D R N H T W L P V S D D A C V R E-000H 
233 
Scheme 50: Native Chemical Ligation of MCP 1(233). 
The reaction was quenched with a mixture of MeCN/H 20/TFA (1:1:0.1) and was 
analysed by LC-MS using reverse phase conditions. The LC-MS data shows the 
presence of a desired mass of MCP 1 at the retention time of 18.40 mm (mass 7702.7 
[M], 1926 [+4], 1541 [+5], 1284 [+5], 1101 [+6]) as well as unreacted starting 
material 237 at 18.34 mm (2007 [+2], 1004 [+4], 670 [+6]) (figure 50 & table 15). 
The purification attempts of this crude ligation mixture by LC-MS(ZMD) using 
reverse phase conditions (Luna C18 column, 0.1 % TFA in acetonitrile and water as 








Figure 50: UV Trace of LC-MS for Ligation Mixture of MCP 1 233 (Luna 51 CI 8 column and 0-85 
% MeCN (0.1 % TFA)1H 20 (0.1 % TFA) as a gradient with flow rate of 0.2 ml min - ' at 214 nn). 
Entry 	Retention time 	 MS (ESI) 
1 	18.40 min 	1926 [+4], 1541 [+5], 1284 [+5], 1101 [+6] 
2 	18.38 min 	 2007, 1004, 670 
2 	18.34min 	 1988, 994 
3 	18.20 min 	 2872, 2332, 1857, 1320, 1016 
Table 15: Mass Data of LC-MS for Crude Ligation Mixture of MCP 1(233). 
5.11 Gel electrophoresis of MCP 1 Reaction Mixture 233 
After unsuccessful purification attempts of the crude ligation mixture of MCP 1 
(233) on LC-MS(ZMD), it was decided to run a protein gel electrophoresis to 
confirm the presence of MCP 1. Gel electrophoresis results revealed that the 
presence of a strong band at desired mass range &7700 of MCP 1 (233) (expected 
mass 7702) and also a low molecular weight band ( 4000 region), which might be 
due to unreacted starting material (figure 51). At this stage it was anticipated that 
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refolding of crude ligation mixture of MCP 1 might help in the separation of starting 
materials from the refolded MCP 1. In order to investigate this idea the refolding of 
crude mixture of MCP 1 was performed. 
5.12 Refolding Studies of Crude MCP 1 (233) 
The renaturation protocol involved dialysis against refolding buffer [0.1M Tris-HC1 
(pH 8.2), 3 mM reduced glutathione (GSH), 0.3 mM oxidised glutathione (GSSH) 
and 1 mM ETDAI. The dialysis cassette (PIERCE SLIIDE—A-LYZER ® DIALYSIS 
CASSETTE 3500 MWCO 0.1-0.5 ml capacity) was hydrated with water by leaving 
it in water for 3 min prior to refolding. The crude ligation mixture of MCP 1 (5 mg 
contained 6 M Gn HC1) was dissolved in 6 M Gn HCl solution (0.5 ml). The ligation 
mixture was centrifuged and 300 il of supernatant solution was dialysed against 
refolding buffer overnight. After 18 hrs the refolding buffer was changed and dialysis 
was continued for another 4 hrs. The refolded reaction mixture was again eluted on a 
gel using gel electrophoresis by procedure described in 5.11. Comparison of protein 
samples before and after refolding by gel electrophoresis showed a strong band in 
expected mass range (mass range z7700 as well as low molecular weight impurity 
4000 region (figure 51). Unfortunately, the starting material was not separated from 
the desired product, even after refolding experiment. 
Aliquots were taken from the dialysis cassette and analysed by LC-MS using reverse 
phase conditions. The LC-MS data shows that the presence of only one mass unit 
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[1925 ( 4)] that matches the mass of the target MCP 1 (233). No mass peak for any 
fragments could be identified, including starting material. The lack of any such 
signals was probably due to low signal to noise ratio (figure 52). (Calculated masses 
for refolded/unfolded MCP 1(233) are 7698.7/7702.7). 
See Blue® Plus ladder (3-250 kD) 
Crude ligation sample (20 L1) 
Refolded sample (20Al) 
Refolded sample (15 l) 
Refolded sample (10 il) 
Crude ligation sample (10 Al) 
Crude ligation sample (15A l) 
1 	234 	567 
Figure 51: Gel electrophoresis of MCP 1 Crude and Refolded Reaction Mixture 233. 
•4-JI.a. i 
Figure 52: UV trace of LC-MS for refolded crude MCP 1 mixture (233) (Luna 5 C18 column and 0- 
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5.13 Conclusions and Future Work 
In conclusion, we have successfully demonstrated the synthesis of peptide segments 
(228, 229, 230, 232 and 237) from Fmoc-SPPS in good quantity. However, the 
purification of peptides by LC-MS(ZMD) purification system was not efficient. The 
native chemical ligation reactions of 230 and 233 were working well, but due to 
insufficient purified peptide quantity the ligations were not achieved in good quantity 
to afford the desired polypeptide. Analysis of the ligation mixtures by gel 
electrophoresis suggested that the desired MCP 1 module (233) had been formed. 
The LC-MS data for final ligation of MCP 1 (233) shows related mass units of 
desired masses and at the same time the starting material 237, which was not 
separable from the desired product. Some preliminary refolding studies were 
conducted to attempt separation of starting material from product, but these studies 
has not yielded pure product. 
The chemical synthesis of MCP 1 could be achieved using the similar synthetic 
strategy (figure 45) as discussed in this chapter. To obtain reasonable quantity of the 
MCP 1 (233), the synthesis would be worth performing with at least a 0.15 mmol 
scale of cysteine fragment 237 and 0.15 mmol scale of thioester fragment 232, with 
an efficient HPLC purification system and protocol. The final cleavage of thioester 
fragment 232 should be performed under anhydrous conditions for at least 48 his to 
avoid the oxidised methionine as a major by-product and to avoid the loss of product. 
Final purification of MCP 1 (233) should be performed using C4 column instead of 




6.1 Materials and Methods 
Solid phase reactions were performed in isolute reaction tubes and agitated on an 
agitator at room temperature. Peptides and glycopeptides were synthesized by 
manual Fnioc-SPPS, using TBTU, HOBt and DIPEA in DMF activation conditions, 
unless otherwise stated. After each peptide coupling and Fmoc cleavage, the resin 
was washed extensively with peptide synthesis grade DMF, DMF/MeOH, DCM and 
DMF. Peptide masses were calculated from proteomic server called 'ExPASy'. 
Thin layer chromatography (TLC) was performed with pre-coated silica on 
aluminium plates (Merck 60 F 254) and eluted plates were visualized under UV light 
(254 nm) or anisaldehyde solution dip. Flash colunin chromatography was carried 
out using silica gel (35-70 .t) and was purchased from Fisher Scientific. Microwave 
reactions were performed in a CEM Discover automated microwave synthesizer with 
an Explorer Carousel. Amino acids, pre-loaded resins and resins were purchased 
from Novabiochem, unless otherwise stated. PEGA I 900 was obtained from Polymer 
Laboratories, United Kingdom. Chitobiose octaacetate was purchased from Dextra 
Labs. cz-Chymotrypsin from bovine pancreas type II (lyophilized powder, Z 40 
units/mg protein, 3 x  crystallized from 4 x crystallized chyrnotrypsinozen) and 
thermolysin from Basillus thermoproteolyticus rokko (lyophilized powder contains 
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20 % buffer salts as calcium and sodium acetate, 42 units/mg solid) were obtained 
from Sigma. 
The coupling of glycosyl amines with aspartic acid derivatives and hydrolysis of tert-
butyl ester reactions were performed under nitrogen atmosphere, unless otherwise 
stated. All reagents and solvents were laboratory grade and were used as supplied, 
unless otherwise stated. 
'H NMR, ' 3 C NMR, COSY and HSQC spectra were recorded on Bruker arx 250 and 
dpx 360 spectrophotometers. Chemical shifts (ö) are referenced to the residual 
solvent peak and are quoted in parts per million (ppm). The abbreviations used to 
indicate the multiplicity are s = singlet, d = doublet, q = quartet, dd = double doublet, 
ddd = double double doublet, t = triplet, m = multiplet. The coupling constants (J) 
are given in Hertz (Hz). Infrared spectra (IR) were recorded as KBr discs on Jasco-
FT/JR spectrophotometer using standard techniques and kmax values are quoted in 
cm -1 . UV spectra were collected on a Unicam UV/Visible spectrophotometer. 
Nominal mass spectra were recorded on a Micrornass Platform II instrument under 
positive ionisation technique. Fast Atom Bombardment (FAB) high resolution mass 
spectra were recorded on a Kratos MS50TC instrument. Melting points were 
determined on Gallenkamp melting point apparatus. LC-MS was carried out on a 
WatersTM Alliance 2790 separation module with a W aters TM 486 tunable absorbance 
detector set at 214 nm and 254 nm coupled to a Micromass Platform II spectrometer 
with Masslynx version 3.5 software. A Luna 5 p. C18 (250 x  2 mm) column was 
employed as the stationary phase. The mobile phase was MeCN (0.1 % TFA)/H 20 
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(0.1 % TFA) with a flow rate of 0.2 ml min- I  at 214 nm and 254 nrn UV detection. 
Preparative LC-MS was performed on a Micromass ZMD using a Luna 5 t Cl 8 
column (250 x  10 mm) and MeCN (0.1 % TFA)/H 20 (0.1 % TFA) as a gradient over 
30 min with a flow rate of 5 ml min 1 . 
The protein gel electrophoresis was performed using a NuPaGE 4-12 % Bis-Tris 1 
gel, NuPaGE® MES SDS running buffer (20 x 500 ml), in an Invitrogen apparatus at 
200 V for about 35 mm. 
6.1.1 Determination of First Amino Acid Loading onto Resin by 
Fmoc Cleavage 
The UV absorbance (A) at Xmax 301nm (s = 7800 M'cm) of three pre-weighed 
amount of resin (weight in mg, wt) in a specific volume of 20 % piperidine in DMF 
(v in ml) was used to calculate the loading according to equation 1, deduced from the 
Beer-Lambert equation. The absorbance was measured using quartz cuvettes, against 
a blank containing 20 % piperidine in DMF to give three concordant results. 
A x v 
Luv I mmol I g 




6.1.2 Kaiser Test 
The progress of the solid phase peptide and glycopeptide synthesis was monitored by 
Kaiser test. 
Solution A: 5 g of ninhydrin in 100 ml of ethanol 
Solution B: 80 g of liquefied phenol in 20 ml of ethanol 
Solution C: 2 ml of 0.001 M KCN (aq) in 98 ml of pyridine 
. After each peptide coupling wash the resin with standard washing protocol 
and then transfer a few beads of resin into an Eppendorf tube. 
Add 2 drops of solutions A, B and C to Eppendorf tube. 
. Warm up the solution at 100 °C for 1 min in a heating well. 




6.2 Synthesis of fl-Glycosyl Amines via Microwave-Assisted 
Kochetkov Amination 
6.2.1 General Procedure for Microwave-Assisted Kochetkov 




An automated microwave tube was charged with reducing sugar 96-102 (0.25 g), 
ammonium carbonate (1.25 g, 5 fold excess) and anhydrous DMSO (0.8 ml). The 
tube was sealed and placed into the microwave instrument at 40 °C, 250 psi pressure 
and 10 watts microwave power for 90 min using the cooling facility. The reaction 
mixture was transferred into a round bottom flask and was freeze dried for over night 
to remove excess of ammonia and DMSO affording fl-glycosyl amines 103-109 as 
hygroscopic solids in excellent yields. The yields of the crude glycosyl amines were 
calculated from 'H NMR spectra in D20 and are based on the integration of the 
anomeric proton peak of the crude glycosyl amines 103-109 and substrates 96-102. 




6.2.1.1 Synthesis of 







To a stirred suspension of commercially available chitobiose octaacetate (from Dexta 
Labs, 0.2 g, 0.29 mrnol) and 6 ml of dry MeOH in a 50 ml round bottom flask was 
added 0.5 M sodium methoxide (0.2 ml) in methanol. The reaction mixture was 
stirred under nitrogen atmosphere and at room temperature for 1.5 hrs. Amberlist 15 
H resin was added to the reaction mixture to adjust the pH to neutral. The resin was 
filtered and the filtrate was concentrated under reduced pressure to afford 101 as a 
white solid (0.12 g, 96%). 
6.2.2 Synthesis of 2_ac eta mido-2-deoxy-/J-D-glucopyraflOSYlamifle 8 ' 
103 
OH 
0 HO 	 NH2 
3 AcHN 1 
103 
The synthesis of glycosyl amine 103 was achieved using the general procedure 6.2.1 
from reducing sugar 96. The crude glycosyl amine 103 was isolated as a colourless 
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hygroscopic solid in 90 % yield. The crude product 103 yield was obtained by 
measuring the ratio of the anomeric proton peak of 96 (4.6 ppm) and 103 (4.1 ppm) 
(lit. 8 ' 8H 4.15 ppm). 61-1  (250 MHz, D20): 4.1 (d, f,,2 = 8.6 Hz, 1H, H-i) ppm; MS 
(ES!): Calculated mass for C 8H 16N205, mlz 220.1 and was found at 221.1 [M+H] 





The synthesis of glycosyl amine 104 was obtained using the general procedure 6.2.1 
from reducing sugar 97. The crude glycosyl amine 104 was isolated as an off-white 
hygroscopic solid in 80 % yield. The crude product 104 yield was obtained by 
measuring the ratio of the anomeric proton peak of 97 (4.58 ppm) and 104 (4.2 ppm) 
(lit- 81  öi, 4.1 ppm). oH (250 MHz, D20): 4.2 (d, J1,2 = 8.7 Hz, 1H, H-i) ppm; MS 
(ES!): Calculated mass for C 6H 13N05, mlz 179.1 and was found at 179.9 [M+H] +  
6.2.4 Synthesis of 
sylamine 8 ' 105 
OH 	 OH 





The synthesis of glycosyl amine 105 was obtained using the general procedure 6.2.1 
from reducing sugar 98. The crude glycosyl amine 105 was isolated as a colourless 
hygroscopic solid in 75 % yield, The crude product 105 yield was obtained by 
measuring the ratio of the anomeric proton peak of 98 (4.46 ppm) and 105 (4.07 
ppm) (lit. 8 ' oH 4.12 ppm). oH (250 MHz, D 20): 4.07 (d, .11,2 = 8.8 Hz, IH, H-I) ppm; 
MS (ESI): Calculated mass for C 12H23N010, mlz 341.3 and was found at 342.2 
[M+H] 
6.2.5 Synthesis of 
pyranosylamine 8 ' 106 
HOOH 	 OH 
HO %.- 	 NH
HO 
106 
The synthesis of glycosyl amine 106 was achieved using the general procedure 6.2.1 
from reducing sugar 99. The compound 106 was isolated as a colourless hygroscopic 
solid in 95 % yield. The crude product 106 yield was obtained by measuring the ratio 
of the anomeric proton peak of 99 (4.45 ppm) and 106 (4.08 ppm) (ht- 81  0 k-, 4.13 
ppm). 01j (250 MHz, D 20): 4.08 (d, J,,2 = 8.8 Hz, IH, H-I) ppm; MS (ESI): 
Calculated mass for C, 2H23N0,0, mlz 341.3 and was found at 342.2 [M+H] +  
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6.2.6 Preparation of O-a-D-glucopyranosyl-(l —*4)-JJ-D-glucopyra 
nosylamine8 ' 107 
OH 
HO\O OH 
HO N, 46 
NH2 
107 
The synthesis of glycosyl amine 107 was obtained using the general procedure 6.2.1 
from reducing sugar 100. The compound 107 was isolated as an off-white 
hygroscopic solid in 70 % yield. The yield of the crude product 107 was obtained by 
measuring the ratio of the anorneric proton peak of 100 (4.62 ppm) and 107 (4.1 
ppm) (lit- 81  6H 4.12 ppm). oH (250 M1-Iz, D 20): 4.1 (d, JI,2 = 8.8 Hz, IH, H-i) ppm; 
MS (ESI): Calculated mass for C 12H23N010, m/z 341.3 and was found at 342.2 
[M+H] 
6.2.7 Preparation of 0-2-acetamido-2-deoxy- fl-D-glucopyranosyl- 
(1 	 108 
OH 	 OH 
H t o\ 2° 	 NH2 




The synthesis of glycosyl amine 108 was achieved using general procedure 6.2.1 
from reducing sugar 101. The product 108 was isolated as an off-white hygroscopic 
solid in 35 % yield. The crude product 108 yield was obtained by measuring the ratio 
of the anomeric proton peak of 101 (4.45 ppm) and 108 (4.09 ppm) (lit. S 4.15 
ppm). 8 11 (250 MHz, D20): 4.09 (d, J1 ,2 = 8.7 Hz, 1H, H-i) ppm; MS (ESI): 
Calculated mass for C 16H29N3010, m/z 423.2 and was found at 424.1 [M+H] 










' HO, 4 6 
109 	OHO\___L_ NH, 
3 HO 
The synthesis of glycosyl amine 109 was achieved using general procedure 6.2.1 
from reducing sugar 102. The product 109 was isolated as a colourless hygroscopic 
solid in 75 % yield. The yield of the crude product 109 was obtained by measuring 
the ratio of the anomeric proton peak of 102 (4.9 ppm) and 109 (4.1 ppm) (lit. 
81 
4.12 ppm). ö j, (250 MHz, D 20): 4.1 (d, .11 ,2 = 8.6 Hz, 1H, H-i) ppm; MS (ESI): 
Calculated mass for C 18H33N0 15 , mlz 503.4 and was found at 504.2 [M+H] 
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6.2.9 Large Scale Preparation of 2-acetamido-2-deoxy-fl-D-gIuCo 





3 AcHN 1 
103 
A large microwave reaction tube was charged with 2-acetamido-2-deoxy-D-
glucopyranose 96 (3 g), ammonium carbonate (15 g, 5 fold excess) and anhydrous 
DMSO (3 ml). The tube was placed into the microwave instrument using fibre optic 
system at 40 °C, 250 psi pressure and 10 watts microwave power for 90 min using 
the cooling facility. The reaction mixture was transferred into a round bottom flask 
and was freeze dried for overnight to afford 103 as a colourless hygroscopic solid in 
60 % yield. The crude product 103 yield was calculated based on integration of the 
amoneric proton peak of 96 (4.6 ppm) and 103 (4.1 ppm) (lit. 
81  s,-, 4.15 ppm). öij 
(250 MHz, D20): 4.1 (d, J1,2 = 8.6 Hz, IH, H-I) ppm; MS (ESI): Calculated mass for 
C8H 16N205, mlz 220.1 and was found at 221.1 [M+H] +  
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6.3 Synthesis of Glycosylated-Asparagine Building Blocks 
6.3.1 Preparation of N acarbobenzyJoxyN _I2_acetamido-2-deoxy-
/1 _D_glucopyranosylaminel-L-aSparagifle iso-butyl ester" 110 
OH 









To a stirred suspension of 103 (0.17 g, 0.77 mmol) in anhydrous DMF (3 ml) and 
NaHCO3  (0.13 g, 1.53 mmol) was added 114 (0.34 g, 1.15 inmol) in anhydrous DMF 
(3 ml). The reaction mixture was stirred at room temperature for 2.5 hrs. The solvent 
was removed under reduced pressure. The crude product was purified by flash 
chromatography using 12 % MeOH in CHC13 as an eluent to afford 110 as a white 
solid (0.25 g, 62 %). melting point 194°-196 °C (lit. 
84 melting point 195-196.5 °C; 
Rf: ( 10 % MeOH in CHCI3) 0.2; Remaining data, such as 'H and ' 3 C NMR and mass 




6.3.2 Preparation of N 
/J_D_glucopyranosylaminel_L-aSparagifle 84 111 
OH 
HO O\> i 0 





To a stirred solution of 110 (0.15 g, 0.3 mmol) in DMF (2 ml) and phosphate buffer 
(pH 7.0, 2 ml) was added 2 M HC1 to adjust the pH to 7.0, followed by L-cysteine (9 
mg) and papain (43 mg). The reaction mixture was stirred at 35 °C for 8 hrs and the 
pH was maintained at 7.0 by adding 0.2 M NaOH solution. The stirring was 
continued for further 7 hrs. The reaction mixture was filtered through a pad of celite, 
subsequently washed with water (3 ml) and the filtrate pH was adjusted to 4.0 by 
adding 2 M HC1. The reaction mixture was concentrated under reduced pressure. The 
crude product was purified by flash chromatography using 20 % MeOH in CHC13 as 
an eluent to afford 111 as a white solid (85 mg, 63 %, isolated yield). Melting point 
172°-174 °C (lit. 84 melting point 174°-176 °C); R f: (EtOAc: MeOH: H 20) (7:2:1) 
0.25. The purified compound 111 data such as 'H, 1 
3  C NMR and mass spectral data 




6.3.3 Preparation of N ufluoreny1methoxycarboflyIN 16-12-acetamido 











To a 25 ml round-bottom flask was added N-a-Frnoc-L-aspartic acid-a-tert-butyl 
ester (0.49 g, 1.2 mmol), anhydrous DMF (3 ml), HOBt (0.15 g, 1.1 mmol) and 
HBTU (1.13 g, 3.0 mmol). After stirring for 15 mm, a solution of 103 (0.22 g, 1.0 
mmol) in anhydrous DMF (3 ml) was added. The reaction mixture was stirred at 
room temperature under nitrogen atmosphere for 24 hrs. The solvent was removed 
under reduced pressure. The crude product was purified by flash chromatography 
using 13 % MeOH in CHCI 3 as an eluent to afford 115 as a viscous material, which 
was co-evaporated with toluene (2 x 10 ml) followed by triturating with ether 
afforded 115 as an off-white solid (0.54 g, 88 %). melting point 182°-184 °C; R f : ( 15 
% MeOH in CHCI3) 0.23; Vmax (KBr): 3304 (OH), 2924, 1702 (C0), 1655 (C0), 
1547 (C=O), 1084 cm'; oH (250 MHz, CD30D-d4): 7.63 (d, 2H, J= 7.3 Hz, 2 x 
Art-I), 7.54 (d, 2H, J= 7.3 Hz, 2 x  ArH), 7.25 (t, 2H, J= 7.4 Hz, 2 x  ArH), 7.15 (t, 
2H, J= 7.4 Hz, 2 x  ArH), 4.82 (d, 1H, J= 9.7 Hz, H-i), 4.31 (m, 2H, Asn a-CH, 
Fmoc-CH), 4.09 (m, 2H, Fmoc-CH2) , 3.65 (m, 3H), 3.23 (m, 3H), 2.70 (m, 2H, 2 x 
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Asn fl-H), 1.82 (s, 3H, (NHCOCH3), 1.28 (s, 9H, OC(CH3)3) ppm; öc (90 MHz, 
CD 30D-d4): 172.6 (C=O), 170.8 (C0), 170.1 (C=O), 162.91 (CO), 156.9, 143.3 
(qC), 140.7 (qC), 126.9, 126.3, 124.3, 119.0 (ArC), 81.1, 78.4, 77.8, 74.3 (CH), 
69.8, 66.1, (CH 2 ), 54.2, 50.8, 47.5 (CH), 36.6 (CH2), 26.3 OC(CH3)3, 21.0 
(NHCOCH3) ppm; HRMS (FAB): Calculated mass for C 31 H3 9N3010, 614.2714 
[M+H] and was found at 614.2712 [M+H] 4 . 
6.3.4 Preparation of N a_fluoreny1methoxycarbony1NP_I2aCeta 







To a 50 ml round-bottom flask was added 115 (0.49 g, 1.2 mmol), anhydrous DCM 
(9 ml), TFA (9 ml) and anisole (0.9 ml). The reaction mixture was stirred at room 
temperature under nitrogen atmosphere for 4 hrs. The reaction mixture was 
concentrated under reduced pressure and co-evaporated with toluene (2 x  20 ml) 
followed by DCM (2 x 20 ml). The residue was triturated with ether to afford 116 as 
an off-white solid (0.155 g, 86 %). melting point 240 °C decomposed; R f: (EtOAc: 
MeOH: H 20) (7:2:1) 0.31; Vmax (KBr): 3306 (OH), 3072, 1697 (C0), 1654 (C0), 




Hz, 2 x ArH), 7.60 (d, 2H, J = 7.3 Hz, 2 x  ArH), 7.37 (t, 2H, J = 7.5 Hz, 2 
x ArH), 
7.35 (t, 2H, J 7.5 Hz, 2 x ArH), 4.98 (d, IH, J 9.7 Hz, H-I), 4.42 (t, IH, J 6.1 
Hz, Asn a-CH), 4.28 (t, 2H, J = 6.1Hz, Frnoc-CH2), 4.19 (m, 1H, Fmoc-CH), 3.65 
(m, 3H), 3.35 (m, 2H), 3.31 (d, 1H, J = 6.2Hz), 2.42 (m, 2H, Asn /3-Cl2), 1.87 (s, 
3H, NHCOCH3) ppm; Sc (90 MHz, D20 + DMSO-d6): 178.2 (C0), 175.6 (C0), 
174.4 (C=O), 158.1 (C=O), 144.9 (qC), 141.9 (qC), 129.2, 128.6, 126.3, 121.3 
(ArC), 79.2, 78.6, 75.2, 70.5 (CH), 67.5, 61.5 (CH2), 55.3, 53.8, 47.9, (CH), 39.4 
(CH2), 23.1 (NHCOCH3) ppm; HRMS (FAB): Calculated mass for C 27H31N3010, 
558.2088 [M+H] and was found at 558.2089 [M+H] 




46.0 	 46 






To a 25 ml round-bottom flask was added N-a-Fmoc-L-aspartic acid a-tert-butyl 
ester (0.25 g, 0.62 mmol), anhydrous DMF (3 ml), HOBt (83 mg, 0.61 mmol) and 
HBTU (0.58 g, 1.53 mmol). After stirring for 15 mm, a solution of 105 (0.175 g, 
0.51 mmol) in anhydrous DMF (3 ml) was added. The reaction mixture was stirred at 
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room temperature under nitrogen atmosphere for 24 hrs. The solvent was removed 
under reduced pressure. The crude product was purified by flash chromatography 
using 20 % MeOH in CHCI3 as an eluent and the fractions were concentrated under 
reduced pressure followed by co-evaporation with toluene (2 x 10 ml) to remove the 
residual solvents. The residue was triturated with ether to afford 117 as a white solid 
(0.34 g, 92 %). melting point 176°-178 °C; R f: (30 % MeOH in CHCI3) 0.38; Vmax 
(KBr): 3398 (OH), 1716 (C=O), 1539 (CO), 1429 ciii'; 8 11 (250 MHz, CD 3 0D-d4 ): 
7.70 (d, 211, J= 7.3 Hz, 2 x  Aril), 7.60 (d, 2H, J= 7.3 Hz, 2 x ArH), 7.34 (t, 2H, J 
7.0 Hz, 2 x  ArH), 7.26 (t, 2H, J=  7.0 Hz, 2 x ArH), 4.96 (d, 1H, J = 12.1 Hz, H-i), 
4.35 (t, IH, J = 6.0 Hz, Asn a-CH), 4.26 (m, 2H, Fmoc-CH 2 ), 4.17 (t, IH, 1=6.5 
Hz, Fmoc-CH), 3.77 (ddd, 4H, J = 1.86 Hz, 11.9 Hz, 22.7 Hz), 3.57 (dd, IH, I = 4.5 
Hz, 11.0 Hz), 3.45 (dd, IH, 1=4.5 Hz, 11.0 Hz), 3.38 (m, 2H), 3.21(m, 5H), 2.76 
(m, 2H, AsnJ3-CH 2), 1.35 (s, 9H, OC(CH3)3) ppm; öc (90 MHz, CD 3 0D-d4): 171.3 
(C=O), 170.2 (C=O), 156.5 (C=O), 143.3 (qC), 140.6 (qC), 126.9, 126.3, 124.4, 
119.0 (ArC), 102.7, 81.3, 78.9, 78.4, 76.2, 75.8, 75.4, 72.9, 71.7, 69.4 (CH), 66.2, 
60.5, 59.7 (CH 2), 50.7, 37.9 (CH), 36.6 (CH 2), 26.3 C(CH3)3 ppm; HRMS (FAB): 




6.3.6 Preparation of P-fluoreny1methoxycarbOfly1-N 11 10pDg1uco 
pyranosyl-(1 	 118 
OH 	 OH 
OH 
118 
To a 50 ml round-bottom flask was added 117 (0.15 g, 0.2 mmol), anhydrous DCM 
(6 ml), TFA (6 ml) and anisole (0.6 ml). The reaction mixture was stirred under 
nitrogen atmosphere at room temperature for 4 hrs. The reaction mixture was 
concentrated under reduced pressure and co-evaporated with toluene (2 < 20 ml) 
followed by DCM (2 x 20 ml). The residue was triturated with ether to afford 118 as 
an off-white solid (0.11 g, 80%). melting point 180 1 -182 °C; vmax (KBr): 3367 (OH), 
2919, 1699 (C=O), 1541 (C=O), 1163, 1078 cm'; ö (360 MHz, D 20 + DMSO-d6); 
7.71 (d, 2H,J= 7.5 Hz, 2 x  ArH), 7.51 (d, 2H,J = 7.5 Hz, 2 x  ArH), 7.31 (t, 2H,J 
7.3 Hz, 2 x  Aril), 7.23 (t, 2H, J= 7.3 Hz, 2 x  Aril), 4.75 (d, IH, J= 9.2 Hz, H- 1), 
4.35 (m, 3H, Fmoc-C112, Asn a-CH), 4.11 (t, 2H, J = 6.2 Hz, Fmoc-CH), 3.72 (m, 
2H), 3.63 (in, 2H), 3.55 (m, 4H), 3.35 (m, 5H) 2.85 (m, 2H, Asn fl-CH2) ppm; oc (90 
MHz, D20 + DMSO-d6 ): 175.7 (C=O), 174.1 (C=O), 158.9 (C=O), 145.2 (qC), 
142.4 (qC), 129.8, 129.2, 126.8, 122.7 (ArC), 104.2, 80.7, 79.8, 77.8, 77.0, 76.5, 
74.7, 73.0, 72.7, 71.0 (CH), 68.2, 62.1, 61.3 (CH 2), 48.2, 39.4 (CH), 38.5 (CH 2 ) 
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ppm; HRMS (FAB): Calculated mass for C 31 H38N2015, 679.2350 [M+H] and was 
found at 679.2352 [M+H] 4 . 
6.3.7 Preparation of ]Vu-11 uoreny I methoxycarbonyIN '7-fO-fJ-D-gala 
ctopyranosyl-(1 _*4)flDg1ucopyranosyIamine1-L-aSparagifle tert-
butyl ester 119 
HOOH 	 OH 
Ho\ Q 0HO\._._ O 
119 
To a 25 ml round-bottom flask was added N-a-Fmoc-L-aspartic acid a-tert-butyl 
ester (0.23 g, 0.56 mmol), anhydrous DMF (3 ml), HOBt (76 mg, 0.56 rnmol) and 
1-IBTU (0.53 g, 1.41 mmol). After stirring for 15 mm, a solution of 106 (0.16 g, 0.47 
mmol) in anhydrous DMF (3 ml) was added. The reaction mixture was stirred at 
room temperature under nitrogen atmosphere for 24 hrs. The solvent was removed 
under reduced pressure. The crude product was purified by flash chromatography 
using 20 % MeOH in CHC13 as an eluent followed by triturating with ether to afford 
119 as an off-white solid (0.24 g, 70 %). melting point 170 °C decomposed; R f: (30 
% MeOH in CHC13) 0.38; 'max (KBr): 3397 (OH), 1698 (C0), 1539 (C0), 1428 
cm'; ö 11 (360 MHz, CD3 0D-d4): 7.87 (d, 2H, J = 7.5 Hz, 2 x  ArH), 7.71 (d, 2H,J 
7.5 Hz, 2 x  ArH), 7.43 (t, 2H, J = 7.4 Hz, 2 x  ArH), 7.38 (t, 2H, J = 7.4 Hz, 2 X 
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AM), 4.93 (d, IH, J= 9.2 Hz, H- 1), 4.51 (t, IH, J= 6.7 Hz, Asn a-CH), 4.40 (m, 
2H, Fmoc-CH2), 4.28 (t, 1H, J = 6.7 Hz, Fmoc-CH), 3.84 (m, 5H), 3.55 (m, 614), 
3.34 (m, 2H), 2.79 (m, 2H, Asn/3-CH2), 1.49 (s, 9H, OC(CH3)3) ppm; öc (90 MHz, 
CD30D): 170.9 (C=O), 170.1 (C=O), 156.2 (C=O), 143.3 (qC), 140.6 (qC), 127.0, 
126.4, 124.5, 117.2 (ArC), 103.2, 81.1, 78.9, 78.7, 76.2, 75.2, 72.8, 71.6, 70.5, 68.3 
(CH), 66.0, 60.5, 59.8 (CH2), 50.6 (CH), 37.9 (CH 2), 36.6 (CH), 26.3 OC(CH3)3 
ppm; FIRMS (FAB): Calculated mass for C35H46N2015, 735.2976 [M+H] and was 
found at 735.2977 [M+H] . 
6.3.8 Preparation of J\1"fluoreny1methoxycarbofly1-M 6-I0-fi-D-ga1a 









To a 50 ml round-bottom flask was added 119 (0.15 g, 0.2 mmol), anhydrous DCM 
(6 ml), TFA (6 ml) and anisole (0.6 ml). The reaction mixture was stirred at room 
temperature under nitrogen atmosphere for 4 hrs. The reaction mixture was 
concentrated under reduced pressure and co-evaporated with toluene (2 x  20 ml) 
followed by DCM (2 x 10 ml). The residue was triturated with ether to afford 120 as 
an off-white solid (0.12 g, 87 %). melting point 192°-194 °C; Vmax (KBr): 3389 (OH), 
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2931, 1715 (C=O), 1654 (C=O), 1540 (C=O), 1080 cm -1 ; ö (250 MHz, DMSO-d 6): 
8.16 (d, 2H, J= 7.3 Hz, 2 x  ArH), 7.98 (d, 2H, J= 7.3 Hz, 2 x  ArH), 7.67 (t, 2H, J 
7.4 Hz, 2 x  ArH), 7.61 (t, 2H,J = 7.4 Hz, 2 x  ArH), 5.10 (t, 1H,J = 9.1 Hz, H-I), 
4.63 (m, 1H, Asn a-CH), 4.47 (m, 3H, Fmoc-CH, CH 20.95 (m, 6H), 3.35 (m, 7H), 
2.85 (m, 2H, Asn /3-CH 2) ppm; öc (90 MHz, D20 + DMSO-d6): 175.2 (C0), 174.4 
(C=O), 158.7 (C=O), 145.1 (qC), 142.3 (qC), 129.7, 129.2, 126.7, 122.8 (ArC), 
104.1, 80.8, 79.9, 77.9, 77.6, 77.0, 76.4, 73.0, 72.6, 71.0 (CH), 68.2, 62.0, 61.3 
(CH 2), 52.2, 39.6 (CH), 38.5 (CH 2 ) ppm; HRMS (FAB): Calculated mass for 
C31H38N2015, 679.2350 [M + H] and was found at 679.2355 [M+ H] 
6.3.9 Preparation of 
mido-2-deoxy-/1-D-glucopyraflOsyl-(l -4)-2-acetamido-2-deoxy-JJ-D-
glucopyranosyl amine-L-asparagine tert-butyl ester 121 
OH 	 OH 
	
H\\° 	 i 





To a 25 ml round-bottom flask was added N-a-Fmoc-L-aspartic acid ct-tert-butyl 
ester (0.15 g, 0.38 mrnol), anhydrous DMF (3 ml), HOBt (50 mg, 0.38 mmol) and 
HBTU (0.21 g, 0.57 mmol. After stirring for 15 mm, a solution of 108 (0.16 g, 0.47 
mrnol) and DJPEA (67 t1, 0.38 mmol) in anhydrous DMF (3 ml) was added. The 
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reaction mixture was stirred at room temperature under nitrogen atmosphere for 24 
hrs. The solvent was removed under reduced pressure. The crude product was 
purified by flash chromatography using 22 % MeOH in CHCI3 as an eluent to afford 
sticky material, which was co-evaporated with toluene (2 x  10 ml), followed by 
triturating with ether to afford 121 as an off-white solid (0.106 g, 70 %). Rf: (25 % 
MeOH in CHCI3) 0.23; Vma% (KBr): 3307 (OH), 2924, 1704 (C0), 1673 (C=O), 
1547 (C=O), 1094 cm'; ö (360 MHz, DMSO-d 6): 8.30 (d, IH, J = 8.9 Hz, NH), 
7.91 (d, 2H,J= 7.3 Hz, 2 x  ArH), 7.83 (d, 2H,J = 7.3 Hz), 7.53 (t, 2H,J = 7.4 Hz, 2 
x ArH), 7.34 (t, 2H, J 7.4 Hz, 2 x  ArH), 5.15 (d, IH, J= 5.4 Hz), 5.05 (d, IH, J 
5.3 Hz), 4.85 (t, 1H, J= 9.4 Hz, 11-1), 4.81 (d, 1H, J= 4.7 Hz), 4.78 (t, 1H, J = 4.7 
Hz), 4.63 (t, IH, J= 4.8 Hz, Asn a-CH), 4.38 (rn, 3H, Fmoc-CH, Cl 2), 3.75 (m, 
2H), 3.64 (m, 2H), 3.20 (d, 2H, .1 = 10.1 Hz), 3.05 (m, 2H), 2.75 (m, 2H, Asn fi-
Cl 2), 1.87 (s, 3H, NHCOCH3), 1.82 (s, 3H, NHCOCH3), 1.41 (s, 9H, OC(CH3)3) 
ppm; oc (90 MHz, DMSO-d6): 172.0 (C=O), 171.1 (C=O), 170.9 (C0), 170.6 
(C=O), 157.3 (C=O), 145.2 (qC), 142.1 (qC), 129.1, 128.8, 128.5, 121.6 (ArC), 
104.3, 82.7, 80.6, 80.1(d), 78.4, 78.1, 75.4, 74.3, 72.1 (CH), 67.1 (Fmoc-CH2), 
62.4, 61.1 (sugar CH2 ), 58.9, 56.8, 48.0 (CH), 38.4 (Asn fl-CH2), 29.8 OC(CH3)3, 
24.5, 24.2 (NHCOCH3) ppm; MS (ESI): Calculated mass for C39H52N4015, mlz 
816.3 and was found at 817.2 [M+H]. 
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6.3.10 Preparation of 
m ido_2_deoxy flDgIUCOpyran0sY(l *4)2_acetamidO-2-deOXY-I 1 D 
giucopyranosy1amineI_LasParag 	122 
OH 	 OH 
4 6 	 4 16 
1 O 
122 
To a 25 nil round-bottom flask was added 121 (32 mg, 0.04 mmol), anhydrous DCM 
(2 ml), TFA (2 ml) and anisole (0.2 ml). The reaction mixture was stirred at room 
temperature under nitrogen atmosphere for 4 hrs. The reaction mixture was 
concentrated under reduced pressure and co-evaporated with toluene (2 x  10 ml) 
followed by DCM (2 x 10 ml). The residue was triturated with ether to afford 122 as 
an off-white solid (26 mg, 89 %). oH (360 MHz, DMSO-d 6): 8.57 (d, 1H, J = 9.4 
Hz), 8.24 (d, 1H, J= 9.4 Hz), 8.16 (bs, 1H, 7.88 (d, 2H, J= 7.3 Hz, 2 
x AM), 7.74 
(d, 1H, J = 9.2 Hz), 7.71 (d, 2H, J = 7.3 Hz, 2 x AM), 7.46 (d, IH, J = 
8.32 Hz), 
7.41 (t, 2H, J= 7.4 Hz, 2 x AM), 7.32 (t, 2H, J— 7.4 Hz, 2 x AM), 4.83 (t, 1H, J 
9.3 Hz, 11-1), 4.25 (m, 4H), 3.76 (m, 2H), 3.52 (m, 6H), 3.22 (m, 214), 3.13 (m, 3H), 
2.83 (m, 2H, Asn/3-CH2), 1.85 (s, 3H, NHCOCH3), 1.81 (s, 3H, NHCOCH3) ppm; 
HRMS (FAB): Calculated mass for C 35H45N4015, mlz 761.2883 [M+H] + and was 




6.3.11 Preparation of 	 - IO-a-D- 
glucopyranosyl 





HO 	 OH 






To a 25 ml round-bottom flask was added N-ct-Fmoc-L-aspartic acid a-tert-butyl 
ester (0.2 g, 0.48 mmol), anhydrous DMF (3 ml), HOBt (64 mg, 0.48 mmol) and 
HBTU (0.27 g, 0.71 mmol). After stirring for 15 mm, a solution of 109 (0.12 g, 0.24 
mmol) in anhydrous DMF (3 ml) was added. The reaction mixture was stirred at 
room temperature under nitrogen atmosphere for 24 hrs. The solvent was removed 
under reduced pressure. The crude product was purified by flash chromatography 
using 23 % MeOH in CHCI 3  as an eluent to afford 123 as a white crystalline solid 
(0.15 g, 71 %). melting point 126°-130°C; R (25 % MeOH in CHC1 3 ) 0.1; Vmax 
(KBr); 3369 (OH), 2919, 1697 (C0), 1545 (C0), 1163, 1078 cm'; 8H (360 MHz, 
CD 3 0D-d4): 7.68 (d, 2H, J = 7.4 Hz, 2 x ArH), 7.55 (d, 2H, J = 7.4 Hz, 2 
x ArH), 
7.28 (t, 2H, J= 7.3 Hz, 2 x ArH), 7.20 (t, 2H, J= 7.3 Hz, 2 x ArH), 5.08 (m, 2H, H-
1', 11-1"), 4.80 (d, IH, J= 13.6 Hz, H-i), 4.39 (t, 1H, J= 6.0 Hz, Asn a-CH), 4.26 
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(m, 2H, Fmoc-CH2), 4.12 (t, 1H, J = 12.9 Hz, Frnoc-CH), 3.74 (m, 5H), 3.59 (m, 
5H), 3.45 (m, 5H), 3.22 (rn, 3H), 2.75 (m, 2H, Asn,8-CH2), 1.35 (s, 9H, OC(CH3)3) 
ppm; öc (90 MHz, CD30D-d4): 171.2 (C0), 170.14 (C0), 156.45(C0), 143.2 
(qC), 140.5 (qC), 126.8, 126.2, 124.3, 118.9 (ArC), 100.9 (Cl'), 100.7 (Cl"), 81.2 
(C 1), 79.3, 79.0, 78.9, 76.7, 76.1, 73.1, 72.9, 72.8, 72.2, 71.7, 71.4, 69.5 (CH), 66.2 
(Fmoc-CH2), 60.7, 60.1 (sugar, CH 2), 50.6 (Asn a-CH), 47.3 (CH), 36.9 (Asn /3-
CH2), 26.2 OC(CH3)3 ppm; MS (ESI): Calculated mass for C 41 H56N2020, mlz 896.8 
and was found at 897.6 [M+H] 4 , 919.3 [M+Na] 4 . 
6.3.12 Preparation of 
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124  
To a 25 ml round-bottom flask was added 123 (95 mg, 0.11 mmol), anhydrous DCM 
(4 ml), TFA (4 ml) and anisole (0.4 ml). The reaction mixture was stirred at room 
temperature under nitrogen atmosphere for 4 his. The solvent was removed under 
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reduced pressure and co-evaporated with toluene (2 x 15 ml) followed by DCM (2 x 
15 ml). The residue was triturated with ether to afford 124 as an off-white solid (79 
mg, 92 %) Vmax (KBr): 3387 (OH), 2932, 1675 (C=O), 1540 (C0), 1151 cm'; oH 
(360 MHz, CD30D-d4): 7.81(d, 2H, J= 7.4 Hz, 2 x  ArH), 7.68 (d, 2H, J = 7.4 Hz, 2 
x ArH), 7.41 (t, 2H, J = 7.3 Hz, 2 x  ArH), 7.33 (t, 2H, J= 7.3 Hz, 2 x  Aril), 5.20 
(m, 2H, H-I', 11-1"), 4.83 (d, 1H, J = 10.6 Hz, H-i), 4.62 (m, 4H), 4.32 (m, 3H, 
Fmoc-CH, CH 2), 3.84 (m, SH), 3.71 (m, 4H), 3.56 (m, 5H), 3.35 (m, 4H), 2.87 (m, 
2H, Asn fl-Cl2 ) ppm; 0c  (90 MHz, CD 3 0D-d4 ): 172.9 (C0), 171.4(C0), 156.5 
(C=O), 143.2 (qC), 140.6 (qC), 126.8, 126.3, 124.4, 119.0 (ArC), 100.9 (C V), 100.6 
(Cl"), 79.1 (C 1), 77.0, 76.7, 76.2, 73.1, 73.0, 72.8, 72.3, 71.8, 71.5, 71.4, 69.5 
(CH), 66.3 (Fmoc-CH2), 65.0, 60.7, 60.1 (sugar CH 2), 49.9, 47.1 (CH), 38.0 (Asn/3-
CH2 ) ppm; HRMS (FAB): Calculated mass for C 37H48N2020, 841.2878 [M+H] and 
was found at 841 .2 866 [M+H]t 
6.3.13 Preparation of 
pyranosyamineI_Lasparagifle tert-butyl ester 125 
OH 







To a 25 ml round-bottom flask was added N-a-Fmoc-L-aspartic acid ct-tert-butyl 
ester (0.55 g, 1.3 rnmol), anhydrous DMF (3 ml), HOBt (0.17 g, 1.1 mmol) and 
HBTU (1.3 g, 3.3 mmol). After stirring for 15 mm, a solution of 104 (0.2 g, 1.1 
mmol) in anhydrous DMF (3 ml) was added. The reaction mixture was stirred at 
room temperature under nitrogen atmosphere for 24 hrs. The solvent was removed 
under reduced pressure. The crude product was purified by flash chromatography 
using 10 % MeOH in CHC1 3 as an eluent, subsequently was co-evaporated with 
toluene (2 x 10 ml) followed by triturating with ether to afford 125 as an off-white 
solid (0.55 g, 87 %). R1: (15 % MeOH in CHC13) 0.2; Vmax (KBr): 3302 (OH), 2930, 
1710 (C=O), 1662 (C=O), 1547 (C=O), 1084 cm -1 . oH (250 MHz, CD 30D-d4 ): 7.69 
(d, 2H, J= 7.4 Hz, 2 x  ArH), 7.56 (d, 2H, J= 7.4 Hz, 2 x  Aril), 7.28 (t, 2H, J= 7.3 
Hz, 2 x  ArH), 7.21 (t, 2H, J= 7.3 Hz, 2 x  ArH), 4.78 (d, IH, J= 9.4 Hz, H-I), 4.24 
(t, IH, J = 5.91Hz, Asn a-CH), 4.12 (rn, 3H, Fmoc-CH, CH 2), 3.70 (m, IH), 3.55 (m, 
1H), 3.27 (m, 4H), 2.66 (m, 2H, Asn /3-CH 2) 1.35 (s, 9H, OC(CH 3 )3 ppm; 0c  (90 
MHz, CD30D-d4): 171.6 (C=O), 170.2 (C=O), 154.4 (C=O), 143.5 (qC), 140.9 
(qC), 126.5, 126.0, 124.5, 119.2 (ArC), 81.1, 78.4, 77.8, 74.3, 69.8 (CH), 66.1 
(Fmoc-CH 2), 54.2 (sugar CH2), 50.8 (CH), 39.6 (Asn 8-CH 2), 35.0 (CH), 27.3 
OC(CH 3 )3 ppm; HRMS (FAB): Calculated mass for C29H37N2010, 573.2448 [M+H] 4 
and was found at 573.2450 [M+H]'. 
172 
Experimental 







To a 50 ml round-bottom flask was added 125 (0.49 g, 0.86 mmol), anhydrous DCM 
(9 ml), TFA (9 ml) and anisole (0.9 ml). The reaction mixture was stirred at room 
temperature under nitrogen atmosphere for 4 hrs. The reaction mixture was 
concentrated under reduced pressure and co-evaporated with toluene (2 x  10 ml) 
followed by DCM (2 x  10 ml). The residue was triturated with ether to afford 126 as 
an off-white solid (0.42 g, 95 %). Vmax (KBr): 3306 (OH), 3072, 1697 (C0), 1654 
(C=O), 1540 (C=O), 1283, 1081 cm -1 ; 6 11 (360 MHz, DMSO-d 6): 7.79 (d, 2H, J= 7.3 
Hz, 2 x  ArH), 7.50 (d, 2H, J = 7.3 Hz, 2 x  Ar!!), 7.37 (t, 2H, J = 7.4 Hz, 2 x  ArH), 
7.35 (t, 2H, J = 7.4 Hz, 2 x  ArH), 4.88 (d, IH, J = 9.9 Hz, H- 1), 4.32 (t, 1H, J = 
6.1Hz, Asn a-CH), 4.26 (m, 2H, Fmoc-C11 2), 4.19 (m, 1H, Fmoc-CH), 3.65 (m, 3H), 
3.35 (m, 2H), 3.31 (m, IH), 2.42 (m, 2H, Asn fl-CH 2) ppm; MS (ESI): Calculated 
mass for C25H29N2010, 516.2 [M] 4 and was found at 517.1 [M+H]t 
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Glycopeptides 127 and 128 were assembled on a Wang resin (100-200 mesh, 0.82 
mmolgf 1 of loading) by manual and stepwise Fmoc-SPPS. 
6.4.1 General Procedure for Attachment of First Amino Acid 
The Wang resin (0.24 g, 0.2 mmol) was allowed to swell in DMF containing DMAP 
(0.1 eq) in an isolute tube for 1 hr. The residual solvent was removed by filtration 
and replaced with a pre-activated solution of Fmoc-Thr(O tBu)-OH (6 eq) and DIC (3 
eq) in DMF (3 ml). The mixture was left on an agitator, room temperature for 
overnight and washed thoroughly with DMF, DMF/MeOH (1:1), DCM and finally 
DMF. The loading (0.56 mmolg') was calculated from UV detection of the Fmoc 
deprotection using the general procedure 6.1.1. 
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6.4.2 General Procedure for Fmoc Cleavage 
The Fmoc group was removed by shaking the resin with 3 ml solution of 20 % 
piperidine in DMF, on an agitator for 1 hr. The resin was washed thoroughly with 
DMF, DMF/MeOH, DCM and finally with DMF. 
6.4.3 General Procedure for Fmoc-SPPS 
The Fmoc-amino acid (4 eq)/glyco-amino acid (2 eq) was activated with TBTU (4 
eq), HOBt (4 eq) and DIPEA (8 eq) in DMF (3 ml). The activated solution was 
added to the resin and the reaction mixture was left on an agitator and room 
temperature for 4 hrs. The resin was filtered and washed with DMF, DMFIMeOH 
(1:1), DCM and DMF. In case of glyco-amino acid coupling the coupling was double 
coupled and the reaction mixture was left on an agitator for overnight. 
6.4.4 Final Cleavage of the Glycopeptide 127 
After final amino acid coupling the Fmoc was removed using the procedure 6.4.2. 
The resin was washed thoroughly with DMF, DMF/MeOH, DCM and ether. The 
resin was dried in a vacuum oven for overnight. The dried resin was transferred into 
a 25 ml round bottom flask and the 5 ml of cleavage mixture TFAIH 20/EDT/TIS 
(95:2.5:2.5:1) was added to the flask. The reaction mixture was stirred at room 
temperature under nitrogen atmosphere for 4 hrs. The resin was filtered and washed 
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with TFA (2 ml). The filtrate was concentrated under reduced pressure and 
precipitated with cold ether to afford crude glycopeptide 127. The crude 
glycopeptide was dissolved in 1 ml of MeCN/H 20/TFA (1:1:0.1 %) and was freeze 
dried for overnight to afford crude glycopeptide 127 as a white solid (19 mg, 67 %). 
The glycopeptide 127 was analysed on analytical LC-MS using a Luna 5p.  C18 
column 5-95 % MeCN (0.1 % TFA)/H 20 (0.1 % TFA) as a gradient for 33 mm 
under 214 nm. The glycopeptide 127 was eluted from the column with a retention 
time of 18.3 mm. Glycopeptide 127 was analysed by HRMS (FAB): Calculated mass 
for C35H57N 130 1 6S, 948.3845 [M+H] and was found at 948.3849 [M+H]t 
6.4.5 Fmoc-SPPS of Clycopetide 128 
OH 	 OH 
H l \>. 
OH 
f 
H 2N-Cys-Asp-Arg-HN CO-His-Thr-COOH 
128 
The glycopeptide 128 was assembled and cleaved from the resin as well as side chain 
protecting groups were removed using the procedures 6.4.1, 6.4.2, 6.4.3 and 6.4.4. 
The crude glycopeptide was dissolved in I ml of MeCN/H 20/TFA (1:1:0.1 %) and 
was freeze dried for overnight to afford 128 as a white solid (17 mg, 54 %). The 
glycopeptide 128 was analysed on analytical LC-MS using a Luna 5 t C18 column 
5-95 % MeCN (0.1 % TFA)/H 2 0 (0.1 % TFA) as gradient for 33 min at 214 nrn. The 
glycopeptide 128 was eluted from the column with a retention time of 19.1 mm. 
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Glycopeptide 128 was also analysed by FIRMS (FAB): Calculated mass for 
C 39H64N 1 2021S, 1069.4108 [M+H] and was found at 1069.4105 [M+U] 
6.5 Enzyme Cleavable Linkers for Peptide and Glyco 
peptide Synthesis 
6.5.1 General Procedure for Attachment of Linker to PEGA 1900 
A solution of HMPA, HMBA or HOA (3 eq), HOBt (6 eq) and DIC (6 eq) in DMF 
(2-3 ml) was added to the PEGA 1900 (0.15 mmolg dry, 10 % wt. in MeOH). After 
rotation on an agitator and at room temperature for overnight, subsequently the resin 
was washed extensively with DMF, DMFIMeOH (1:1), DCM and finally DMF. 
6.5.2 Coupling of First Amino Acid 
The resin was allowed to swell in DMF containing DMAP (0.1 eq) in an isolute tube 
for 1 hr. The residual solvent was removed and replaced with a pre-reacted solution 
of Fmoc-amino acid (10 eq) and DIC (5 eq) in DMF. The reaction mixture was left 
on an agitator, room temperature for overnight and washed thoroughly with DMF, 
DMF/MeOH (1:1), DCM and finally DMF. 
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6.5.3 General Procedure for Fmoc-Deprotection 
A solution of 20 % piperidine in DMF (2-3 ml) was added to the resin. The reaction 
mixture was left on an agitator for 1 hr. The resin was filtered and washed 
thoroughly with DMF, DMF/MeOH (1:1), DCM and finally DMF. 
6.5.4 General Procedure for Coupling of Fmoc-Amino Acid/Glyco-
Amino Acid 
A solution of Fmoc-amino acid (4 eq)/glyco-amino acid (2 eq), HOBt (4 eq), TBTU 
(4 eq)) and DIPEA (8 eq) in DMF (2-3 ml) was added to the resin. The reaction 
mixture was left on an agitator and at room temperature for 4 hrs. The resin was 
washed extensively with DMF, MeOH/DMF (1:1), DCM and finally with DMF. The 
progress of the reaction was monitored by Kaiser test. In case of glyco-amino acid 
coupling the reaction mixture was left for overnight and in some cases double 
coupled. 
6.5.5 General Procedure for Side Chain Deprotection 
The following deprotection mixtures were used for the deprotection of the side chain 
groups prior to enzymatic cleavage. 
Experimental 
6.5.5.1 Fmoc-Ser(Trt)-OH (DCM/TFAITIS, 94:1:5) 
6.5.5.2 Fmoc-Asp(O-2-Ph 1 Pr)-OH (DCM/TFAITIS, 90:2:8) 
6.5.5.3 Fmoc-Lys(Mtt)-OH (DCM/TFAITIS, 94:1:5) 
The resin was washed with DCM and then treated with the deprotection mixture (2 
ml) for 5 mm. This process was repeated for three times. Finally, the resin was 
washed with DMF, DMF/MeOH (1:1), DCM and again with DMF. 
6.5.6 General Procedure for Cleavage with Chymotrypsin! 
Thermolysin 
All enzymatic reactions were performed on a 75 mg scale of resin (corresponding to 
7.5 mg dry weight, 0.001 mmol) in potassium phosphate buffer (1 ml, 0.1 M, pH 8) 
containing chymotrypsin or thermolysin (2 mg/ml). The resin was washed with the 
buffer prior to enzymatic reaction. After rotation on an agitator, at room temperature 
for 16 hrs, the resin was washed with buffer and the filtrate was analyzed by LC-MS. 
6.5.7 TFA Cleavage (for HMPA Linker Only) 
The cleavage mixture (1 ml) TFAIH20 (95:5) was added to the resin (75 mg, 
corresponding to 7.5 mg dry weight, 0.001 mmol) and allowed to rotate on an 
agitator, at room temperature for 3 hrs. The TFA mixture was analysed by LC-MS at 
254 nrn and was compared with enzymatic cleavage. 
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6.5.8 LC-MS Analysis and LC-MS(ZMD) Purification 
Methods 
6.5.8.1 General Procedure for LC-MS Analysis 
The hydrolysis mixture was analysed by LC-MS using a Luna 5 t C18 column (250 
x 2 mm) and 0-85 % MeCN (0.1 % TFA)1H20 (0.1 % TFA) as a gradient with flow 
rate of 0.2 ml min 1 at 254 nm for 33 mm. Chymotrypsin, thermolysin and TFA 
(HMPA linker only) hydrolysis yields were calculated from LC-MS data. 
6.5.8.2 General Procedure for LC-MS Analysis 
The peptide was dissolved in I ml mixture of MeCN/H 20/TFA (1:1:0.1) and was 
analysed by LC-MS using a Luna 5 C18 column (250 x 2 mm) and 5-60 % MeCN 
(0.1 % TFA)/H 20 (0.1 % TFA) as a gradient with flow rate of 0.2 ml min - ' at 214 rim 
for 33 mm. 
6.5.8.3 General Procedure for LC-MS(ZMD) Purification of Peptide 
The peptide (5-10 mg) was dissolved in 1-2 ml mixture of MeCN/H 20/TFA (1:1:0.1) 
and was purified by LC-MS(ZMD) using Luna 5 C18 column (250 x  10 mm) and 
5-30 % MeCN (0.1 % TFA)/H20 (0.1 % TFA) as a gradient with flow rate of 5 ml 
min- ' for 30min. 
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6.5.8.4 General Procedure for LC-11S(ZMD) Purification of Peptide 
The peptide (5-10 mg) was dissolved in 1-2 ml mixture of MeCN/H 20/TFA (1:1:0.1) 
and was purified by LC-MS(ZMD) using a Luna 5 t C18 column (250 x  10 mm) 
and 5-60 % MeCN (0.1 % TFA)/H20 (0.1 % TFA) as a gradient with flow rate of 
5m1 mind for 30 mm. 
6.6 Initial Observations 
6.6.1 Fmoc-SPPS of Fmoc-Phe-Asp and Cleavage by Chymotrypsin 
150 
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The dipeptide 150 was assembled on PEGA resin using the general procedures 6.5.1, 
6.5.2, 6.5.3 and 6.5.4. The side chain protecting group was removed by general 
procedure 6.5.5.2. The substrate 150 was subjected to chymotrypsin hydrolysis using 
181 
Experimental 
the procedure 6.5.6. The enzymatic hydrolysis mixture was analysed by LC-MS 
employing the general procedure 6.5.8.1. 
6.6.2 Coupling of Fmoc-Amino Acid onto PEGA Using Different 
Linkers and Cleavage with Chymotrypsin 













Wang linker (HMPA) was attached to PEGA 1 900 using the procedure 6.5.1. 
Subsequently, different Fmoc—amino acids were coupled to the linker using the 
general procedure 6.5.2. The side chain protecting groups were removed with 
appropriate conditions 6.5.5 to afford substrates 153-161. The resin substrates 153-
161 were washed thoroughly with buffer prior to enzymatic reaction and were 
incubated with chymotrypsin using the general procedure 6.5.6. The cleavage of 
Fmoc-amino acid 162-170 was analysed by LC-MS using the general procedure 
6.5.8.1. Substrates 153-161 were also subjected to TFA hydrolysis using procedure 
MOM 
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6.5.7. The hydrolysed Fmoc-amino acids 162-170 were analysed by general 
procedure 6.5.8.1. The TFA hydrolysis yields were calculated from LC-MS data and 
were assumed as a 100 %. Chyrnotrypsin hydrolysis yields were also calculated from 
LC-MS and were compared with TFA cleavage yields. 
6.6.2.2 Base Labile HMBA Linker 171-173 
0 
HN 
R 	 HN 




162, 163, 166 
HydroxymethylbenzoiC acid (HMBA) was attached to PEGA I900 using the procedure 
6.5.1. Subsequently, different Frnoc—amino acids were coupled to the linker, 
employing the general procedure 6.5.2. The side chain protecting group was removed 
with appropriate conditions 6.5.5 to afford substrates 171-173. The resin bound 
substrates 171-173 were washed thoroughly with buffer prior to enzymatic reaction 
and were incubated with chymotrypsin using the general procedure 6.5.6. The 
cleavage of Fmoc-amino acids 162, 163 and 166 were analysed by LC-MS using the 
general procedure 6.5.8.1. The hydrolysis yields were calculated from LC-MS data. 
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6.6.2.3 Hydroxyoctanoic Acid (HOA) Linker 174-176 
0 
HN 







Hydroxyoctanoic acid (HOA) was attached to PEGA using the procedure 6.5.1. The 
Fmoc—amino acids were coupled to linker employing the general procedure 6.5.2. 
The side chain protecting groups were removed with appropriate conditions 6.5.5 to 
afford substrates 174-176. The resin bound substrates 174-176 were washed 
thoroughly with buffer prior to enzymatic reaction and subsequently incubated with 
chymotrypsin using the procedure 6.5.6. The cleavage of Fmoc-amino acids 162, 166 
and 168 were analysed by LC-MS using the general procedure 6.5.8.1. 
6.7 Fmoc-SPPS of Glycopeptide on PEGA 1900  178 and Cleavage with 
Chymotrypsin 179 
OH 














6.7.1 Attachment of HMPA to PE6A 1 900 
A solution of HMPA (6.8 mg, 0.045 rnmol), HOBt (10.2 mg, 0.09 mmol) and DIC 
(14 j.il, 0.09 mmol) in DMF (1.5 ml) in an isolute tube was added to the PEGA1900 
resin (1 g, 0.15 mmolg d,  10 % wt. in MeOH). The reaction mixture was left on an 
agitator and at room temperature for overnight. The resin was washed extensively 
with DMF, DMF/MeOH (1:1), DCM and finally DMF. Kaiser test indicated that the 
coupling was complete. 
6.7.2 Coupling of Fmoc-Ser(Trt)-OH 
The resin was allowed to swell in DMF containing DMAP (0.1 eq) in an isolute tube 
for 1 hr. The residual solvent was removed and replaced with a pre-activated solution 
of Fmoc-Ser(Trt)-OH (85 mg, 0.15 mmol) and DIC (12 p.1, 0.075 mmol) in DMF (2 
ml). The reaction mixture was left on an agitator and room temperature for overnight. 
The resin was washed thoroughly with DMF, DMF/MeOH (1:1), DCM and finally 
DMF. 
6.7.3 Fmoc-Deprotection 
A solution of 20 % piperidine in DMF (2 ml) was added to the resin. The reaction 
mixture was left on an agitator for 1 hr. The resin was washed thoroughly with DMF, 
DMF/MeOH (1:1), DCM and finally DMF. 
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6.7.4 Coupling of Fmoc-Gly-OH 
A solution of Fmoc-Gly-OH (22 mg, 0.075 mmol), HOBt (10 mg, 0.075 mmol), 
TBTU (24 mg, 0.075 mmol) and DIPEA (26 p1, 0.15 mmol) in DMF (2 ml) in an 
isolute tube was added to the resin. After 4 hrs, the resin was washed extensively and 
the Kaiser test indicated that the coupling was complete. The Fmoc group was 
removed using 20 % piperidine in DMF for 1 hr. 
6.7.5 Coupling of Glyco-Amino Acid 116 
A solution of 116 (42 mg, 0.075 mmol), HOBt (10 mg, 0.075 mmol), TBTU (24 mg, 
0.075 mmol) and DIPEA (26 p1, 0.15 mmol) in DMF (2 ml) was added to the resin. 
After 16 hrs, the resin was washed thoroughly with DMF, DMF/MeOH (1:1), DCM 
and finally DMF. Side chain protecting group (Trt) was removed using the procedure 
6.5.5.1 to afford the substrate 178. 
6.7.6 Cleavage of Glycopeptide 179 using Chymotrypsin 
The resin bound glycopeptide 178 (75 mg corresponding to 7.5 mg dry weight, 0.001 
mmol) was washed with potassium phosphate buffer (0.1 M, pH 8.0) and was treated 
with chymotrypsin (2 mg/ml) in potassium phosphate buffer (1 ml, 0.1 M, pH 8) at 
room temperature for 16 hrs. The resin was filtered, washed with buffer and was 
analysed by LC-MS at 21 4nm, using the general procedure 6.5.8.1. The glycopeptide 
IVIO  
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179 was eluted with a retention time of 17.2 mm. The substrate 178 was also treated 
with TFA to compare the reaction yield, using the general procedure 6.5.8.1. The 
glycopeptide 179 yield was 100 % based on LC-MS data and compared to TFA 
cleavage. MS (ESI): Calculated mass 701.19 and was found at 702.2 [M+H] 
6.8 Synthesis of N-Linked Glycopeptides as Potential 
Substrates for Proteases 








= Sugar, X= Gly, none, 
200-206 
The Wang linker (HMPA) was attached to PEGA 1 900 employing the general 
procedure 6.5.1. Subsequently, the fist amino acid was coupled to the linker using 
procedure 6.5.2. The Fmoc group was removed employing the general procedure 
6.5.3. Remaining peptide and glycopeptide synthesis was carried out by the general 
procedure 6.5.4. Finally, the side chain protecting groups were removed using the 
procedure 6.5.5.1 to afford the substrates 200-206. 
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Fmoc -A?n-Phe-X-HN 0 	
H PEGA 
OH 	HMPA 
o = Sugar, tert-Butyl, XGIy, none 
200-206 
Fmoc -Pisn-Phe-COOH + Fmoc In-Phe-X-Ser-COOH 
207-213 	 214-220 
Chymotrypsin hydrolysis reactions were achieved using the general procedure 6.5.6. 
The enzymatic cleavage reaction mixture was analysed by LC-MS using the general 
procedure 6.5.8.1. The hydrolysis products ratios were compared from LC-MS data. 
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6.8.3 Thermolysin Mediated Hydrolysis of Peptide 200, Glyco 
peptides 201 and 202 









The peptide 200 and glycopeptides 201-202 were synthesised using the general 
procedure 6.8.1. Thermolysin mediated hydrolysis reactions were obtained using the 
general procedure 6.5.6. The enzymatic cleavage reaction mixture was analysed by 
LC-MS employing the general procedure 6.5.8.1. 
6.9 Total Chemical Synthesis of Membrane Co-factor 
Protein Module 1 (MCP 1) 
6.10 Fmoc-SPPS of Peptide 228 on a Wang Resin 




6.10.1 Fmoc-SPPS of C-Terminal Cysteine Fragment 228 
The C-terminal cysteine fragment 228 was assembled on a pre-loaded Fmoc-
Glu(OtBu)-Wang resin (0.08 g, 0.05 mmol, which is based on 0.62 mmolg 1 of 
loading). Fmoc group was removed with 20 % piperidine in DMF (3 ml) for 1 hr. 
The remaining peptide synthesis was obtained using the general procedure 6.5.4 
followed by 6.5.3. The resin was washed with DMF, DMF/MeOH, DCM and then 
with ether. The resin was dried under vacuum for overnight. 
6.10.2 Cleavage of Side Chain Protecting Groups and Peptide 228 
from Resin 
The vacuum dried resin (0.05 g, 0.025 mmol) was transferred into a 25 ml round 
bottom flask and was added 6 ml cleavage mixture of TFAIEDT/H 20/TIS 
(94:2.5:2.5:1) and the reaction mixture was stirred at room temperature under 
nitrogen atmosphere for 4 hrs. The resin was filtered and washed with 3 ml of TFA. 
The filtrate was concentrated under reduced pressure and precipitated with cold ether 
to afford a white solid. The crude peptide was dissolved in 1 ml mixture of 
MeCN/H20/TFA (1:1:0.1) and freeze dried for overnight to afford 228 as a white 
fluffy solid (18 mg, 32 %, based on 0.62 mmolgf 1 of loading). The crude peptide 
228 was analysed by LC-MS by employing the general procedure 6.5.8.2. 
Subsequently, crude peptide was purified by LC-MS(ZIV[D) using the general 
conditions 6.5.8.3 to afford 228 as a white fluffy solid. The purified peptide 228 was 
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again analysed by LC-MS using the general procedure 6.5.8.2 and desired product 
was observed with a retention time of 15.29 mm. Calculated mass, 2180.3 [M] and 
was found at 2180.9 [M+H], 1090.9 [+2], 727.7 [+3] 
6.11 Fmoc-SPPS of Middle Thioester Fragment 229 on Sulfamyl 
butyrylNovaSyn-TG Resin 
AcmS 
H2N° K K G FY I P P L AT HT NH)(SBn 
229 
6.11.1 Fmoc-SPPS of Middle Thioester Fragment 229 
The middle thioester fragment 229 was assembled on a pre-loaded Ala-
sulfamylbutyrylNovaSyn-TG resin (0.434 g, 0.1 mmol, based on 0.23 mmolg' of 
loading). The peptide synthesis was obtained using the general procedures 6.5.4 
followed by 6.5.3. The resin was washed extensively with DMF, DMFIMeOH, DCM 
and then with ether. The resin was dried in vacuum oven for overnight. 
6.11.2 Activation and Cleavage of Peptide 229 from Resin 
The oven dried resin (0.2 g, 0.05 mmol) was transferred into an isolute tube and was 
added NMP (3 ml), iodoacetonitrile (0.4 ml, 5.0 mmol) and DIPEA (0.1 ml, 0.5 
mmol). The reaction mixture was left on an agitator for 24 hrs with exclusion of 
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light. The resin was washed thoroughly with DMF, DMF/MeOH, DCM and finally 
with ether and was dried in a vacuum oven for overnight. The resin was transferred 
into a 25 ml round bottom flask and was added dry TifF (5 ml), benzyl mercapton 
(0.29 ml, 2.5 mmol) and sodiumthiophenoxide (3 mg, 0.025 mmol). The reaction 
mixture was stirred at room temperature under nitrogen atmosphere for 24 hrs. The 
resin was filtered and washed with THF (3 ml). The filtrate was concentrated under 
reduced pressure and precipitated with cold ether to afford fully protected peptide as 
a white solid. The fully protected thioester was transferred into a 25 ml round bottom 
flask and was added 5 ml cleavage mixture of TFAfH 20/TIS (95:2.5:2.5) and stirred 
the reaction mixture at room temperature under nitrogen atmosphere for 4 hrs. The 
solvent was removed under reduced pressure and precipitated with cold ether to 
afford a white solid. The solid was filtered and dissolved in 1 ml mixture of 
MeCN/H20/TFA (1:1:0.1) and freeze dried for overnight to afford 229 as a white 
fluffy solid (25 mg, 27 %). The crude peptide thioester 229 was analysed by LC-MS 
using the general procedure 6.5.8.2. Subsequently purified by LCMS(ZMD) using 
the general procedure 6.5.8.3 to afford 229 as a white fluffy solid. The purified 
peptide thioester 229 was again analysed by LC-MS employing the general 
procedure 6.5.8.2. The desired peptide 229 was eluted with a retention time of 17.92 
mm. Calculated mass for peptide 229, 1987.3 [M] + and was found at 1988.1 [M+H], 
994.6 [+2], 663.6 [+3]. 
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6.12 Native Chemical Ligation to Afford Peptide 230 
AcmS-. 
H2NCOK K G Y FY IPP LATH TACD RN HT W LP VSD D ACYR E-COOH 
230 
The middle peptide thioester 229 (0.38 mg, 0.458 pmol) and cysteine fragment 228 
(0.4 mg, 0.458 imol) were dissolved in 0.1 M sodium phosphate buffer (1H 7.5) 
containing 6 M Gn HC1 in an Eppendorf tube. To the same tube 3 tl of thiophenol (1 
% v/v) was added and the reaction mixture was left on an agitator and at room 
temperature for 24 hrs. The final concentration of the reaction mixture was 
maintained at 1.5 mM. The reaction mixture was analysed by LC-MS using the 
general procedure 6.5.8.2. Calculated mass for peptide 230, 4043.4 [M] and was 
found at 1349.3 [+3] and 1011.9 [+4]. After 24 hrs, another 0.2 mg of 229 was added 
to the reaction mixture and was stirred at room temperature for another 24 hrs. The 
reaction was quenched with 2 ml mixture of MeCNIH 20/TFA (1:1:0.1) and analysed 
the reaction mixture on LC-MC employing the general procedure 6.5.8.2. 
6.13 Fmoc-SPPS of N-Terminal Thioester Fragment 232 
0 




6.13.1 Preparation of N fluoreny1methoxycarbOfly1-N--tert-




To a stirred solution of N afluonylmethoxycarbonylNctertbutyloxycarbonyl.L. 
lysine (2.0 g, 4.26 mmol), dry pyridine (0.343 ml, 4.26 mmol) in dry CH 2C12 (12 ml) 
was added cyanuric fluoride (0.72 ml, 8.52 mmol). The reaction mixture was stirred 
at room temperature under nitrogen atmosphere for 3 hrs. The reaction mixture was 
diluted with CH2C12 (50 ml) and washed with excess of water (3 x  100 ml). The 
solvent was dried over calcium chloride and was concentrated under reduced 
pressure to afford crude product 238 as a white solid. The crude product was 
recrystallised from CH 2C12: hexane mixture to afford 238 as a white solid (1.6 g, 80 
%). melting point: 126-128 °C (lit. 88 128-130 °C). 
6.13.2 Loading of Fmoc-Lys onto Sulfamylbutyryl AM Resin"' to 
Afford 239 






The sulfamylbutyryl AM resin (0.2 g, 0.22 mmol based on 1.1 mmolg 1 ) was allowed 
to swell in an isolute tube in CH202  (2 ml) containing DMAP (0.053 g, 0.44 mmol) 
and DIPEA (0.12 ml, 0.66 mmol). The compound 238 (0.31 g, 0.66 mmol) in CH202 
(2 ml) was added to the resin. The reaction mixture was left on an agitator and at 
room temperature for 2 hrs. The resin wash filtered and washed with DMF, 
DMF/MeOH (1:1), DCM to afford 239. The resin 239 was dried under vacuum oven 
for overnight. The loading was calculated using the general procedure 6.1.1 and was 
found to be 0.58 mmolg'. 
6.13.3 Fmoc-SPPS of N-Terminal Thioester Fragment 232 
The resin 239 (0.2 g, 0.12 mmol) was transferred into an isolute tube and was added 
20 % piperidine in DMF (2 ml). The reaction mixture was left on an agitator for 1 hr. 
The resin was washed extensively with DMF, DCM, DMF/MeOH (1:1) and DMF. 
The remaining peptide thioester was achieved using general procedures 6.5.4 and 
6.5.3. After final amino acid, Boc-Ser(O tBu)-OH coupling the resin was washed 
extensively with DMF, DMFIMeOH, DCM and finally with ether. The resin was 
dried in a vacuum oven for overnight. 
6.13.4 Activation and Cleavage of N-Terminal Thioester 232 
The oven dried resin (0.2 g, 0.12 mmol) was transferred into an isolute tube and was 
added NMP (5 ml), iodoacetonitrile (0.86 ml, 12 mmol) and DIPEA (0.21 ml, 1.2 
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mmol). The reaction mixture was left on an agitator for 24 hrs with exclusion of 
light. The resin was washed thoroughly with DMF, DMFIMeOH, DCM and ether. 
The resin was dried in vacuum oven for overnight. The dried resin was transferred 
into a 25 ml round bottom flask and was added dry THF (5 ml), benzyl mercaptan 
(0.7 ml, 6.0 mmol) and sodiumthiophenoxide (8 mg, 0.06 mmol). The reaction 
mixture was stirred at room temperature under nitrogen atmosphere for 24 hrs. The 
resin was filtered and washed with THF (5 ml) and the filtrate was concentrated 
under reduced pressure and precipitated with cold ether to afford a white solid. The 
ether solution was centrifuged and repeated two times this process to remove the 
trace of the BnSH to afford fully protected thioester. The fully protected thioester 
was dissolved in a 5 ml mixture of TFAJEDT/H 20/TIS (94:2.5:2.5:1) and was stirred 
under nitrogen atmosphere at room temperature for 24 hrs. The solvent was removed 
under reduced pressure and precipitated with cold ether to afford 232 as a white 
solid. The white solid was dissolved in 1 ml of MeCN/H 20/TFA (1:1:0.1) and freeze 
dried for overnight to afford 232 as a fluffy white solid (17 mg, 4 %). The crude 
peptide thioester 232 was analysed by LC-MS employing the general procedure 
6.5.8.2. Subsequently, purified by LC-MS(ZMD) using the general purification 
procedure 6.5.8.4 to afford 232 as a white fluffy solid. The purified peptide thioester 
232 was analysed by LC-MS using the general procedure 6.5.8.2. The desired 
compound 232 was eluted with a retention time of 19.42 mm. Calculated mass for 




6.14 Fmoc-SPPS of C-Terminal Cysteine Fragment 237 
H2N-C K K G Y F Y I P PLAT  H T I CDR  N H T W L P V S D D A C Y RE -COOH 
237 
6.14.1 Fmoc-SPPS of Peptide Fragment 237 
The C-terminal cysteine fragment 237 was assembled on a pre-loaded Fmoc-
Glu(OtBu)-Wang resin (0.24 g, 0.15 mmol, based on 0.62 mmolg' of loading). Fmoc 
group was removed with 20 % piperidine in DMF (3 ml) for 1 hr. The remaining 
peptide synthesis was achieved using the general procedures 6.5.4 and 6.5.3. The 
resin was washed extensively with DMF, DMF/MeOH, DCM and then with ether. 
The resin was dried under vacuum for overnight. 
6.14.2 Cleavage of C-Terminal Cysteine Peptide 237 from Resin 
The oven dried resin (0.22 g, 0.075 mmol) was transferred into a 25 ml round bottom 
flask and was added a 8 ml cleavage mixture of TFAIEDTIH20/ TIS (94:2.5:2.5:1). 
The reaction mixture was stirred at room temperature and nitrogen atmosphere for 5 
hrs. The solvent was removed under reduced pressure and precipitated with cold 
ether to afford a white solid. The ether solution was centrifuged to afford crude C-
terminal cysteine fragment 237 as a white solid (0.096 g, 32 %). The crude peptide 
237 was analysed by LC-MS employing the general procedure 6.5.8.2. Subsequently, 
purified by LC-MS(ZMD) using the general purification conditions 6.5.8.4 to afford 
197 
Experimental 
237 as a white fluffy solid. The purified peptide 237 was again analysed by LC-MS 
employing the general procedure 6.5.8.2. The desired product was eluted with a 
retention time of 21.22 mm. Calculated mass for peptide 237, 4014.56 [M] and was 
found at 2007.6 [+2], 1339.6 [+3], 1004.9 [+4], 804.5 [+5], 670.7 [+6]. 
6.15 Native Chemical Ligation to Afford 233 
H 2N-SDACEEPPTFEAM ELIGKPKPYYEIGERVDYK 
C K K G Y F Y I P PLAT  H T I CD RN H T W L P V S DD A C Y R E-COOH 
233 
The N-terminal peptide thioester 232 (0.6 mg, 0.157 tmol) and C-terminal cysteine 
fragment 237 (0.6 mg, 0.157 pmol) were dissolved in 0.1 M sodium phosphate buffer 
(0.12 ml, pH 7.5) containing 6 M Gn HC1 in an Eppendorf tube. To the same tube 1.4 
jil of thiophenol (1 % v/v) was added and the reaction mixture and was left on an 
agitator and at room temperature for 27 hrs. The final concentration of the reaction 
mixture was maintained at 1.5 mlvi. The reaction was quenched with 1 ml mixture of 
MeCN/H20/TFA (1:1:0.1). The reaction mixture was analysed on LC-MS employing 
the general procedure 6.5.8.1. Calculated mass for 233 (MCP 1), 7702.7 [M] and 
was observed at 1926.5 [+4], 1541.5 [+5] and 1101 [+7] as a major mass units. 
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6.16 Gel electrophoresis of Ligation Mixture of 233 
The gel electrophoresis of MCP 1, 233 reaction mixture was performed using a 
NuPaGE 4-12 % Bis-Tris 1.0 gel, See Blue ® Plus 2 ladder (3 kD-250 kD) and 
NuPaGE® MES SDS running buffer (20 x 500 ml) in an Invitrogen apparatus, at 200 
V for nearly 35 min run time. The gel was stained with EZ blue for 1 hr and was 
destained with water for overnight. Gel electrophoresis results showed a strong band 
of desired mass range (7702 amu of MCP 1) and also a low molecular weight band, 
which might be due to unreacted starting material (nearly 4000 region). 
6.16.1 Sample Preparation for Gel electrophoresis 
Crude ligation mixture of MCP 1, 233 (5 mg contained 6 M Gn HCl) was dissolved 
in 300 tl of SDS-buffer (sodium dodecyl sulphate). The loading buffer was heated in 
a well plate at 110 °C for 5 min and then centrifuged for 3 min at 13000 g. The 
centrifuged material was loaded onto the gel with different concentrations. 
6.17 Refolding Protocol for Crude Ligation Reaction Mixture of 233 
The crude ligation mixture of MCP 1 (233) (5 mg contained 6 M Gn HC1) was 
dissolved in a freshly prepared 6 M Gn HCl solution (0.5 ml) The dialysis cassette 
(PIERCE SLIDE—A-LYZER ®  DIALYSIS CASSETTE 3500 MWCO 0.1-0.5 ml 
capacity) was hydrated with water by leaving it in water for 3 min prior to refolding. 
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The ligation mixture was centrifuged and 300 p.1 of supernatant solution was dialysed 
against refolding buffer (0.1M Tris-HC1 (pH 8.2), 3 mM reduced glutathione (GSH), 
0.3 mM oxidised glutathione (GSSH) and 1 mM ETDA) for overnight. After 18 hrs 
refolding buffer was changed and dialysis was continued for another 4 hrs. The 
refolded reaction mixture was eluted on a gel electrophoresis as described in 6.16 
and analysed by LC-MS using the general procedure 6.5.8.1. (Similar refolding 
experiment was performed initially by dissolving the crude ligation mixture of MCP 
1 (233) in water instead of 6 M Gn HC1. The gel electrophoresis results for both 
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An Efficient Synthetic Route to 
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Glycopeptide Synthesis 
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OH 	 OH 	 OH 	 0 
R1( 	
(NH4)2CO3 (5 fold) 
Microwave (10 watts). 
OH DMSO (Anhydrous). 	 2a .1 	H2N—Cys—Asp—  Arg-HN Ia -f 	40°C. 250ps1. 90mm 






	= OH. = Glycopeptide 8 
OH 
g$ycopeptide synthesis requires access to gram quantities of glycosylated amino acid building blocks. Hence, the efficiency of 
of such building blocks is of great importance. Here, we report a fast and highly efficient synthetic route to Fmoc..protected asparaginyl 
from unprotected sugars in three steps with high yields. The glycosylated amino acids were successfully in into target 
ides T and 8 by standard Fmoc solid-phase peptide synthesis. 
is estimated that more than half of all proteins carry 
bohydrate side chains, with the majority being N-glycans 
ked to asparagine residues that are part of the Asn-X-Ser/ 
r tripeptide codon for N-glycosylation) Very little is 
derstood about how the glycan chains specifically modu-
e stability and activity of glycoproteins because of the 
mplexity and heterogeneity of glycoprotein samples iso-
ed from biological sources. Glycopeptides are therefore 
portant targets for in vitro synthesis, 2  and with the advent 
the native chemical ligation of peptides even small- and 
dium-sized glycoproteins are now targeted by chemical 
Apweiler, R.; Hermjakob, H.; Sharon, N. Biochim. Biophys. Ada 
99, 1473, 4. 
(a) Marcaurelle, L. A.; Bertozzi, C. R. Glycobiology 2002, 12 (6), 
R-77R (b) Warren, J. D.; Miller, J. S., Keding, S. J.; Danishetky, S. J. 
Am. Chem. Soc. 2004, 126, 6576. 
(a) Dawson, P. E.; Kent, S. B. H. Annu. Rev. Biochem. 2000, 69, 
3. (b) Shin, Y.; Winans, K. A.; Bakes, B. J.; Kent, S. B. H.; Ellman, J. 
Bertozzi, C. R. J. Am. Chem. Soc. 1999, 121 9 11684. (c) Dudkin, V. 
Miller, J. S.; Danishefsky, S. J. J. Am. Chem. Soc. 2004, 126, 736. (d) 
.1021/o1048342n CCC: $27.50 © 2004 American Chemical Society 
ibllshed on Web 0913012004 
N-Glycans can influence glycoprotein biosynthesis, struc-
ture, and activity in many ways. One intriguing question is 
that of the role of the highly conserved core pentasaccharide 
of N-glycans. Although N-glycosylation is diverse across 
tissues and species, the pentasaccharide core which is linked 
through the reducing N-acetylglucosamine to an asparaginyl 
side chain of the polypeptide is conserved in almost all higher 
organisms. Recent crystallographic and NMR data has shown 
that the core, especially the first two N-acetylglucosamine 
residues, can have important interactions with the protein 
and be responsible for stabilization of the active protein 
structure .4 - 
To address questions of the structure—activity relationship 
of N-glycans, we are seeking to develop synthetic methods 
that would give us good access to glycopeptides carrying 
Bang, D.; Chopra, N.; Kent, S. B. H. J. Am. Chem.- Soc. 2004, 126, 1377. 
(a) hnperiali, B.; O'Connor, S. E. Curr. Opin. Chem. Biol. 1999, 3 
(6), 643. (b) Petrescu, A. J.; Milac, A. L.; Petrescu, S. M.; Dwek, R. A.; 
Wormald, M. R. Glycobiology. 2004, 14 (2), 103. 
/ 
N-glycan core structures and a number of specific 
During previous work on the synthesis of glycopeptides, 
to strategies have been employed. One approach introduces 
the carbohydrate as part of a glycoamino acid building block 
dtring solid-phase synthesis of the polypeptide chain. 5 
Atematively, the carbohydrate can be attached to a selec-
ti1ely deprotected aspartic acid residue once the polypeptide 
has been formed using the method developed by Lansbuiy. 6 
B3, a similar route, unnatural glycopeptides have also been 
gnerated using selective alkylation of free cysteine residues. 7 
Both of the routes to peptides bearing N-glycans generally 
use /3-glycosylainines as key intermediates , 8  with subsequent 
acylation by a suitably protected amino acid or a polypeptide 
side chain depending on the approach taken. Such glycosyl-
amines are accessible by two routes: from suitably protected 
glycosyl azides requiring multiple protection and deprotection 
steps (generally five steps) or by direct amination (one step) 
using the Kochetkov reaction.' The latter method starts with 
afully depr9tected reducing sugar which is treated with 40-
5) times excess ammonium bicarbonate for 6 days. 8 The 
longer reaction times and difficulties in removing ammonium 
bcarbonate effectively by evaporation (a process that takes 
sveral days) have been a major drawback of the Kochetkov 
amination reaction.  9" ° 
PromptedSby reports that imine formation can be acceler-
ated by microwave irradiation," we decided to study the 
Kochetkov reaction using microwave irradiation. Our aim 
vas to develop methodology that would overcome the 
rbstantial practical drawbacks of this key reac tion for ycopeptide synthesis, in particular, shorten reaction times 
and reduce the amount of bicarbonate needed. 
Initially, the reaction conditions were optimized for 
N-acetyl gluèosamine (la), which is conserved as the 
educing monosaccharide unit of the pentasaccharide core 
Table 1). Of the various solvents tested, only DMSO resulted 
n good yields of 2a (Table 1, compare the first four entries). 
Gratifyingly, the reaction was found to be efficient with only 
p-fold excess (w/w) of ammonium carbonate over sugar 
ompared to the 40-50-fold excess needed under thermal 
&onditions. 8  Reactions appeared to be complete after 90 mm 
A microwave irradiation (10 W), while maintaining the 
vessel temperature at 40 °C and maximum pressure at 250 
In additin to the product 2a, a small amount of side 
roduct,' diglycosylamine, was also observed by mass 
(5) ' (a) Wagner, M.; Dziadek, S.; Kunz, H. Chem. Eur. J. 2003, 9 (24), 
018. (b) Meinjohanns, E.; Meldal, M.; Paulsen, H.; Dwek, R A.; Bock, 
J. Chem. Soc., Perkin Trans. 1"8, 1, 549. 
Cohen-Anisfeld, S. T.; Lansbury, P. T., Jr. J. Am. Chem. Soc. 1993, 
15, 10531. 
Macmillan: D.; Dames, A. M.; Bayrhuber, M.; Flitsch, S. L. Org. 
ett 2002, 4, 1467. 
(a) Likhosherstov, L.; Novikova, 0.; Deiveitskaja, V. A.; Kochetkov, 
1. K. Carbohydr. Res. 1986, 146, Cl —CS. (b) Vetter, D.; Gallop, M. A. 
tioconjugate Chem. 1995, 6,316. 
Lubineau, A.; Auge, J.; Drouillat, B. Carbohydr. Res. 1995, 266, 
11. 
Tokuda, Y.; Takahashi, Y.; Matoishi, K.; Ito, Y.; Sugai, T. Synlet: 
002,4, 57. 
Perreux, L.; Loupy, A. Tetrahedron 2001, 57, 9199. 







Microwave (10 watts), AcHN OH Solvent (Anhydrous), 
la 400.60°C, 250psi, 45-90min 	
La 
solvent 	T(°C) time (min) 	product 	diner-9 (%) 
MeOH 	40 90 	no product 	ND 
CH3CN 40 90 no product ND 
DMF 	40 90 	trace 	 ND 
DMSO 40 90 80-90 5 
DMSO 	50 90 	60-70 	15 
DMSO 60 90 50-60 20 
DMSO 	40 45 	60-70 	 5 
ND (not determined). Dimerization of the amine increased with 
temperature from 40 to 60°C. 
spectrometry. Such a dimer is formed by further condensation 
of 2a to starting sugar. The formation of this dimer in up to 
10% yield has also been observed in thermal reactions 81' and 
has been shown not to interfere with subsequent acylations. 
The formation of dimer was significantly increased at higher 
temperatures such as 50 and 60 °C (Table 1), and reaction 
temperatures were therefore generally kept at 40 °C. 
The optimized reaction conditions were used successfiully 
to afford glycosylamines 2a—f from mono-, di-, and tn-
saccharides la— f in excellent yields (Table 2). in all cases, 




substrate R, R product (yield. %)8 
la H NHAc 2a(87) 
lb Glc (flu- OH 2b (86) 
ic Gal (81- OH 2c (75) 
Id GlcNAc (flu - NHAc Zd (35) 
le Glc(al-4)Glc (a!- OH 2e (75) 
if Glc(al- OH 2f(70) 
Yields were calculated from 'H NMR spectra in 1)20 and are based 
on the integration of the anomeric proton of crude glycosylamine and 
substrate. 
the small excess of ammonium carbonate and DMSO was 
easily removed by freeze-drying the reaction mixture over-
night to yield a colorless hygroscopic solid, which could used 
for further acylation studies without any purification. Selec-
tive formation of the -glycosylamine was demonstrated by 
NMR. 
Formation of glycosylamines was also attempted starting 




(NH4)2CO3 (5 fold) 
Microwave (10 watts), 
OMSO (Anhydrous), 
400C, 250psi, 90mm 
Org. Left., Vol. 6, No. 22, 2004 
deacetylation and animation could be achieved at the same 
tie. However, under our reaction conditions only 1 -0- 
de: I acetylated glycosides together with trace amounts of 
glycosylamines were observed. 
crude glycosylamines 2a—e were then used for the 
tion of glycoarnino acid building blocks (Table 3). 
Tib1e 3. Synthesis of Fmoc-Protected Glycoamino Acids from 
Cude Glycosylamines 






BTU, HOBt, DMF. 








3ubstrate R1 R 	product (yield. %)b 
2a H NHAc 	4a (89) 
2b Glc (81 - OH 4b (86) 
2c Gal (81- OH 	4c (79) 
Zd G1cNAc (81- NI-lAc 4d (74) 
Ze Glc(al-4) Gic (al- OH 	4e (81) 
Overall yields from 2a—e. 
(:oupling of the amines (2a—e) with N-a-Fmoc-protected 
L-aspartic acid a-tert-butyl ester using HOBtIHBTIJ as 
(;oUpliflg agent and subsequent acidic deprotection resulted 
in the corresponding Fmoc-protected glyco amino acids 4a—e 
in good overall yields. Optimized yields were obtained with 
only 1.2-fold excess of amino acid over crude amine, which 
;hows that most of the ammonium carbonate had been 
;uccessfully removed during workup from the previous 
,reaction mixture. 
Alternatively, the Cbz-protected glycoamino acid 6 was 
iprepared via acylation of 2a with the 9-acyl fluoride of N-u-
:cbz-protected L-aspartic acid a-isobutyl ester, followed by 
enzymatic hydrolysis of the isobutyl ester with papain 
(Scheme l).b0 
L,One of the future aims of our studies is the chemical 
synthesis of the measles binding domains of the CD46 
complement cofactor in humans. Structural studies have 
Ishown that the core saccharides (in particular, the first two G1cNAc residues) interact strongly with the polypeptide 
backbone, and functional studies have highlighted that 
glycosylation is essential for measles virus recognition. 2 
Our aim is the total synthesis of such receptor modules 
bearing defined natural and unnatural carbohydrate chains 
using native chemical ligation. Such synthesis requires access 
to glycosylated peptides such as 7 and 8. 
(12) Casasnovas, J. M.; Larvie, M.;.Stehle, T. EMBOJ. 1999, 18,2911 
L, Vol 6, No. 22, 2004 
Scheme 1. Synthesis of Cbz-Protected Glycoamino Acid 6 
OH 	 OH 
NH2 AdqN
Z.sp(F).OBu 
NaHCO,, DMF, RI. 	AdiN 
2.5Iws bzHN 
0 






Thus, the glycosylated asparagine building blocks 4a and 
4b were incorporated into target glycopeptides 7 and 8 using 
Fmoc-based solid-phase peptide synthesis on the Wang resin 
(Scheme 2). 
Scheme 2. Fmoc-SPPS of Glycopeptide 7 and 8 
H2N—Thr— WANG• 
Fmoc-SPPS, TBTU,HOBt, 
DIPEA, DMF, RT, 4hrs 
then 20%Pipendine in DMF for lhr. 
H 2N— Asn_-His—Thr— WANG 
Boc Cys—Asp-Arg— 9- Hs —Thr— WANG 
TFA (94%)! H 20 (2.5%)! EDT (2.5%) /TIS (1%) 
RT, 4hrs 
H 2N— Cys—Asp-Arg— n— His—Thr— COOH 
OH 
9 = = Glycopepttde 7 
AcHN 
OH 	 OH 
= 	
Glycopeptide 8 9  
OH 	 OH 
Reaction conditions for each coupling step were 4-fold 
excess of amino acid with TBTU, HOBt, and DIPEA in DMF 
for 4 h, followed by Fmoc deprotection using 20% piperidme 
in DMF for 1 h. All amino acid coupling steps were single 
couplings except for coupling of the glycoamino acids 4a 
and 4b, which were incorporated into peptide using double 
coupling before Fmoc deprotection to ensure completion. 
The crude glycopeptides were cleaved from the resin using 
a mixture of TFA (94%)1H 20 (2.5%)IEDT (2.5%)/TIS (1%) 
for 4 h, in good overall yields (67% for 7 and 54% for 8 
based on a loading of 0.56 mmollgram of resin). Analysis 
by LC—MS(ESI) confirmed their structure. 
4003 
\' 
In summary, we have developed a short (three-step) 
synthetic route from unprotected sugar to glycosylated 
asparagine building blocks for glycopeptide synthesis by 
using microwave-assisted Kochetkov amination as a key 
reaction. This route can be applied to mono- and oligo-
saccharides and yields glycosylated asparagine building 
blocks in a short period of time with minimal workup. The 
overall yields of the microwave-assisted aininations appear 
similar to that reported for the thermal conversion and 
sjggest that this methodology will be very useful for other 
applications such as the preparation of glycoconjugates for 
subsequent immobilization.°' The application of the gly-
coaminO acid building blocks in glycopeptide synthesis of 7 
arid 8, which are key intermediates for the synthesis of  
glycoproteins by native chemical ligation, was successfully 
demonstrated. 
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hstrct—A range of glycopeptides containing protease cleavage sites were synthesized on solid support using Fmoc-based solid 
iase glycopeptide synthesis. The immobilized peptides were studied as substrates for the proteases chymotrypsin and thermolysin. 
or chymotrypsin, N-glycosylation of an Asn residue at the P 2  site appears to reduce hydrolysis whereas glycosylation of the P
1 site 
oes not appear to affect peptide hydrolysis by thermolysin. 
2004 Elsevier Ltd. All rights reserved. 
1. Introduction 
Me of the effects of protein glycosylation has been 
hewn to be protection of the polypeptide backbone 
rom proteolysis by proteases. 1  Proteases are important 
nd abundant enzymes in biological systems, which are 
often specific for certain polypeptide sequences, charac-
erized as P 1 , P2. P3 ,... and P', P, V3 ,. . ., etc 
.2  depend-
rig on their position to the scissile bond as shown in 
igure 1. Very few studies have been conducted to inves-
igate the susceptibility of glycopeptides to hydrolysis by 
)roteases. Bock et al. have shown that non-natural gly -
osylation of an aspartic acid residue by lactose and 
	
P 2 	P 1 
o R2 	0 	H 
H o A1 	0 
Protease 
o R 2 H 0 	 H H 11 
)NrM?oH + 	1T 
H a R1 	 0 
Fiiure 1. Proteolytic cleavage of peptides and proteins with proteases. 
Tie amino acids flanking the hydrolysis site are commonly labeled as 
Pt P2,.. and P1', P2',... etc. 
Corresponding author. Tel./fax: +44 (0)131 650 4737; e-mail: 
ilitsch(ascd.ac.uk  
057-4166I$ - see front matter © 2004 Elsevier Ltd. All rights reserved. 
dd:lO.1016/j.tetasy.2004.l 1.031 
lactitol in the recognition site of the protease savinase 
can protect soluble glycopeptides from proteolytic cleav- 
age' with the effect most pronounced in the P 1 position. 
Herein, we have looked at naturally occurring glycosyl-
ation motifs, in particular N-glycan motifs (Asn-X-
SerlThr) in which the Asn residue is glycosylated by 
the highly conserved core saccharides (GlcNAc in I 
and chitobiose in 2) and analogues (Gic in 3 and cello-
biose in 4) shown in Figure 2. These were tested against 
the commonly used proteases, chymotrypsin from 
bovine pancreas and thermolysin from Bacillus ihermo-
proteolyticus rokko. 
2. Results and discussion 
The core structure of N-glycosylation is highly con-
served in the majority of higher organisms, both in the 
peptide and carbohydrate component. Many of these 
structures will contain the tripeptide codon Asn-X-SerI 
Thr, where X can be any amino acid except proline. Fur-
thermore, the N-glycan linkage between sugar and poly-
peptide (Fig. 2), and the first five carbohydrate building 
blocks (the 'pentasaccharide core' Manctl-3(Manzl-
6)M an I -4G1cNAc I -4GIcNAc) are universally found 
throughout nature. The present study has therefore 
focused on these highly conserved core structures, incor-
porating at the same time potential proteolysis sites. 
In previous work,4  it was found that on the solid 
support PEGA 1900  (polyethylene glycol acryl amide, 
22 	 M. Bejugwn et at / Tetrahedron: Asymmetry 16 (2005) 21-24 
OH 
0 








3R=H 	 0 
4 R=01  -GIc 
FIgire 2. Natural N-glycans I and 2 and analogues 3 and 4. 
available from Polymer Laboratories, UK) both chymo-
trypsin and thermolysin have access to all reactive sites 
and can cleave susceptible peptide bonds on the resin 
quantitatively. Given that peptides and glycopeptides 
are often not soluble in aqueous buffers, it was decided 
to evaluate the substrates on solid phase. Thus, glyco-
peptides 9a-f and a control peptide 9g were synthesized 
on PEGA 1900 , linked to the resin via the Wang linker 
(HMPA, hydroxymethyiphenylacetic acid) (Scheme 1). 
The unglycosylated peptide 9g containing a teri-butyl 
ester of aspartic acid was selected as the control peptide 
sequence because problems with dehydration were 
excountered when trying to generate peptides with the 
corresponding natural Asn residue at the glycosylation 
sie on solid support. 
the first step, the HMPA was coupled to amino func-
)nalized PEGA 1900 resin 5 in the presence of HOBt 
A DIC in DMF. After 16 h of reaction, the resin 6 
is washed thoroughly with DMF, DCM and finally 
ith DMF. Next, Fmoc-Ser(Trt)-OH was coupled by 
st forming the symmetrical anhydride in the presence 
• DIC to give 7. After Fmoc deprotection, the desired 
otected peptides 8a-g were synthesized using standard 
rnoc solid-phase synthesis protocols with Fmoc-i-ami-
) acidlglycoamino acid (4 equiv), TBTU (4 equiv), 
OBt (4 equiv) and DIPEA (8 equiv) in DMF for 4 h. 
the case of the glycoamino acid couplings, the reac-
n time was increased to 20 h. The glycoamino acids  
were synthesized using a short and efficient method re-
cently described in our laboratory- 5 Final deprotection 
of the serine trityl protecting group was achieved with 
TFAJTISIDCM (1:5:94) for 4 x 5 min to generate com-
pounds 9a-g. The chemical synthesis could be conve-
niently monitored by hydrolysis of the Wang linker 
using TFAIH 20 (95:5) and subsequent analysis by 
LC-MS. This chemical cleavage allowed us to determine 
the loading of the resin and hence efficiency of subse-
quent enzymatic hydrolysis. The solid supported pep-
tides 9a- g (0.075 g, 0.001 mmol), were washed 
thoroughly with buffer and then subjected to enzymatic 
hydrolysis by incubating with different proteases such as 
chymotrypsin and thermolysin (2 mg/mL in 0.1 M 
potassium phosphate buffer, pH 8) for 16 h (Table I). 
The hydrolysis mixtures were analyzed by LC-MS.' 
We have recently discovered that the protease chymo-
trypsin can catalyze the hydrolysis of the ester bond of 
the Wang linker in peptides such as 9a-g in competition 
with any peptide bond containing phenylalanine or tyro-
sine in the P 1  position.' Thus two possible products 10 
and 11 can be generated by hydrolysis of 9a-g with chy-
motrypsin. If one assumes that glycosylation at the Asn 
residue in 9a-g has little influence on cleavage of the 
Wang linker, formation of 11 is a useful internal stan-
dard to look at the susceptibility of the Phe-Ser bond 
to enzymatic hydrolysis. Such a standard is particularly 




(I) 	 (ii) 
HO)L J 
Fmoc-Ser(Trt)-FIMPA--Q 
PEGA 1900 	 HMPA- PEGA 
(Oii) 
Fmoc -Phe- X -Ser-HMPA- 	
(iv) 	
Fmoc 	- X-Ser(Th)-HMPA- 
9a-g 	 8a-g 
= Carbohydrate, X = none 8a-d, 9a-d 
= Carbohydrate, X = Gly,  , 8e,f, 9e,f 
= tert-Butyl, X = Gly, 8g, 9g 
Scheme 1. Fmoc-based solid phase synthesis of peptides and glycopeptides 9a-g. The identity of carbohydrate side chains are shown in Table I. 
Reagents: (i) HMPA. HOBt, DIC, DMF, rt, overnight. (ii) (a) Fmoc-Ser(Trt)-OH, DIC, DMAP (cat.), DMF, it, overnight; (b) 201/6 piperidine/ 
DMF. it, I h. (iii) Fmoc-t.-amino acidlglycoamino acid. TBTU, HOBt, DIPEA, DMF. rt, 4 h. (iv)TFAJTISIDCM (1:5:94), 5 min x4. 
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tile 1. Proteolytic hydrolysis results of peptides and N-linked glycopeptides 
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I 	 Fmoc- 	n-- 
lOa-g 
+ Fmoc- 	n- 
11a-g 
-X-Ser-COOH 
Fmnr.-Aan- 	.XSerHMPAO H 
9a-g 	 I 	(ii) 	.. 
Fmoc n-COOH 
12a-c 
.eagents: (i) Chymotrypsin (2 mg/mL of 0.1 M KPi buffer pH 8), rt, 16 h. (ii) Thermolysin (2 mglmL of 0.1 M KPi buffer pH 8), rt, 
16 h. .i are 
srbohydrate side chains as shown in the table. 
ates for substrates immobilized to solid support. Previ-
us studies have shown that kinetics can be limited by 
liffusion of enzyme into the resin.' 
thalysis of the products of incubating 9a-g with therm-
ilysin and chymotrypsin are shown in Table 1. When 
he glycosylated peptide 9a was incubated with chymo-
rypsin, hydrolysis of the Wang linker was preferred to 
sydrolysis of the Phe-Ser bond leading to a mixture of 
Oa and ha in a ratio of 1:2, respectively (entry 1). It 
was interesting to note that the product lOa could be 
solated, given that in itself it should be a substrate for 
;hymotrypsin. However, we had previously observed 
hat soluble FmocPheAsp and FmocPheGly did not 
indergo any hydrolysis when incubated with chymo-
.rypsin. A possible explanation might be issues of solu-
,ilty of the peptide, which could make it inaccessible to 
nymatic hydrolysis. 
sugar and the sugar-protein linkage in 9a present 
Lhe natural highly conserved core structure. When the 
ne t saceharide was added to form chitobiosyl peptide 
b (entry 2), selectivity for the Wang linker cleavage 
was not significantly enhanced. Equally, hydrolysis 
ra ios were the same for the unnatural glycopeptides 
9c and 9d (entries 3 and 4) suggesting that the 2-N-acetyl 
groups of G1cNAc and chitobiose are not involved in 
stabilization of the linkage towards hydrolysis by chy- 
m trypsin. The ratio of hydrolysis products also re- 
m med similar when a glycine residue was inserted 
in o the Phe-Ser sequence (entries 5 and 6), suggesting 
that cleavage at the Wang linker was not much affected 
by distant glycosylation. However, when the N-glycan 
site on the peptide in the P 2 position was replaced with 
the tcrt-butyl ester of aspartic acid 9g (entry 7), the selec-
ii ity was reversed and the Phe-Ser bond was preferen-
ti41Iy cleaved to give lOg and hg in a ratio of 6:1. 
Thus it appears that even a monosaccharide in the P 2 
position can inhibit proteolysis by chymotrypsin. 
The peptides 9e-g are also potential substrates for the 
protease thermolysin and were therefore further investi-
gated. Based on the previous research' thermolysin 
would be expected to cleave the Asn-Phe bond but not 
the Wang linker. Analysis of the incubation products 
of 9e-g with thermolysin (entries 8-10) appeared to 
show that glycosylation at the P 1 site did not affect pro-
teolysis giving products 12a-c in quantitative yields. 
Conclusion 
In conclusion, we have shown that the natural N-glycans 
in glycopeptides can protect the peptides from proteoly -
sis. However, our results in combination with those of 
others show that protection from hydrolysis is highly 
dependent on the individual protease and on the posi-
tion of the glycosylation site in respect to the scissile 
bond. 
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HydroxymethyIPheflOXY linkers that are commonly used in 
sclid phase peptide synthesis are surprisingly susceptible to 
ef1cient cleavage by the protease chymotrypsin with a broad 
range of amino acid residues being tolerated at the scissile 
b+nd; this enzyme-cleavable linker system has been applied 
tc4 peptide and glycopeptide synthesis. 
e current trend for miniaturisation and automation of syn-
esis and analysis at the interface of chemistry and biology has 
suited in an increasing demand for synthetic tools that can 
used on solid supports, and which are also biocompatibk 
ocatalysts are particularly attractive tools because they can 
) rate under mild, physiological aqueous conditions with 
ry high chemo-, regio- and stereo-selectivity. Thus, several 
oups have described enzyme-cleavable linkers which allow 
r the release of a variety of different compounds from solid 
pports through enzyme-mediated hydrolysis. In general, 
ch linkers have been specifically designed and synthesized to 
corporate enzyme recognition motifs, some of which remain 
tags in the compound library. The need for such motifs 
as limited the application of enzyme-cleavable linkers. In this 
per, we describe the unexpected discovery that the protease 
hymotrypsin can cleave ester linkers that are commonly 
employed in solid phase peptide synthesis, such as the Wang 
Lnker (hydroxymethylphenoxyaCetic acid, HMPA). Cleavage is 
slot limited to peptides containing C-terminal aromatic amino 
acids normally associated with chymotrypsin recognition motifs 
but can be used for a wide range of peptide sequences. The 
application of such enzyme-cleavable linkers to solid phase 
peptide and glycopeptide synthesis is also described. 
In the present studies, the chymotrypsin-catalyzed cleavage 
of peptides such as I (Scheme 1), which were linked through a 
standard Wang linker to PEGA QQ [a copolymer of poly(ethylene 
glycol) and polyacrylamide], was investigated. PEGA was 
chosen as the support because it has been shown to provide 
fully accessible functionalized sites for enzyme catalysis." Rather 
unexpectedly, the predominant hydrolysis product of 1 was the 
dipeptide FmocPheAsp 2 as opposed to the expected FmocPhe 




o 	 0 
Chyinotrypsin 
01M KPi buffer (pH 8) 
rt. 16 h 
F 1fJOH 




Scheme I Enzymatic hydrolysis of solid-supported FmocPbeAsp.  
Chymotrypsin is well known to be specific for phenylalanine 
and tyrosine residues in the P1 site and thus the PheAsp bond 
should present an excellent substrate site for this protease. The 
ester bond of the Wang linker, on the other hand, was flanked by 
a negatively charged amino acid (Asp) in the pseudo P1 position 
(i.e. the position that would be occupied by the P1 residue in 
the corresponding amide) and such a substrate would not be 
expected to be cleaved by chymotrypsin. Also surprising was the 
stability of dipeptide 2 as the major product in the reaction 
mixture: even if 2 was initially formed by ester hydrolysis, 
one would expect it to be hydrolysed rapidly in solution by 
chymotrypsin. This was further investigated by incubation of 
a pure sample of 2 with chymotrypsin in solution; however, 
no hydrolysis product 3 was observed, possibly due to the 
insolubility of 2 in aqueous buffer. 
The interesting lability of the commonly used Wang linker to 
chymotrypsin-catalyzed hydrolysis had not been reported before 
and was further investigated. First of all, the C-terminal amino 
acid residue attached to the Wang linker was replaced by amino 
acids with diverse functionalities to investigate the tolerance of 
chymotrypsin at the 'pseudo P1' site of the ester. A series of 
resin-bound Fmoc-i-amino acids incorporating the acid-labile 
Wang linker was synthesized and subjected to treatment with 
chymotrypsin (2 mg ml in 0.1 M potassium phosphate buffer 
pH 8) for 16 h (Table 1). Release of the Fmoc-protected amino 
acid was monitored by high performance liquid chromatography 
after the specified reaction time. The results show that complete 
hydrolysis was achieved for Fmoc-i-amino acids containing 
hydrophobic (entries 1, 2 and 3), polar (entry 4) and charged 
(entries 5 and 6) side-chains. FmocGly 5g appeared to be the 
only substrate obtained in poor conversion (entry 7)•6 Hydrolysis 
was also possible, but much more sluggish, with substrates 
containing larger hydrophobic protecting groups (e.g. entry 8). 
The Wang linker is popular in Fmoc peptide synthesis 
because of its acid lability. However, acid lability did not 
seem to be important for chymotrypsin hydrolysis, since the 
base-labile HM BA (hydroxymethylbenzoiC acid) linker was also 
readily cleaved by the enzyme (Table I, entries 9-11). Thus, 
chymotrypsin can be employed to cleave both acid- and base-
labile ester linkers and might be useful for orthogonal linker 
strategies. 
Work reported by Bordusa and colleagues' has shown that 
chymotrypsin can accept activated esters of aromatic alcohols, 
in which the leaving group (which would be the Wang linker in 
structure 4) binds to the aromatic pocket (Si site). To investigate 
if the present linker presents such a substrate mimetic, the non-
aromatic hydroxyoctanoic acid (HOA) was investigated as a 
third ester linker system. Again, enzymatic hydrolysis appeared 
to be unaffected by the change in linker structure (entries 12-14), 
and suggests that the selective ester cleavage by chymotrypsin in 
4 might be a result of the much more labile ester bond rather 
than due to any additional recognition of the aromatic group of 
the HMPA or HMBA linker.'  
A great advantage of biocatalysis over chemical synthesis 
is that reactions can often be highly stereoselective. Thus, 
chymotrypsin is known to be highly specific for L-amino acids. 
Such stereospecificity was also observed for the present linker 
cleavage: whereas the L-amino acid in 4a was efficiently cleaved 
This journal Is © The Royal Society of Chemistry 2005 	1 Org. Oiomol. Chem., 2005, 3, 2505-2507 
Table I Enzymatic cleavage of PEGA-supported Fmoc-amino acids 
It 	 It 




bufte(pH8) 	 0 0 
43-0 	 5a-h 
'cç 
0 	 0 HOA 
Entry 	Substrate 	R 	 Linker 	Product 	
Conversion (%)b 
41 CHPh HMPA 5* 100 
2 	4b CH HMPA Sb 
100 
3 4c CH2CII(CH,) : HMPA Sc 
100 
4 	4d CH 1OH IIMPA Sd 
60 
5 4e CH 2 CO2 H HMPA Se 
100 
6 	41 (CH 2 )4NH 2 HMPA 51 
100 
7 4g H HMPA 59 
24 
8 	4b CH 2CO2(2-1 PrPh) HMPA Sb 
25 
9 41 CH 2 Ph HMBA 5* 
100 
10 	4j CH HMBA Sb 
100 
Ii 4k CH 2COH HMBA Se 100 
12 	 41 CH 2CO2 H HOA Se 
100 
13 4m H HOA Sg 
35 
14 	43 CH 2 Ph HOA 5* 
100 
15 40 -CH2Ph HMPA 50 
0 
• HMPA (hydroxymethyiphenoxyacetiC acid). HMBA (hydroxylmethylbenzoic acid), HOA (hydroxyoctanoic acid). 6 Conversion rates are calculated 
using "PLC analysis after a 16 h reaction time and compared to the standard TFA cleavage for HMPA linkers. 
from the resin, its D-eflafltiOmer 4o did not yield any 5o under the 
same conditions. This result confirms that the observed cleavage 
of the linker is indeed catalyzed by the enzyme. Given that the 
C-terminal amino acid is often prone to racemisation during 
peptide synthesis or cleavage, chymotrypsin-catalyzed cleavage 
tAthesis, 
n attractive option for the simultaneous cleavage and kinetic 
olution/purification of C-terminal epimers. 
n interestmg application for enzyme-cleavable linkers is in 
copeptide synthesis because of the additional complexity 
t the carbohydrate side-chains bring to solid phase peptide 
in particular problems of acid lability. Here, a protocol 
sing enzymes as highly selective and orthogonal catalysts 
rider physiological conditions is very attractive. To test out the 
pplicability of the enzyme-labile linker we chose as a target the 
ighly conserved N-glycan motif (Asn—X—Ser/Thr tripeptide 
on where X = any amino acid except Pro) 9 in particular, 
he tripeptide Asn—Gly—Ser, in which the Asti side-chain was 
-glycosylated. 
In the first step the HMPA linker was attached to PEGA I 
0.15 mmol g- ' (dry), I 00/owt in MeOH] to yield 6. The first amino 
cid. FmocSer(Trt)—OH was coupled to 6 via the symmetrical 
nhydride approach and the trityl side-chain protecting group 
as selected in order to enable its deprotection in the presence 
I the TFA-labile HMPA linker. The glycopeptide 7 was 
hen assembled using standard Fmoc solid phase glycopeptide 
vnthesis using the glycoamino acid, FmocAsn(GlcNAc)—OH, 
prepared by a newly improved method in our laboratory. The 
resin-bound glycopeptide 7 was then subjected to the enzymatic 
leavage conditions resulting in quantitative hydrolysis to give 
the desired glycopeptide 8 in l00% conversion (Scheme 2). Thus, 
enzyme cleavage is as efficient as TFA cleavage and is compatible 
with glycopeptide functionalities. 
In summary, we have shown that the commonly used 
HMPA and HMBA ester linkers, as well as alkyl ester linkers 
can be cleaved quantitatively in PEGA 1  by chymotrypsin-
catalyzed hydrolysis under neutral conditions. Enzyme catalysis 
is therefore a useful complementary method to the cleavage 
of such esters under acidic or basic conditions. The linkers 
are commercially available and can be incorporated using 




PEGA,C 	 6 
1 (b) 5 steps 





F,T,OcHN 	fl 0 0 
OH 
HO ' 
ii, f7 Ac4IN 
FInOcHN NH 	COOH 
0 
Scheme 2 Chemo-enzymatic synthesis of glycopeptide 8. Reagents and 
conditions: (a) HMPA, HOW, DIC, DMF; (b)(l) FmocSer(Trt)-011, 
DIC, DMAP (cat.), DMF. (2) 20% piperidine/DMF. (3) FmocGly-OH, 
TBTU, 11013t, DIPEA, DMF. (4) 20 0/a piperidine/DMF, (5) FmocAsn-
(GlcNAc)-OH, TBTU, HOBt, DIPEA, DMF, (6) TFA-T1S--CHCl 2 
(1 : 5 : 94); (c) a-chymotrypsin, potassium phosphate buffer (0.! M. 
pH 8, 2 mg ml) or TFA-H 20 (95 : 5). HOBt = 1-hydroxy-
benzotriazole; DIC = I ,3-diisopropylcarbodiimlde; TBTU = 0- 
(benzotriazol- I yl)N,N,N',N'-tetramethYlUrOfliUm tetrafluoroborate; 
DIPEA = N,N'-diisopropylethylamine; TIS = triisopropylsilane. 
Furthermore, in combination with PEGA 1va  they do not require 
any additional spacers to ensure sufficient accessibility of 
enzyme. The application to longer peptides has recently been 
demonstrated. " The only limitation to this methodology is that 
it may not be suitable for the hydrolysis of peptides containing 
aromatic amino acids anywhere in the sequence other than the 
6 J Org. BIomol. Chem., 2005, 3, 2505-2507 
ester terminus, due to the competing hydrolysis at the specified 
amide bond. 
Despite its known preference for aromatic/hydrophobic 
residues at the P1 site of amides, chymotrypsin appears to 
cleave esters of a range of hydrophilic and charged amino acids 
efficiently in high yields. Thus, the present enzyme-labile ester 
linkers can be used for the synthesis of a much broader range 
of peptide sequences than previously suggested,' and is not 
restricted to those with C-terminal aromatic amino acids. 
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